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ABSTRACT
Thermodynamic aspects of molecular recognition have been studied using 
yeast phosphoglycerate kinase (PGK) and two antibiotics, ristocetin and vancomycin, 
as model systems.
The binding of 3 natural substrates, ADP, ATP and 3-phosphoglycerate to 
wild-type and two mutant forms of PGK was examined using kinetic techniques and 
isothermal titration microcalorimetry. The latter technique was also used to investigate 
the binding of various ligand molecules to PGK and to study the formation of the 
ternary complex- PGK.3-PG.ADP.
The thermodynamic parameters (Ka, AH°, AG°, AS°) relating to substrate 
binding to PGK are very sensitive to experimental conditions. Some of the factors 
which were found to influence the binding parameters include the buffer system, 
anion concentration, magnesium concentration and pH. For example, the AH0 values 
for the binding of 3-phosphoglycerate to PGK were different for each buffer system 
investigated. This effect is due to protonation changes which occur when 3- 
phosphoglycerate binds to the enzyme.
The proposed binding sites for ADP and 3-phosphoglycerate are on separate 
domains and are some distance apart and therefore it might be expected that the 
binding of one substrate would not affect the binding of the other substrate. However 
the microcalorimetric experiments revealed that 3-phosphoglycerate binds much more 
weakly to the binary PGK. ADP complex than to PGK alone, whereas, the binding of
Ill
ADP is apparently enhanced by 3-phosphoglycerate. These results are consistent with 
ADP binding at two sites and displacing 3-phosphoglycerate at one of the sites.
The binding of bacterial cell-wall analogue peptides to ristocetin A and 
vancomycin was also studied by isothermal titration microcalorimetry. This work was 
in collaboration with Dr. Williams, Cambridge University. Four peptides were used 
in this study: one monopeptide (N-acetyl D-ala), two dipeptides (N-acetyl D-ala-D- 
ala, D-ala-D-ala) and one tripeptide (diacetyl L-lys-D-ala-D-ala). The ligand with the 
highest binding affinity for both antibiotics was the tripeptide. The trend in binding 
affinity continued with N-acetyl D-ala-D-ala followed by N-acetyl D-ala. The 
remaining peptide, D-ala-D-ala, did not bind to either antibiotic.
The thermodynamic parameters associated with the binding of the dipeptide 
and the tripeptide to vancomycin were dependent on antibiotic concentration. This is 
probably due to the tendency of the antibiotic to dimerise at higher concentrations. A 
model is proposed to explain the observed thermodynamic data, where we assume that 
an antibiotic dimer is formed which can bind two peptide molecules at two equivalent 
sites.
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11 INTRODUCTION
1.1 Molecular recognition
Specificity is one of the most important features of biological reactions. 
Enzymes, in particular, achieve remarkable specificity and are able to distinguish 
between ligands that differ by just one functional group or between stereoisomers. 
This almost perfect recognition by enzymes for substrates is echoed by other 
biological macromolecules. For example, the immune system relies on the specific 
recognition of antigens by antibodies; hormones interact only with their target 
receptors; and regulatory proteins that control DNA transcription are able to bind to 
the correct site on the DNA molecule. All these biomolecular recognition processes 
are a result of the ligands having a structure which is complementary to the receptor 
in terms of size, shape and interactions.
Biological complexes are stabilised by multiple intermolecular non-covalent 
interactions, such as hydrogen bonding, van der Waals, electrostatic and hydrophobic 
effects. Non-covalent interactions although weaker than covalent bonds, have the 
advantage of allowing molecules to associate with high affinity and yet dissociate 
quickly (Frieden, 1975). Complex formation is usually a balance between favourable 
intermolecular interactions and unfavourable entropy effects resulting from restricting 
a ligand at a binding site. However, the major problem in predicting binding energies 
is that non-covalent forces are modified in aqueous solution, thus the solvation of both 
receptor and ligand and the changes in solvation which occur on complex formation 
must be considered. This problem cannot as yet be modelled theoretically and so
2experimental techniques are used to study molecular recognition, and both the 
structural and thermodynamic aspects must be addressed.
Many molecular recognition experiments aim to investigate individual 
intermolecular interactions and provide an estimate of the stabilising energy for that 
particular interaction. This may be done, for example, by systematically varying 
functional groups on the ligand or macromolecule and noting effect on binding 
parameters. Ligands can be altered using chemical techniques, macromolecules by 
e.g. site-directed mutagenesis (Appendix A).
Structural techniques are used in molecular recognition studies to obtain a 3- 
dimensional view of the complex. NMR or X-ray crystallography are generally used. 
2D-NMR techniques can provide well-resolved structures for proteins containing up 
to 100 amino acid residues, but for more than 100 amino acid residues peaks begin to 
overlap and the spectrum becomes difficult to interpret (Wright, 1989). X-ray 
crystallography can be used for any size of macromolecule providing that the 
macromolecule can be crystallized in a form suitable for X-ray diffraction studies and 
that heavy atom derivatives can be found. Hydrogen bonding interactions can be 
proposed from the structure of a complex using distance and geometric 
considerations, however, it is not yet possible to predict the stability of a complex 
from the structure, nor is it possible to quantify the relative importance of the many 
interactions involved in forming the complex. Therefore experiments that provide at 
least some of the thermodynamic binding parameters are required. These are usually 
estimated from direct binding studies, spectroscopic experiments or, in the case of 
enzymes, kinetic studies. Most of these experiments determine the equilibrium 
constant and free energy of binding, but few are conducted at different temperatures 
to allow the determination of enthalpy and entropy values.
3An improved understanding of molecular recognition would be useful for 
rational drug design or modification of enzyme catalysis. Most drugs act either by 
inhibiting a target enzyme or by binding to a receptor protein; if the recognition 
phenomenon was better understood then it would be possible to develop structure- 
activity hypotheses and design new pharmaceutical compounds. An example of this 
type of work is the development of new trimethoprim analogues with improved 
selectivity. Trimethoprim, a drug used to treat bacterial infections, functions by 
inhibiting the enzyme dihydrofolate reductase (DHFR) effectively blocking the 
synthesis of some amino acids and purine and pyrimidine bases. Trimethoprim binds 
3000 times more tightly to E.coli DHFR than to vertebrate DHFR (Davis et al., 
1990). Structural information (Matthews et al., 1985, Oefner et al., 1988) in 
conjunction with theoretical studies (Osguthorpe et al., 1988) and free energy studies 
of the binding of trimethoprim to the binary complex of DHFR.NADH (Fleischman 
& Brooks, 1990) led to the development of the novel analogues, which have an 
increased selectivity of 50 000 times for bacterial enzymes.
Enzymes may act as catalysts by binding to the transition state for the 
reaction with higher affinity than the substrate (Pauling, 1946, Wolfenden, 1969, 
Kraut, 1988). A study of enzyme-substrate recognition could provide information on 
specificity requirements and catalysis. Enzyme catalysis could then be modified by 
altering the amino acid residues at the active site of the enzyme. The simplest strategy 
to alter the specificity of an enzyme is to swap functional groups, i.e. replace an 
enzyme side-chain with a residue containing the same functional group that is present 
in the substrate. The specificity of subtilisin was altered in this way. Subtilisin is a 
proteolytic enzyme which normally cleaves peptide bonds adjacent to amino acid 
residues with large side-chains such as phenylalanine. Subtilisin was made to 
recognise alanine and glycine residues instead of phenylalanine, by substituting a
4phenylalanine residue for a glycine present in the active site (Estell et al., 1986).
1.2 Aims of thesis
The aim of this thesis is to explore the basic thermodynamics of the 
interactions involved in molecular recognition using microcalorimetry. Two model 
systems were selected for investigation: the first involving an enzyme, yeast 
phosphoglycerate kinase (PGK) and its interaction with substrates; the second involves 
two antibiotics, vancomycin and ristocetin, binding to small peptides.
PGK is a monomeric enzyme comprising two domains of approximately 
equal size. The function of PGK is to transfer a phosphoryl group from 1,3- 
diphosphoglycerate to adenosine diphosphate (ADP) to give adenosine triphosphate 
(ATP) and 3-phosphoglycerate. The crystal structure of yeast PGK is known (Watson 
et al., 1982) and several mutant forms are available; therefore PGK appeared to be a 
suitable candidate for molecular recognition studies. In particular, since PGK is a 2 
substrate/2 product enzyme, it allows the possibility of examining the binding of 
actual substrates, one at a time, or non-productive ternary complexes, rather than 
simply inhibitors or substrate analogues. PGK is also of interest since a domain 
movement is believed to occur when both substrates bind to the enzyme; this would 
be expected to lead to some interesting thermodynamic properties, observable by 
microcalorimetry.
Vancomycin and ristocetin are antibiotics active against gram positive 
bacteria. Both antibiotics are small heptapeptides with rigid structures and well- 
defined binding cavities. This work is in collaboration with Dr.D.H. Williams, 
Cambridge University and extends previous microcalorimetric investigations by 
Rodriguez-Tebar et al. (1986) of the binding of cell-wall analogue peptides to the
5antibiotics. Being smaller molecular systems, these offer potential advantages over the 
much larger protein system, which can be hard to interpret.
1.3 Basic thermodynamics
T he thermodynamic quantities which are o f  interest in describing ligand 
binding are the standard Gibbs energy change AG°, the standard enthalpy change AH°, 
the standard entropy change AS0 and the heat capacity change at constant pressure 
ACp°.
F o r  the formation of a simple 1:1 binding com plex  between a 
m acrom olecule , M, and a ligand, L, at equilibrium,
M + L ML,
the equilibrium  constant, K (which is equivalent to the association constant, Ka, and 
the reciprocal o f  the dissociation constant, Kd) is given by:
aM aL
w here  a ML, a M and a L are the activities o f  the corresponding species. Lack of 
know ledge o f  the activity co-efficients means that concentrations, [M ], [L] and [ML], 
ra ther  than activities are customarily used, therefore
[ML] (1.2)
Ka = -----------
[M] [L]
This is a reasonable approximation since activity coefficients in dilu te  solutions are 
usually close to unity.
6The standard free energy change of binding is related to the equilibrium 
constant by the following equation:
AG° = -RT InK, (1.3)
where R is the gas constant (equal to 8.314 Imol^K"1) and T is temperature. For 
significant binding to occur, AG° must be negative. The free energy change has both 
enthalpic and entropic components as shown in equation 1.4.
AG° =  AH° - TAS°. (1.4)
AG° represents a balance between the tendency of a system to minimise its energy and 
to maximise its entropy.
The enthalpy change for a process is equal to the heat evolved or absorbed by 
the system during that process under constant pressure, and is defined by
AH° = AU° +  PAV, (1.5)
where P is pressure, V is volume and U is the internal energy of the system which 
includes contributions from the potential and rotational, vibrational and translational 
energies of all the molecules in the system. The PAV term takes account of any work 
done on or by the system by volume changes. Exothermic processes which liberate 
heat are denoted by negative AH0 values and endothermic processes have positive 
values. AH° can be measured directly by calorimetry or by measuring the association 
constant at several temperatures and then applying the van't Hoff relationship: 
dlnKa AH0 (1.6)
d(l/T) R .
However, errors in measuring Ka values consequently lead to high errors in AH° 
values.
7The entropy change can be expressed at the molecular level as 
AS° = -R I n C w ^ /w ^ j ) , (1.7)
where wfree/wboun(1 is the ratio of the number of ways that the system may exist in 
either the free or bound states. The entropy change can be calculated from the 
enthalpy change and the equilibrium constant using equations 1.3 and 1.4.
Both AH° and AS° are dependent on temperature because of heat capacity
effects
The change in heat capacity (ACp°) provides information concerning, for 
example, hydrophobic interactions between the macromolecule and ligand. A negative 
value of ACp° usually indicates that there is an increase in hydrophobic interactions
determined by measuring AH° values at two or more temperatures using the following 
equation.
T2.
AH°(T2) - AH°(T1) = ACp° dT
(1.8)
T1
TZ
AS°(T2) '  AS°(T1) = (ACp°/T) dT
T1
(1.9)
whereas a positive value indicates a decrease in hydrophobic interactions. ACp° is
ACp° = d(AH°)/dT. ( 1. 10)
1.4 Non-covalent forces (general)
Microcalorimetry can provide direct information on the energetics of ligand 
binding. However, it is important to evaluate the relative strength and importance of 
the various non-covalent forces which contribute to the overall binding energy.
8Hydrogen bonding, hydrophobic, electrostatic and van der Waals interactions will be 
discussed in this and the following section with a view to outlining the types of 
thermodynamic effects each interaction might exert on ligand binding.
1.4.1 Hydrogen bonding
A hydrogen bond is formed when two electronegative atoms are linked by a 
hydrogen atom which is covalently bound to one of them. The hydrogen bond is the 
strongest of the non-covalent interactions with a typical free energy in the gas-phase 
of 25-79 kJmol'1 (Weiner, 1984, Meot-Nir & Sieck, 1986). Hydrogen bonds are 
partially directional since the interaction is strongest when the three interacting atoms 
are co-linear, hydrogen bonds can therefore be important in determining geometric 
constraints between enzyme and substrate and hence specificity.
The contribution to overall binding energy of a macromolecule-ligand 
hydrogen bond depends on its surroundings; the effective strength is altered in the 
presence of water due to competition with water hydrogen bonds. In aqueous solution, 
a macromolecule and ligand will participate in hydrogen bonding to surrounding 
water molecules and, therefore, there may be no net gain in the number of hydrogen 
bonds formed when the two molecules associate. This is demonstrated by the usually 
low enthalpy and free energy values associated with hydrogen bond formation 
between groups in water (Klotz & Franzen, 1962). There may be, however, an 
increase in entropy of the system due to the release of hydrogen-bonded water 
molecules to the bulk phase, which may go some way to stabilizing the interaction. In 
general, however, hydrogen bonds may be more important in controlling specificity 
rather than stabilizing the complexes themselves.
91.4.2 Hydrophobic effects
Hydrophobic effects are a consequence of the strong interactions of water 
molecules with each other. When a hydrophobic molecule (such as a hydrocarbon) is 
transferred to an aqueous environment it is unable to participate in hydrogen bonding 
and therefore neighbouring water molecules compensate by forming the maximum 
number of hydrogen bonds with each other, thus there is an increase in local order 
around the solute. This leads to a slightly favourable change in enthalpy but a large 
unfavourable change in entropy. There is therefore a driving force to bring 
hydrophobic molecules together in aqueous solution since this decreases the 
hydrophobic surface area accessible to water and hence some of the ordered water 
molecules are released resulting in a large increase in entropy (Kauzmann, 1959). 
These effects also give rise to significant heat capacity changes.
1.4.3 Electrostatic forces
The energy relationship between two point charges is given by Coulomb's
law:
AE = q ^ 2k (1-11)
er,
where qn = unit charge, k is a constant and e is the dielectric constant. 
For oppositely charged species there is an attractive force which is related to the 
distance, r, between the charges; this is a non-directional attraction. Polar solvents 
have a shielding effect on the ions and therefore reduce the attraction; the degree to 
which this happens depends on the dielectric constant of the solvent. Water, which is 
a highly polar solvent, has a large dielectric constant of 80 and consequently 
electrostatic interactions are weakened in aqueous solution. Electrostatic interactions
10
between a macromolecule and ligand are also weakened by high salt concentrations. 
The contribution of electrostatic bonds to complex formation is mainly an entropy 
effect due to the release of electrostricted water molecules.
In addition to charge-charge interactions, there are also electrostatic 
attractions between molecules with permanent dipoles or induced dipoles. The van der 
Waals or dispersion interaction is a special type of electrostatic interaction which can 
occur between any pair of atoms, even between apolar atoms.
1.4.4 van der Waals forces
Van der Waals interactions arise when a transient dipole in one molecule 
induces dipoles in surrounding molecules. These interactions are effective only over 
short distances since the attractive energy varies as the inverse sixth power of 
distance. Van der Waals interactions are, therefore, most effective when there is close 
packing between molecules. Although these interactions are weak individually, they 
are additive and when summed over the entire binding site can contribute significantly 
to binding.
The possible thermodynamic contributions of the various non-covalent forces 
to ligand binding in water can be summarised in table 1.1 (Eftink & Biltonen, 1980).
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Table 1.1 Thermodynamics o f various intermolecular, non-covalent interactions
Type of interaction AH AS ACP
Hydrophobic * 0 > 0 < 0
Electrostatic * 0 > 0 >  0
Hydrogen bond < 0 < 0 < 0
van der Waals 7 7 7
There are difficulties in estimating the contribution of van der Waals 
interactions to overall binding energies since it is impossible to measure these 
quantities in isolation experimentally, however, the values estimated for the other 
types of non-covalent interactions probably include contributions from van der Waals 
interactions.
1.5 Non-covalent forces in biological complexes
The role of non-covalent forces in stabilising biological complexes has been 
the subject of many research investigations. However, few of these studies have 
determined all the thermodynamic variables related to binding. In particular, some of 
the examples discussed in this section used kinetic techniques, such as measurements 
of Kj or kcat/KM, to obtain free energy values: these values can only approximate to 
the thermodynamic free energies.
1.5.1 Hydrogen Bonding
Hydrogen bonds between neutral partners stabilize binding free energies of 
enzyme-substrate complexes by approximately 2.1-7.5 kJmol"1, whereas hydrogen
12
bonds between charged partners have a contribution of 12.5-25.1 kJmol-1 (Fersht,
1987). These values have been measured in several laboratories using different model 
systems. One such model system was based on protein engineering studies of the 
tyrosyl-tRNA synthetase complex (Fersht et al., 1985). Enzyme side-chains believed 
to be participating in hydrogen bonding to substrate were identified from the crystal 
structure of the complex; these were then subjected to site-directed mutagenesis 
experiments. Each side-chain was modified and the contribution of the side-chain to 
the free energy of binding was evaluated. Kinetic experiments were used to determine 
values for kcat and KM for wild-type and mutant enzymes and AAG was calculated 
using equation 1.19 . The values calculated were 2.1-6.3 kJmol'1 for hydrogen 
bonding interactions between uncharged groups and 14.6-18.8 kJmol"1 for interactions 
between charged groups.
Similar results were obtained using a model system involving the enzyme, 
glycogen phosphorylase, which catalyses the reversible phosphorolysis of glycogen to 
give glucose-1-phosphate (Street et al., 1986). In this instance the carbohydrate 
substrate was modified to remove or alter hydrogen bonds by constructing deoxy and 
fluorodeoxy analogues of the natural substrate. The inhibition constants for each 
analogue (Kj) were measured and the free energy differences between analogues, 
AAG0, were calculated from the expression
AAG° = RT In (KI2/Kn ). (1.12)
Values of approximately 4.2 kJmol"1 for uncharged H-bonds and 
approximately 12.5 kJmol'1 for charged H-bonds were found.
However, there are examples in which hydrogen bonding contributions have 
been found to have a greater stabilising effect than proposed above. A hydrogen bond 
in a thermolysin-inhibitor complex was found to have an energy of 16.7 kJmol'1,
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although the hydrogen bonding partners are uncharged (Bartlett & Marlowe, 1987). 
Likewise, a higher energy (nearly 42 kJmol"1) was found for a single hydroxyl group 
of a transition state analogue of adenosine deaminase (Kati & Wolfenden, 1989). 
These examples demonstrate that the values for hydrogen bonding can vary over a 
wide range.
1.5.2 Hydrophobic effects
The energetics of hydrophobic effects have been estimated from the 
partitioning of solutes, such as hydrocarbons or amino acid side-chains, between 
aqueous and non-polar solvents (Leo et al., 1971, Radzicka & Wolfenden, 1988). 
These type of experiments revealed that the hydrophobic free energy is proportional to 
the surface area of the solute. This means that if the hydrophobic surface area 
removed from solvent on ligand binding can be measured (using for example 
molecular surfacing algorithms) then this can be correlated to the hydrophobic free 
energy using a factor of 192-197 J/mol.A2 (Sharp et al., 1991). This value gives good 
agreement with experimental results based on mutant protein stability measurements, 
where the effect of removing hydrophobic amino acid residues on protein stability was 
measured by comparing the denaturation of wild-type and mutant proteins (Kellis et 
al., 1989, Shortle et al., 1990).
1.5.3 Electrostatic effects
Proteins may contain amino acid residues with functional groups that are 
charged under physiological conditions; these include the negatively charged aspartic 
or glutamic acid and the positively charged histidine, arginine or lysine amino acid 
residues. These residues may participate in electrostatic interactions to the substrate 
molecule. It is difficult to estimate the contribution of electrostatic forces to binding
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energies since the dielectric constant at the enzyme active site is unknown. The 
internal protein dielectric constant has been estimated to be between 2-6 (Gilson & 
Honig, 1987, Gilson et al., 1985) but this value probably increases at the protein- 
water interface. For example, a dielectric constant of 40-50 for the active site of 
subtilisin has been measured by examining the effect of mutational changes of the 
charge of surface residues on the pKa of an active site histidine (Russell et al., 1987). 
Protein engineering techniques have been used to make experimental measurements of 
electrostatic contributions to enzyme-substrate binding. Experiments with subtilisin as 
the model enzyme measured values of 7.5 and 9.6 kJmoT1 for ion pair interactions at 
two positions in the active site (Wells et al., 1987) and similarity, the electrostatic 
component for the interaction of glutamic acid with a mutant aspartate 
aminotransferase (R292D) has been estimated to be 6.8 kJmoT1 (Cronin & Kirsch,
1988).
1.6 Methods for studying binding
Although the majority of the binding studies to be described in this thesis 
involved microcalorimetry, there are numerous other methods which can be used to 
examine ligand binding. Some of these methods are discussed in this section.
1.6.1 Equilibrium dialysis
Equilibrium dialysis requires a membrane which is permeable to all 
components of the experiment except for the protein. In a typical experiment, an 
enzyme solution is placed in a compartment on one side of the membrane, whilst the 
ligand solution is on the other side. After equilibration the concentration of ligand is 
measured in both compartments. The concentration, [L]j, measured in the 
compartment containing only ligand is equal to the free ligand concentration ([L]).
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The concentration, [L]2, of ligand in the compartment containing enzyme equals the 
free ligand concentration plus the concentration of bound ligand ([ML]). Therefore 
since
[L] = [L]j and [ML] =  [L]2 - [L]p 
the concentration [M] of the unbound macromolecule is
^ i n i t i a l  -  IM L 1 o r  [M ]initial " ^ 2  +  M l "
The association constant for a simple 1:1 complex formation, can be calculated from 
equation 1.13.
[L]x - [L]2
Ka = ----------------------------------------------------------  (1.13)
M l  <[M]initial - [L ]2 +  [L ] ,)
More complicated methods of analysis (e.g. Scatchard plots etc.) are required for 
multi-site binding processes. A Scatchard plot is a graph of r/[L] versus r, where r is 
the degree of binding i.e. moles of ligand bound per mole of protein. The gradient of 
the line gives the negative association constant and the intercept on the x-axis is the 
maximum number of ligand molecules bound.
1.6.2 Equilibrium gel-filtration
Equilibrium gel-filtration experiments can also be used to determine 
association constants. First a column containing a gel-filtration medium which 
excludes enzyme from the beads is equilibrated with ligand. The enzyme is applied to 
the column and as it passes through, it binds to ligand causing the ligand to elute at 
the same rate. The concentration of ligand is continuously monitored in the eluent and 
as the protein elutes a peak in ligand concentration is observed. This is later followed
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by a trough where the ligand would have eluted in the absence of protein. The 
association constant can be calculated in a similar fashion to the equilibrium dialysis 
technique.
1.6.3 Spectroscopic techniques
Changes in spectral properties of the enzyme caused by the interaction with 
substrate can also be used to estimate association constants. If some property (e.g. UV 
absorbance) of the enzyme or ligand is proportional to the amount of complex formed 
then the fractional degree of association (0 is given by
f =  AA/AAmax =  K J L ] /  (1 +  K[L]) (1.14)
where AA is the change in absorbance and AAmax is the total change in 
absorbance between the enzyme in the fully liganded state and the unliganded state. 
Ka is determined by analysis of AA as a function of ligand concentration, [L].
1.6.4 Kinetic experiments
The velocity of an enzyme catalysed reaction at a constant substrate 
concentration is normally directly proportional to the enzyme concentration. However 
a non-linear, hyperbolic relationship is usually observed when the enzyme 
concentration is held constant and the substrate concentration is varied. The velocity is 
proportional to substrate concentration only at low levels and at saturating 
concentrations of substrate the velocity approaches a maximum value, Vmax . Most 
rates are measured in the steady state period of the enzyme reaction, which occurs 
soon after the reaction has started.
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Michaelis and Men ten proposed the following mechanism:
„  ^1 kcat
E + S ^  ES --------► E + P
k -l
The enzyme and substrate first associate to form a non-covalent complex 
(ES) which can then dissociate to give free substrate (S) and enzyme (E) or react to 
give products (P). Since initial velocities are measured, the formation of the enzyme- 
substrate complex from E and P can be neglected because only a small amount of 
product is available in the early stages of the reaction. The velocity of the enzyme 
catalysed reaction is expressed by the Michaelis-Menten equation.
[S] kcat[E]T (1.15)
V = --------------
%  +  IS]
where V is the initial velocity, [S] is the substrate concentration, [E]T is the total 
enzyme concentration and KM is equal to (kcat +  k_1)/k1. KM, the Michaelis constant, 
is equal to the concentration of substrate at which the velocity is equal to half its 
maximum rate. The Michaelis constant is comparable to the dissociation constant. 
However, unlike the dissociation constant, KM specifies the relative concentrations of 
E, S and ES under steady-state conditions and not at equilibrium. KM approximates to 
Kd only if k ^  is much less than k_j so that KM = k_1/k1. kcat is also known as the 
turnover number and is equal to the number of substrate molecules converted to 
products per second.
Michaelis constants are determined experimentally by measuring initial 
velocites at fixed enzyme concentration and varying substrate concentrations. The data
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can then be analyzed to yield values of KM and Vmax. kcat is determined from Vmax 
and the enzyme concentration since
V «  =  kca,[E]T- (1 1 6 )
The ratio kcat/KM can be thought of as the second order rate constant for the 
reaction between substrate and free enzyme since
V =  (1-17)
kca/KM ls related to the total binding energy of an enzyme-substrate complex (AG^ 
by equation 1.18.
(1.18) ,
RT In (kcat/KM) =  RT In (kT/h) - AG* -AGb,
where AG* is the activation free energy, k is Boltzmann's constant and h is Planck's 
constant.
If an enzyme is mutated so that a group involved in binding a substrate is
removed then, assuming that AG* is unaltered, the contribution of that group to
binding in the wild-type enzyme relative to its absence in the mutant (AGrel) is given 
by equation 1.19.
AGrel =  R T  ln ^ k cat/K M)mutant/(k cat/KM )w ild-typJ'
(1.19)
This equation is often used to assess the effect of mutations after site-directed 
mutagenesis experiments.
1.6.5 Molecular mechanics, molecular dynamics and free energy perturbation 
methods
Although the free energy of binding cannot yet be calculated using
19
computational approaches, the difference in binding free energy resulting from 
mutation of an enzyme or modification of a substrate can be calculated using the free 
energy perturbation method (McCammon & Harvey, 1987). This is achieved by 
computationally mutating the enzyme or substrate in a large number of small steps. At
each step the molecule is allowed to adjust structurally and energetically using
molecular dynamics. The free energy change and the change in enthalpy due to the 
mutation can be calculated. An example of this approach would be to study the 
binding of two ligands, Lj and 1^, to a protein. The relative binding affinity is the 
free energy difference AAG, which equals AG2 -AGj for the following processes 
AGj: I^  + M — ► M L!
AG2: L2 + M — ► ML2
However it is easier to calculate AG values for the hypothetical reactions 
AG-ji L | + M — ► L2 + M
AG4: MLj — ► ML2
Since these reactions form a thermodynamic cycle,
AAG =  AG2 - AG! = ^^4  " AC»3> 
the relative free energy can be found using the perturbation method.
A thermodynamic perturbation technique was used to measure the relative 
free energy of binding for the enzyme thermolysin complexed with a pair of 
phosphonamidate and phosphonate ester inhibitors. AAG was calculated to be 17.6 ±
2.2 kJmol'1 (Bash et al., 1987). This value was in close agreement with an 
experimental measurement of 17.1 kJmol'1, determined kinetically (Bartlett & 
Marlowe, 1987).
1.7 Phosphoglycerate kinase
Phosphoglycerate kinase (PGK), which was chosen as a model system in this
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thesis, is a key enzym e in the glycolytic pathway in which ATP is produced  from the 
breakdown o f  glucose to pyruvate. ATP functions as the "energy currency"  o f  the cell 
since its free energy o f  hydrolysis is used to drive endergonic reactions. T he  pathway 
is a ten step process, with each step catalysed by a different enzym e. PGK is the 
enzyme that catalyses the first ATP generating step by transfering a phosphoryl group 
from 1,3-diphosphoglycerate  (1,3-DPG) to ADP to give 3-phosphoglycerate  (3-PG) 
and ATP as depicted in figure 1.1. The true nucleotide substrates are  the metal 
complexes (usually M g 24  ) o f  ADP and ATP
0  O
ll ll
C - O —  P O  2 0 , C - O1 3 Mg2+ i
+ ADP +ATI>
H- ? - H pgk  H~ r H
o  — PO 2 o — PO 2
3 3
,3-diphosphoglycerate 3-phosphoglycerate
F igure  1.1 T h e  reaction  catalysed by PG K in the g lycolytic p a th w a y
O ne o f  the most remarkable features of PGK is that in the 22 know n PGK 
sequences from different sources, including mammalian, plant and bacterial species, 
there is a very high degree o f  conserved residues (Mori et a l., 1986, W atson Sc 
Littlechild, 1990). If all the sequences are aligned in such a way that the tertiary 
structure is taken into consideration, then there are a total o f  62 com pletely  conserved 
amino acid residues and approximately 30% of the rem aining residues are 
conservative alterations (similar in size and charge). Most of  the totally conserved 
residues line the surface of the cleft between the two dom ains, reflecting the
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importance of this region with respect to catalytic action. An experiment which 
proved the conservative nature of PGK was performed by Mas et al. in 1986. Human 
and yeast hybrid PGK enzymes were constructed by joining a human C-domain to a 
yeast N-domain and vice versa. The resultant chimeras exhibited catalytic properties 
which were relatively unchanged.
In 1979 the X-ray structure and amino acid sequence were reported for 
horse-muscle PGK (Banks et al., 1979). Earlier X-ray structures had been published 
for horse-muscle (Blake & Evans, 1974) and yeast PGK (Bryant et al., 1974) 
however, knowledge of the sequence of amino acids allowed the side-chains to be 
clearly defined for the first time. Horse-muscle PGK contains 416 residues and has a 
molecular weight of 45 519. The main feature of the structure is that it is divided into 
two lobes with a deep cleft between the lobes. The polypeptide chain forms most of 
the N-domain before crossing to form the C-domain and then returning to complete 
the N-domain. The interdomain region where the polypeptide chain crosses twice, is 
known as the waist region.
The N- and C- domains are of approximately equal size and are each 
composed of a central 0-sheet structure surrounded by helices and loops of irregular 
structure. The 0-sheet cores contain 6 strands, the order of the strands in the N- 
domain is CDBAEF, and in the C-domain CBADEF. This arrangement found in the 
C-domain is common in nucleotide binding enzymes and is known as the Rossman 
fold (Rossman, 1974). The PGK molecule has a total of 15 helices, 12 internal 0- 
strands and 5 external 0-strands, corresponding to 25% of amino acids in 0-structures 
and 42% in helices.
The analysis of the horse-muscle enzyme structure was followed in 1982 by 
the publication of the sequence and structure of yeast PGK (Watson et al., 1982)
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(figure 1.2). A high degree o f  structural homology was observed between yeast PGK 
and horse-m uscle  PGK and a 65% sequence homology was found. M ore recently, the 
binary com plex o f  pig-muscle PGK and 3-phosphoglycerate  was analysed by X-ray 
crysta llography (Harlos et a l ., 1992).
I V
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F ig u re  1.2 Cryst alio graphic structure o f  Yeast P G K  ( W atson  et al., 1982)
These  X-ray crystallographic studies provided som e information regarding 
the position o f  the substrate binding sites. The location o f  the Mg. A D P and Mg. ATP 
binding site in horse-muscle PGK was found by crystal soaking experiments. This site 
is located on the C-domain, on the surface o f  the cleft, facing the N-domain. The 
adenine ring o f  ATP fits into a hydrophobic slot in the enzym e and the ribose portion 
lies above the pyrolidine ring of Pro 338. The a-phosphate  interacts with Lys 219 and 
the /?- and 7 - phosphates interact with the helix dipole o f  helix 13. Mg. AD P binds in 
a s im ilar w ay, although the magnesium ion is differently positioned. In A D P binding,
23
the Mg2+ ion is between the a- and /?- phosphates and Asp 374, whereas, in ATP 
binding, it is believed to interact with either the /J- or 7- phosphate or both.
The 3-phosphoglycerate molecule could not be located in the density map 
following crystal soaking, but the authors proposed that the most probable position 
would be on the N-domain at a region of basic residues. It was concluded that since 
the nucleotide and 3-phosphoglycerate sites were 12-15 A apart, a large 
conformational change was required to bring the substrates into a position where 
phosphoryl transfer could take place. This would involve a "hinge-bending” motion of 
the enzyme.
Crystal soaking experiments were also performed with yeast PGK crystals 
and the binding site of an analogue of ATP, Mn-adenyl-/J-7-imidodiphosphate, was 
identified. The binding site of the nucleotide substrates is similar to that of horse- 
muscle PGK. The 7-phosphate of ATP hydrogen bonds to main chain N atoms of 
residues 372 and possibly 371. The metal ion is located 3 A from the 7-phosphate and 
5 A from both the a- and J3- phosphates and is hydrogen bonded to the acidic group of 
Asp 372. Difference Fourier maps between crystals grown in ammonium sulphate and 
then transferred to ammonium selenate indicated the presence of a selenate ion in the 
position of the 7- phosphate of ATP.
There was no evidence of 3-phosphoglycerate binding to yeast PGK from the 
X-ray studies. However, an unexplained electron density peak was assigned to the 3- 
phosphoglycerate binding site. This site is in the interdomain region of PGK, with the 
substrate in a suitable position for phosphoryl transfer.
The ambiguity of the position of the 3-phosphoglycerate binding site was 
resolved with the publication of the structure of the binary complex of pig-muscle 
PGK and 3-phosphoglycerate. Crystals of the complex were grown using polyethylene
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glycol as the precipitating agent instead of ammonium sulphate and therefore 3- 
phosphoglycerate was able to bind to the enzyme. The horse-muscle and yeast PGK 
crystals had both been crystallised from ammonium sulphate and it is possible that 
sulphate ions from the mother liquor were competing with 3-phosphoglycerate for the 
binding site (Blake & Rice, 1981).
The 3-phosphoglycerate molecule binds to the N-domain as suggested by 
Banks et al. for the horse-muscle enzyme. The binding interactions include hydrogen 
bonding and electrostatic effects between the substrate and some of the basic patch 
residues. The 3-phosphate group interacts with three arginine residues: Arg 170, Arg 
65 and Arg 122 (horse-muscle PGK numbering). The hydroxyl group is hydrogen 
bonded to residues Asp 23 and Asn 25; this determines the stereospecificity at this 
site. The carboxyl group forms a hydrogen bond with an ordered water molecule 
which is situated at the N-terminal end of helix-14. A diagram of the interactions is 
shown in figure 1.3.
The structure of the 3-phosphoglycerate-PGK binary complex was 
superimposed with the structure of the substrate-free horse-muscle PGK structure and 
a difference in the relative positions of the N- and C- domains was found. The 
domains in the binary complex are rotated by 7.7A compared to the substrate-free 
enzyme. This movement brings the substrate binding sites closer together, although 
they are still too far apart for phosphoryl transfer to occur.
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F ig u re  1.3 D iagram  o f  the in teractions betw een p ig -m u sc le  PG K  a n d  3- 
phosphoglycerate (H arlos et al., 1992)
There  are two possible reasons why a conformational change is needed on 
substrate binding: the first is that by bringing the dom ains together, the substrate 
b inding sites and catalytic residues will be brought into close proximity and the
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second is that domain closure will expel water from the active site, thus preventing 
phosphate transfer to water molecules instead of between substrates.
Conformational changes have been observed or predicted for other enzymes, 
particularly other kinases (Anderson et al., 1979). Hexokinase, an enzyme which is 
similar to PGK in size, shape and catalytic function, has been shown to undergo 
domain closure and this has proved essential for catalytic action (McDonald, 1979, 
Bennett, 1978). The movement is considered as a rotation about an axis in the 
interdomain region, which allows the domains to move relative to each other. For 
horse-muscle PGK, a 20° rotation of two helices in the interdomain region has been 
proposed and modelled (Blake et al., 1986) (figure 1.4). This action brings the 
nucleotide binding site and the basic patch within 5A of each other and causes few 
unfavourable interactions between residues within the protein. Direct evidence for 
domain closure has not been obtained from X-ray crystallography, since it has been 
impossible to crystallise the ternary complex. However, evidence using other 
techniques has been found.
Small angle X-ray scattering measurements of solutions of yeast PGK have 
revealed that the presence of substrates decreases the radius of gyration (Pickover et 
al., 1979). Mg.ATP and 3-phosphoglycerate each individually lead to a small 
decrease, while the presence of both substrates causes a more substantial decrease in 
the radius of gyration of 1.09 ± 0.34A indicating a large conformational change 
consistent with domain closure. Diffuse X-ray scattering data with pig muscle PGK 
show a similar decrease of 1.2A (Sinev et al. , 1989).
Analytical centrifugation studies of free and liganded PGK appeared to give 
further evidence of domain closure (Roustan et al. , 1980).
F igure 1.4 S tereo diagram  o f  PG K  in  the  open , (a), and  closed, (b), con form ations  
(B lake et al., 1986)
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The sedimentation co-efficients for the ternary complex, PGK.ATP.3-PG, 
and the enzyme-sulphate complex were significantly higher than for free PGK or PGK 
with one substrate. These results could be explained by the molecule changing shape 
in the presence of both substrates or sulphate. However, these effects were later 
assigned to aggregation of the enzyme and sedimentation velocity measurements 
conducted in another laboratory, under similar conditions, showed that the 
sedimentation co-efficients were approximately the same for free and liganded PGK 
(Mas & Resplandor, 1988).
High resolution NMR studies reveal that the interdomain region is more 
mobile than the remainder of the molecule and that the enzyme fluctuates between 
several open and closed forms in solution (Tanswell et al. , 1976, Fairbrother et al. , 
1989); this was also suggested from Rayleigh scattering experiments (Cooper et al., 
1989).
It is almost certain that domain closure does occur upon substrate binding to 
PGK and it has been proposed that substrate binding destabilises the interdomain 
interactions, allowing the enzyme to adopt the closed form (Adams & Pain, 1986). 
However the mechanism of this transition is unclear and the question of whether both 
substrates, 3-phosphoglycerate alone or anions initiate the conformational change has 
still to be answered.
Another question which has still to be resolved is whether the substrates bind 
at one or two sites on PGK. The evidence from the crystallographic experiments 
indicates that the nucleotide substrates bind on the C-domain and the triose substrate 
binds on the N-domain. However, equilibrium gel-filtration experiments have 
provided evidence for the presence of more than one binding site for the nucleotide 
substrates and kinetic studies have indicated that there are two sites for both substrates
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(Scopes, 1978b, Larsson-Raznikiewicz, 1979, Schierbeck & Larsson-Raznikiewicz, 
1979). and 31P NMR experiments have been used to study the binding of 
nucleotide substrates to PGK (Nageswara Rao et al. , 1978, Ray et al., 1990, 
Fairbrother et al. , 1990b, Graham & Williams, 1991b) and these have confirmed that 
there are two binding sites for the nucleotides. One of these is equivalent to the site 
determined by crystallography and the other site is on the N-domain. The C-domain 
binding site is a predominantly hydrophobic binding interaction between the enzyme 
and the adenosine portion of the nucleotide, whereas, binding on the N-domain is 
mainly an electrostatic interaction between the phosphate groups and the "basic patch" 
residues. Magnesium ions alter the affinity of the nucleotides for the two sites. In the 
absence of Mg2+ , the primary interaction is at the electrostatic site, but addition of 
Mg2+ reduces the affinity of the electrostatic site and increases the relative affinity 
for the proposed catalytic site on the C-domain.
Steady-state kinetic experiments have demonstrated that the mechanism of 
PGK is of the rapid equilibrium random order type and that the enzyme exhibits 
complex kinetic behaviour (Larsson-Raznikiewicz, 1964, 1967, 1970, Larsson- 
Raznikiewicz & Arvidsson, 1971). Kinetic experiments produce biphasic Eadie- 
Hofstee plots (Scopes, 1978a). These effects could be partially explained by the 
enzyme having more than one nucleotide site as discussed above, but there are other 
complicating factors. The concentration of Mg2+ ions is relevant since this alters 
affinity of ATP for the two sites and also because the magnesium complex with 3- 
phosphoglycerate is inactive as a substrate. Another relevant factor is the presence of 
anions in the assay buffer. Various anions have been shown to activate the enzyme 
activity at low anion concentrations and inhibit at higher concentrations. The effect is 
dependent on the anion: multivalent anions have a greater activating effect, and on 
the substrate concentrations. This effect is used to transform the biphasic Eadie-
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Hofstee plots to linear plots; commonly used assay buffers contain 20 m M  or more 
sulphate. This  means that the Michaelis constants determined for PG K  are very 
dependent on the composition of the assay buffer. T he  anions may act by binding to 
PG K  in the active site. The X-ray studies located a selenate ion in the position o f  the 
7 -phosphate o f  ATP (Watson et a l., 1982). Scopes (1978b) proposed that binding of 
anions at this position could accelerate the rate o f  reaction by aiding in the 
dissociation o f  1,3-diphosphoglycerate, which is the rate-limiting step o f  the reaction. 
Inhibition at higher anion concentrations occurred because the anions com pete  with 
both substrates. N M R  experiments studying the interaction o f  various anions with 
P G K  found that the anions bound preferentially not at the position determined in the 
crystallographic structure, but at the basic patch on the N-domain (Fairbro ther et a l., 
1990a) (figure 1.5). A secondary, very weak, binding site was observed. This site 
involves interaction with surface lysine residues which could possibly be Lys 213 and
Lys 217 at the active site.
i y a t15
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F ig u re l.5  L oca tion  o f  the anion b ind ing  site (adapted  fro m  F a irbro ther  et at., 
1990a)
M any mutant forms o f  yeast PGK have been constructed within the last few 
years, but the two that were used in this work involved the amino acid residues at 
positions 388 and 168. Histidine-388 is located in the interdomain region o f  the 
enzym e where it forms a salt link with g lu tam ate-190. This interaction was originally 
believed to be vital to the hinge-bending mechanism o f  PGK. It was proposed that the 
interaction stabilised the open conformation o f  the enzyme and that substrate binding 
disrupted the salt link and allowed the enzyme to adopt the closed conformation 
(Banks et a l.,  1979). To test this theory, several mutations were made at position 388 
(figure 1 .6 ).
F igure 1.6 P osition  o f  the IIis-388  a n d  G lu-190 in teraction (adap ted  fr o m  
G raham  et al., 1991)
Substitutions o f  His-388 by glutamine (Wilson ct a l., 1987), alanine or lysine 
(Mas et a l., 1988) produced enzymes that remained calalytically active although the
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specific activities were decreased by factors of 5, 7 and 20 respectively. The 
Michaelis constants for ATP were reduced in all cases by a factor of 3, but the effects 
on the Michaelis constants for 3-phosphoglycerate were more varied. Since the 
enzyme was still catalytically active, it was deduced that the His-388/Glu-190 
interaction is not responsible for controlling domain closure. The mutants exhibit 
large reductions in specific activity even though the Michaelis constants indicate that 
substrate binding is not hindered. This implies that the reduced specific activities have 
resulted from perturbations of the enzyme's conformational flexibility. This view is 
supported by depolarized Rayleigh scattering measurements (Cooper et. al., 1989) 
where the binding of 3-phosphoglycerate was observed to "loosen" the protein 
structure of the H388Q mutant, an effect which was not observed for the wild-type 
enzyme. Additionally, DSC (differential scanning calorimetry) studies which monitor 
the heat denaturation of proteins, found that although wild-type PGK undergoes a 
single cooperative transition, H388Q and H388P have two transitions, one 
corresponding to the N-domain and the other to the C-domain (Johnson et al. , 1991, 
Bailey et al., 1990). These experiments |suggest that there are interactive forces 
between the domains in the wild-type enzyme which are disrupted when a mutation is 
made at position 388.
The other mutant enzyme which was used in the microcalorimetric studies 
was R168K. Arginine-168 is a residue located in the basic patch region (figure 1.7). 
This residue was proposed to stabilise the transition state of the enzymic reaction 
following domain movement (Walker et al., 1989). Substitution of arginine by lysine 
shortens the side-chain whilst retaining the charge. The specific activity of R168K is 
more than halved compared to wild-type enzyme (Walker et al., 1989). However, 
since the mutant retains some activity, this positively charged residue cannot be 
essential to catalysis. Kinetic studies reveal that there is an increase in KM for both 
substrates with this mutant, particularly for 3-phosphoglycerate.
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F ig u re  1 .7  C lose-up view o f  the basic pa tch  residues o f  the  N -d o m a in  (Fairbrother  
et al., 1989)
P G K  has previously been investigated by m icrocalorim etry  to study both the 
therm al denaturation of the enzyme (Johnson et a l ., 1991) and the substrate binding 
param eters  (Hu & Sturtevant, 1987). DSC experim ents  have  shown that wild-type
34
PGK undergoes a cooperative transition giving rise to a single ^ symmetric peak, 
whereas the H388Q mutant gives rise to two transitions: one presumably 
corresponding to the unfolding of the C-domain and the other to the N-domain. The 
melting temperature (Tm) of the lower temperature transition was increased in the 
presence of 3-phosphoglycerate and so this transition probably arises from the 
unfolding of the N-domain. The substrate binding studies by microcalorimetry (Hu & 
Sturtevant, 1987) have been much more limited and, as will be shown later, are of 
dubious validity.
1.8 The Vancomycin Group of Antibiotics
Antibiotics of the vancomycin group inhibit bacterial cell growth and are 
important in the treatment of penicillin-resistant staphylococcus infections. These 
antibiotics act by interfering with cell wall synthesis, resulting in eventual destruction 
of the bacterial cell by lysis. Vancomycin, ristocetin, actinoidin and avoparcin are 
some of the members of this group, although the total number of structural variants is 
in the region of one hundred (Williams et al., 1980). Ristocetin, actinoidin and 
avoparcin exist in two forms, A and B, differing in their carbohydrate content.
Gram-positive bacteria have a cell wall made of a cross-linked, multilayered, 
polysaccharide-peptide complex called peptidoglycan. Long polysaccharide chains of 
alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) units are 
cross-linked by short peptides in a multistage biosynthetic process (Ghuysen, 1980) 
(figure 1.8). A peptide unit (L-ala-D-glu-L-lys-D-ala-D-ala) is joined to NAM-uridine 
diphosphate (stage 1) which is subsequently transferred to a carrier lipid (stage 2), 
then NAG and pentaglycine are added (stage 3). The disaccharide is removed from 
the carrier lipid to the growing polysaccharide chain (stage 4). The final step,
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catalysed by a transpeptidase enzyme, is to cross-link the chains (stage 5). A peptide 
bond is form ed between glycine and one o f  the D-ala residues and the terminal D-ala 
residue is released.
NAM-UDP
I
L-ala-D-glu-L-lys-D-ala-D-ala
L-ala D-glu L-lys D-ala-D-ala
NAM-UDP  --------
Stage 1
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L-ala-D-glu-L-lys-D-ala-D-ala
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F ig u re  1.8 S tages in the synthesis o f  the pcptidoglycan
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When the antibiotics inhibit cell growth there is an accumulation o f  U D P-N - 
acetylmuramylpentapeptide precursors (Reynolds, 1961, Wallas & Strominger, 1963, 
Chatterjee & Perkins, 1966). Perkins (1969) proposed that the antibiotic inhibited 
growth by binding specifically to D-ala-D-ala residues at the carboxy terminus o f  the 
cross-linking peptide. This inhibits transpeptidase activity and prevents cross-linking 
o f  the cell wall (figure 1.9).
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F igure  1.9 S ite  o f  action o f  the vancom ycin  type antib iotics
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These early studies using UV difference spectroscopy showed that the 
minimum requirement for binding was a D-ala-D-ala peptide with the C-terminus free 
and the N-terminus acetylated (Perkins, 1969). Further  studies using tripeptides, with 
amino acid substitutions at each position, explored the specificity o f  the binding site 
(Nieto & Perkins, 1971b). Binding is strongest with the tripeptide most closely 
resembling the amino acids incorporated in the cell wall i.e. di-Ac-lys-D-ala-D-ala. 
The residue at the N-terminus and the middle residue are very important in 
determining specificity, peptides containing L-amino acids at either position are 
unable to bind to the antibiotic. The residue at the carboxy terminus gives the highest 
specificity when the residue is diacetyl-L-lys, how ever this position is less sterically 
demanding and D-amino acids can be accepted. Ristocetin is capable o f  binding 
peptides with larger side-chains than vancomycin.
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Figure 1 .10  S tructure o f  vancom ycin  (W altho & W illiam s , 1991)
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Vancomycin is a heptapeptide containing mainly aromatic amino acid 
residues (figure 1.10).This unusual tricyclic structure is formed by three phenol- 
oxidative coupling reactions. It contains glucose and an amino sugar, vancosamine. 
The structure was elucidated by a combination of techniques: chemical analysis, NMR 
and X-ray crystallography of a derivative of vancomycin, CDP-1 (Sheldrick et al., 
1978). It was assumed that the only structural change that had occurred on forming 
CDP-1 was that a primary amide in vancomycin had been hydrolysed to a free 
carboxylate. However, an intramolecular rearrangement (Harris & Harris, 1982b) and 
a 180° flip of an aromatic ring had taken place (Williamson & Williams, 1981). This 
led to a revision of the structure of vancomycin in 1981.
The structural similarities between ristocetin and vancomycin allowed the 
structure of ristocetin to be determined almost entirely by NMR (Kalman & Williams, 
1980, Harris & Harris, 1982a). Ristocetin is a heptapeptide but with a tetracyclic 
structure, formed by four oxidative coupling reactions (figure 1.11). Ristocetin A 
contains the sugars, mannose, ristosamine and a tetrasaccharide. Ristocetin B is 
identical to ristocetin A except that it lacks two of the sugars in the tetrasaccharide 
unit.
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F ig u re  1.11 S tru c tu re  o f  ristocetin  (W illiam s, 1984)
T he  antibiotic-peptide complexes have not been crystallised in a  form suitable 
for X-ray studies. How ever, N M R  studies have provided useful structural information 
(Williams, 1984). Space-filling models of ristocetin and peptides show an obvious 
binding site for a peptide ligand which has been confirmed by NM R studies (Kalman 
& Williams, 1980, Williams et a l., 1983, Williamson & W illiams, 1985). The 
ristocetin binding site contains five amide groups, suitably positioned to form
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hydrogen bonds with di-ac-lys-D-ala-D-ala. T hree  o f  these amide NH groups interact 
with the carboxylate ion, therefore explain ing the requirement o f  a free carboxylate 
ion for binding to take place. The rem ain ing  two amide groups form hydrogen bonds 
to amides in the tripeptide. H ydrophobic  interactions occur between the alanine 
methyl groups and methyl-shaped pockets  on the antibiotic (figure 1.12). A 
conformational change takes place on binding: the benzene ring o f  residue 1 folds 
over the carboxylate ion to form a hydrophobic  pocket that serves to strengthen the 
binding interactions (Waltho & W illiam s, 1989).
OR
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F igure  1.12 S tructure  o f  the ristocetin -d ipep tide  com plex (W illiam s et al., 1991)
Vancomycin also undergoes a conform ational change on binding (Williams & 
Butcher, 1981). This structural change, involving a series of rotations, brings a N- 
methylleucine side-chain into position to form a carboxylate pocket similar to the 
ristocetin pocket. The rest o f  the b inding  site is also similar, the biggest difference
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being the presence o f  a chlorine atom in vancomycin (figure 1.13). The 
conformational change has the effect o f  creating a hydrophobic environm ent around 
the carboxylate ion.
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F igure  1.13 S tru c tu re  o f  the vancom ycin-tripeptide com p lex  (W a ltho  & W illiam s
1989)
It has been proposed that the initial interaction between the antibiotics and 
the peptide is between a protonated amine on the antibiotic and the peptide 
carboxylate (W illiamson et al. 1984). Experiments with N-acetylated derivatives of 
ristocetin (B am a et a l.,  1985, Herrin et a l., 1985) and vancomycin (Kannan et a l., 
1988) have demonstrated that although the protonated amine is not essential for 
binding it does significantly increase the binding affinity. The interaction between the
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rest of the antibiotic and the peptide determines specificity and although the aglycone 
portion of the antibiotic forms the main interactions with cell-wall analogues, the 
sugars act to increase specificity. Vancosamine sterically prevents peptides with side- 
chains larger than methyl at the C-terminus from binding to vancomycin. Similarly, 
the mannose portion of ristocetin prevents the binding of peptides with side-chains 
larger than methyl at the second amino acid from the C-terminus. These features 
prevent the antibiotics binding to intact cell walls and thus increase biological activity 
(Williams & Waltho, 1988).
The formation of a ristocetin dimer in solution was first observed in the 
NMR spectrum. Several resonances of ristocetin A and the ristocetin A-tripeptide 
complex in water (Williams ct al., 1979, Williamson & Williams, 1985, Waltho & 
Williams, 1989) are present as two forms in slow exchange and further NMR studies 
confirmed the presence of an antibiotic dimer in solution. The molecules associate 
through the back faces, leaving the binding sites accessible to the peptide ligand. Four 
intermolecular hydrogen bonds are made between the ristocetin molecules (figure
1.14) (Waltho & Williams, 1989). Three forms of ristocetin were suggested by the 
NMR spectra. Two forms had resonances with similar chemical shifts, whilst the third 
form was considerably different. The ratio of the population of the three forms was 
approximately 5:5:1 using a 15 mM sample. Diluting the sample by a factor of 10 
changed the ratios to 1:1:4. These ratios indicate an association constant of 2 x 103M' 1 
for dimer formation. The two sets of dimer resonances can be explained either by the 
dimer existing in two different forms of equal energy which are in slow exchange or 
there is asymmetry within the dimer with a slow interconversion rate between the two 
halves.
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Figure 1 .1 4  S tru c tu re  o f  Ristocetin D im er (W illiam s & W altho , 1988 )
D im erisation is also believed to occur with vancomycin. Studies o f  the 
specific rotation o f  vancomycin in 0 .02M  citrate buffer at pH 5 showed significant 
aggregation at low concentrations. The aggregation was judged to be total at an 
antibiotic concentration o f  10 mM. Assuming dimerisation had occurred, an 
association constant o f  8  x 102 M ' 1 was calculated (Nieto & Perkins, 1971a).
M icrocalorim etry  previously has been used to investigate the therm odynam ics 
o f  interaction betw een vancomycin, ristocetin and peptidoglycan analogue peptides 
(Rodriguez-Tebar et a l ., 1986). These experiments studied the binding o f  Ac-D-ala
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and three dipeptide ligands, Ac-D-ala-D-ala, Ac-Gly-D-ala and Ac-D-ala-gly, to the 
antibiotics. In all cases, negative values for AG°, AH0, AS° and ACp° were observed. 
There are several reasons for repeating and extending these microcalorimetric studies. 
For example, if the antbiotics dimerise then altering the antibiotic concentration will 
lead to changes in the thermodynamic parameters relating to substrate binding. In the 
paper by Rodriguez et al. it is not clear if the experiments were carried out at one 
antibiotic concentration or at several concentrations and so this point needs to be 
clarified. The choice of ligands is also different in this study and the experiments 
were performed over a wider temperature range to obtain more accurate ACp° values.
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2 MICROCALORIMETRY
2.1 Introduction to calorimetry
Although thermodynamic parameters can be determined by measuring 
association constants and applying the van't Hoff equation, a more direct route to 
thermodynamic information is via calorimetry. Calorimeters are instruments which 
measure heat effects. Hence enthalpy values, in principle, can be directly determined. 
Enthalpy measurements can be conducted at fixed temperatures and since it is not 
necessary to use the van't Hoff equation higher accuracy can be attained. Most 
binding reactions occur with a change in temperature and so calorimetry can be used 
for the study of almost all associations (except when AH° = 0). On the other hand, 
other techniques such as equilibrium dialysis and gel-filtration require specific 
analytical methods to determine the ligand concentrations and therefore a new assay 
has to be devised for each situation. Many spectroscopic techniques require the 
enzyme and substrate solutions to be transparent, however, this is not a requirement 
for calorimetry. Another advantage of calorimetry is that the starting materials can 
usually be recovered.
Highly sensitive microcalorimeters are required for biological applications. 
This is necessary since we are measuring changes in weak non-covalent forces and 
generally wish to use small quantities of biological materials. The types of calorimeter 
suited to this kind of work are called microcalorimeters. Microcalorimeters have 
increased in sensitivity in recent years and can now measure effective temperature
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changes of the order of a millionth of a degree.
In addition to providing information on enthalpy changes, some calorimeters 
have been designed to study temperature induced transitions e.g. protein denaturation. 
These differential scanning calorimeters (DSC) measure the apparent specific heat of a 
system as a function of temperature (Privalov, 1974, Sturtevant, 1974). Ligand 
binding effects have been studied using DSC (Hu & Sturtevant, 1987, Brandts & Lin,
1990), however, isothermal titration calorimetry (ITC) is more commonly employed 
and gives the more direct and (usually) the less ambiguous information.
There are several types of isothermal calorimeters which may be used to 
study ligand binding processes, but the two most suited to biophysical applications are 
those from Thermometric (previously LKB) and the Omega reaction calorimeter from 
MicroCal Inc. The Thermometric models are based on the heat conduction principle.
The LKB heat conduction microcalorimeter was designed by Wadso in 1968 
(Wadso, 1968), using earlier designs with similar principles (Calvet, 1963, Benzinger 
& Kitzinger, 1960). This calorimeter has sample and reference cells contained within 
a heat-sink as shown in figure 2.1. When a reaction occurs in the cells, heat flows 
between the heat sink and the cells. Thermopiles are situated between the cells and the 
heat sink so that all the heat passes through the thermopiles and generates a voltage 
(V) which is proportional to the temperature difference (AT) between the cells and 
heat sink, which in turn, is proportional to the rate of heat flow (dQ/dt).
dQ
dt
kjAT and V = k2AT
(2 .1)
hence dQ
— = kV
dt
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The total heat generated may be obtained by integration o f  equation 
(equal to k j /k 2) is the calibration constant o f  the calorimeter.
Q -  k V.dt
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Figure 2.1 Schem atic  diagram  o f  a hea t-conduction  calorim eter
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The original heat conduction calorimeter designed by Wadso was a batch 
calorimeter. The batch calorimeter contains cells that are divided into two sections. 
The sample cell usually contains, for example, enzyme solution in one compartment 
and ligand in the other, whereas, the reference cell contains buffer. After thermal 
equilibration has been achieved, the calorimeter unit is rotated so that the solutions are 
mixed and the enzyme and ligand can combine. Batch calorimetric experiments are 
easy to perform. However single loadings of the system give only one measurement 
of the heat effect and equilibration times are long. Therefore the time required for a 
single experimental measurement is approximately three hours which is the main 
disadvantage of the batch calorimeter.
Another type of calorimeter which can be used to study ligand binding is the 
flow calorimeter; this is based on the same design principle as the batch calorimeter 
(Monk & Wadso, 1968). The reactant solutions are pumped separately through a heat 
exchanger before mixing, then through the reaction cell and out of the calorimeter. 
The heat exchanger means that equilibration times prior to the experiment can be 
omitted.
The batch calorimeter can be converted to a titration calorimeter by the 
addition of motor-driven syringes, which allow reagents to be added to the reaction 
cells during an experiment (Chen & Wadso, 1982). The titration calorimeter still 
requires an equilibration time of approximately two hours, however, a complete 
titration curve can be obtained from one loading of the calorimeter. Titration 
calorimeters may operate in a stepwise or continuous mode. Enzyme solution is 
equilibrated in the sample cell and then substrate is injected into the cell via a syringe. 
In the continuous mode the signal is a heat flux. Calculation of the heat effect can be 
made if the concentrations of reactant, flow rate of titrant and total volume are 
known. In stepwise mode, heat effects can be measured for each injection. Stepwise
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calorim eters, in addition to determining AH° values, can also give values of  the 
association constant from a single experiment. The cells o f  a batch, titration and flow 
calorim eter are demonstrated in figure 2.2.
E nzym e Substrate
Substrate•. • .  E nzym e
A B
Substrate
zyme....................
I'igure 2 .2  A . Flow cell. A rrow s indicate f lo w  o f  enzym e/suhsirxite so lu tion  th rough  
cell
II. Hatch cell. C ontents o f  cell are m ixed  by rotation o f  the  colorim etric  
un it
C. l i t  ration cell. Substrate is in jected  by a m otor-driven  syringe
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The Omega Reaction Microcalorimeter was recently designed by Microcal 
Inc. specifically for measuring binding constants and heats of binding for biological 
associations (Wiseman et al., 1989, Brandts et al., 1990). It is very sensitive and can 
measure binding constants of up to 10**. The results are analyzed using the 
accompanying software package - Origin. A titration experiment can be achieved in a 
very short time using the Omega calorimeter: equilibration of samples occurs within 
several minutes after loading and the fast-response time of the calorimeter means that 
ligand can be injected at two or three minute intervals.
The calorimeter comprises two coin-shaped cells contained within an 
adiabatic jacket. The cells are made of Hastelloy C and have a volume of 
approximately 1.4 ml. Heaters are positioned on the surface of both cells. Samples 
are introduced into the cells via long, narrow access tubes. The injection syringe has a 
long needle with a stirring blade at the end; this is inserted into the sample cell as 
depicted in figure 2.3. The injection syringe is coupled to a motor which rotates the 
syringe during the experiment to mix the contents of the sample cell. The plunger of 
the syringe is connected to a stepping motor which controls the volume to be injected.
A thermoelectric device is located between the sample and reference cell: this 
measures the temperature difference between the two cells (ATj). The temperature 
difference between the cells and the adiabatic jacket (AT2) is also monitored, using a 
thermopile.
When a reactant is injected into the sample, heat is either released or 
absorbed. This heat effect is monitored by the calorimeter using a feedback system as 
shown in figure 2.4. The reference cell is continuously heated at a slow, constant rate 
which makes ATj non-zero; this activates a feedback system which supplies power to 
the sample cell to return ATj to zero. When an endothermic or exothermic reaction
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occurs in the sample cell, more or less power is required to minimise ATj. The cell 
feedback signal is monitored by the computer and its integral over time is a measure 
of the total heat change resulting from an injection. The jacket feedback operates in a 
similar fashion to maintain the temperature of the jacket to the average cell 
temperature, thus preventing heat loss.
2.2 Calibration
Both the LKB and the Omega calorimeters require a calibration constant to 
convert the observed signal to a heat quantity. The calibration constant is determined 
experimentally using electrical and/or chemical techniques. Electrical calibration is 
accomplished by heating the sample cell at a chosen rate for a selected time period. 
The integral of the heat pulse should agree with the known applied heat; if not, then 
the calibration constant must be altered. Standard chemical reactions can also be used 
to calibrate the calorimeter, for example, the enthalpy of protonation of Tris buffer 
(equal to 47.44 kJmol"1, Grenthe et al., 1970).
2.3 Calculation of thermodynamic parameters from experimental data
For an association reaction, the observed heat effect is equal to the heat of 
binding of enzyme and substrate (Qr) plus the heats of dilution of the components 
(Q d il)  and the heat of mixing ( Q ^ ) .
Q obs =  Q r +  Q dil +  Qraix (2 -3 )
Qdil values for all the components of the experiment have to be measured. 
The following experiments must be performed to obtain the corrected enthalpy of 
binding:
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Contents o f  sample cell Contents o f  syringe
^obs macromolecule ligand
Q i macromolecule buffer
q 2 buffer ligand
q 3 buffer buffer
The heat o f  binding Q r is then equal to
Qr =  Qobs - Qi - Q2 +  Q3 (2-4)
In practice, the heats o f  dilution may be small and can be neglected, 
however, this is not always the case and therefore it is important to perform  all four 
experiments.
If  an enzyme is titrated to saturation with a ligand then the enthalpy change is 
equal to the total reaction heat divided by the protein concentration ([M]):
AH° =  Q / [ M ]  (2.5)
A titration microcalorimeter can be used not only for enthalpy measurements but also 
for the determination o f  association constants, using heat production or uptake as a 
measure o f  the extent o f  the reaction:
Q r =  [ML] AH°/[M]t (2.6)
w here  [M]t is the total concentration o f  macromolecule and [ML] is the concentration 
o f  the complex. This equation can be expressed in terms o f  the association constant 
and the free ligand concentration ([L]), for simple 1:1 binding:
Q = Ka[L]AH° (2.7)
1 +  K J L ]
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Equation 1.16 can be rearranged to give:
1 1 1 (2 . 8)
= +
Q AH° Ka[L]AH°
Therefore a double reciprocal plot o f  1/Q versus 1/[L] will yield values o f  AH0 and 
K a: AH° is obtained from the intercept on the y-axis and Ka is calculated from the 
gradient o f  the line. This method o f  analyzing the experimental data although simple
has two major flaws: first, a double reciprocal plot is biased and places more weight
on the less accurate points and second, this approach requires that the free ligand 
concentration at equilibrium is known: this approximates to the total ligand
concentration only in situations o f  very weak binding. A preferred method is to use 
the hyperbolic relationship for the observed heat as a function o f  total enzyme and 
ligand concentration:
Q  =  - AH°(N[M], +  [L], +  1/Ka){l - ( l-4N [M ],[L ] ,/(N [M ]t +  [L]t +  
l /K a)2) 1/2}/2[M],
w here N  is the num ber o f  binding sites. (2.9)
This equation applies to simple 1:1 binding. For a system with multiple non­
interacting sites, the observed heat effect will be
(2 . 10)
N; AHj [Lj Kt
1 +  Kj[L] 
i= l
w here j is the num ber o f  sets o f  distinct binding sites, Kj, AH; and N| are the 
apparent association constant, enthalpy change and num ber for each set o f  sites.
The calorimetric titration curves can be analysed using a two sets o f  sites 
model, however if there are more than two sets o f  sites then an unique fit to the data
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may not be obtained since there are three variable parameters for each set of sites.
Further complications arise when the binding sites are interactive. The 
binding of one ligand may enhance or decrease the binding affinity of a second 
ligand. The thermodynamic variables can be measured in the absence and presence of 
the other ligand and the changes in AH° values and association constants examined.
2.4 Data analysis
The experimental data obtained from a calorimetric titration can thus be 
analysed to give values of AH°, Ka and the number of binding sites per mole of 
protein. The raw data obtained from an experiment, using the Omega calorimeter, is a 
record of the cell feedback signal as a function of time. The first step in analysing the 
data is to integrate each of the peaks (for both enzyme-substrate titration and dilution 
experiments). The dilution heats are subtracted from the corresponding enzyme- 
substrate heats to give the corrected heat values. The heats for each injection are 
plotted versus the injection number and then a theoretical fit to the experimental 
points is derived, using a least-squares approach, to yield values of N, Ka and AH°. 
The data may be fitted assuming either one set of binding sites or two sets of binding 
sites. All of the data analysis steps can be performed using the Origin software.
It may be found that more than one set of N, Ka and AH° values will give a 
good fit to the experimental data as may occur in situations of weak binding; if this is 
the case then it may be necessary to fix one of the parameters e.g. N =  1.
The mathematical models used in the Origin software to analyse the 
experimental data are given in the following sections.
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2.4.1 M odel fo r  one set of sites
For a 1:1 binding reaction, the binding constant is related to the ligand
concentration, [L], and the fraction o f  sites occupied by ligand, 0, by the equation
0 (2 . 10)
K = ------------------
(1-0)[L]
and
fL]( =  [L] +  N 0[M ]t (2.11)
where [L]( and [M ]t are, respectively, the bulk ligand and bulk macromolecule 
concentrations. Combining equations 2 .10  and 2.11 gives the quadratic equation
(2 . 12)
0 2 -  0
N [ M T N K [ M 1 Jt  t N [M ]t
[ L i t
= 0
The total heat content of  the solution, Q, is equal to
Q =  N 0[M ](AHVo (2.13)
where AH is the enthalpy o f  binding and VQ is the active cell volume. Solving 
equation 2.12 for 0 and substituting into equation 2 .13 gives
N [ M ] t AHVQ
Q = ---- -^-- -
LL] t 1
1 +  5 -  + • ---------------
H [M L  N K [M]
1 +
[L ] 1
N [ M ] . N K  [M]
4 [ L ]  
N [Mj
(2.14)
This equation can be solved for Qj given values o f  N, K and AH at the end o f  the ith
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injection. The calorimeter actually measures the difference in heat, AQ*, between the i 
and i-1 injections, which approximates to
AQi =  Qi - Q(M) (2-15)
Som e corrections are made in the calculations to account for the volume o f  liquid 
which is displaced from the cell on injection.
Initial guesses o f  the fitting parameters n, K, and AH, are made automatically 
and are substituted into equation 2 .14  to find values for AQj for each injection. These 
calculated values o f  AQi are compared with the corresponding experimental values of 
AQj and new values o f  the fitting parameters are found using statistical methods until 
there is an optimum fit between experimental and calculated AQ| values.
2.4.2 Model for two sets of independent sites
This model is used when the ligand is assumed to bind at two non-interacting 
binding sites. Values o f  N, Ka and AH° are derived for each site.
The fractional saturation for each type o f  site (0 1? 02) is used as the progress 
variable during saturation
0 j 02
K , = ----------------------------------  K2 =   (2.16)
(1 - 0 j )  [ L ]  (1 - 02) [ L ]
[L]t =  [L] +  [M ]t(n ,0 , +  n202) (2.17)
w here [L] and [L]t are the free and bulk concentration of  ligand and [M ]t is the bulk 
concentration o f  macromolecule. Combining equations 2 .16  and 2 .17  and rearranging 
yields a cubic equation o f  the form
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(2 . 18)
[L]3 +  p[L]2 +  q[L] +  r =  0
w here
p =  1/Kj +  1/K2 +  (nj +  n2)[M ]t - [L]t 
q =  (n j /K 2 +  n2/K ,) [M ] t - (1/Kj +  l /K 2)[L]t +  1/ (K jK2) 
r =  - [L ],/(K ,K 2)
(2.19)
Equations 2.18 and 2 .19 can be solved for [L] numerically once [L]t, [M ]t, n p  n2, K, 
and K2 are assigned. Substitution of  [L] into equation 2 .16  then gives values for 0j 
and 02.
T he  heat content o f  the solution after the ith injection, Qj, will in general be
Q i =  [M ]tV0 (njOjAHj +  n202AH2). (2.20)
Initial guesses o f  the fitting parameters n 1? n2, K j ,  K2, AHt and AH2, are made and 
are substituted into equations 2.18 and 2.19 to find a value for [L] and then 0j and 02 
using equation 2.16. Values for AQ| are then found using equation 2 .20. The 
parameters are optimised using statistical techniques as described before.
2.5 Associated heat effects
Heat effects are not specific to association reactions, and any other heat 
changes that take place during the experiment will be detected by the calorimeter. 
These additional heat effects may lead to erroneous interpretation o f  the experimental 
data unless appropriate corrections are made to the data. Som e o f  these heat effects 
have already been mentioned i.e. AHdij and AHmix. Less obvious heat effects can be
60
caused by contamination of the protein sample. For example, a calorimetric titration 
of glycogen phosphorylase b with AMP produced biphasic titration curves: this was 
found to be a result of small amounts of AMP amino hydrolase. Removal of this 
contaminating enzyme resulted in monophasic titration curves (Cortijo et al., 1982). 
Measuring the thermodynamic parameters associated with substrate binding to an 
enzyme can be complicated since the heat of reaction will obscure the much smaller 
heat of binding. This problem is usually overcome by examining the binding of an 
inhibitor to the enzyme or by using an enzyme which requires two or more substrates 
to bind before the catalytic reaction occurs; in this case each substrate can be 
investigated individually. Other heat effects may arise from the release or uptake of 
protons by the enzyme or substrate during the binding process, or from changes in the 
state of aggregation of the species involved or even from conformational changes in 
the structure of the macromolecule associated with binding. Calorimetry if interpreted 
with caution can therefore provide information in addition to ligand binding 
thermodynamics.
It is common practice to buffer solutions containing protein in order that the 
pH of the solution remains constant. Consider an association process in which protons 
are released, these protons are picked up by the buffer and will produce a heat effect, 
the size of which depends on the heat of protonation of the buffer. If calorimetric 
experiments of this association are repeated in buffers of different heats of protonation 
then the observed enthalpies of binding will vary. The parameters obtained can be 
used to calculate the number of moles of protons being released to the buffer. The 
observed enthalpy (AH°obs) will equal the enthalpy of the association reaction plus an 
additional heat contribution from the association of the protons and buffer molecules.
AH°obs =  AH°0 + AN AH°b, (2.21)
where AH°0 is the enthalpy change in the absence of buffer effects and AH°b
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is the heat of protonation of the buffer. Plotting AH°obs versus AH°b should give a 
straight line with a slope equal to AN and an ordinate intercept equal to AH°.
2.6 Recent uses of the Omega calorimeter
In the past few years, several uses of the Omega calorimeter have appeared 
in the literature. Some of these have concentrated on macromolecule-ligand 
associations, but other uses have included small molecule associations and kinetic 
studies. A few examples will be mentioned here.
A thermodynamic study of the binding of a- and u- amino acids to the 
isolated kringle 4 (K4) region of human plasminogen was achieved using the Omega 
calorimeter (Sehl & Castellino, 1990). The thermodynamic parameters for binding of 
£-amino caproic acid (EACA) to K4 were found to be approximately constant over a 
range of pH values (5.5-8.2); suggesting that titratable groups on K4 do not affect the 
binding interaction. Further experiments with structural analogues of EACA explored 
the relationship between binding affinity and structure of ligand; the spacing between 
the functional groups of EACA was found to be important.
The Omega calorimeter has also been applied to the study of the binding of 
cations to ATP (Wilson & Chin, 1991). The cations which were investigated by 
calorimetry were Mg2+ , Ca2+ and Sr2+ . In all cases the binding occurred with a 
positive enthalpy change and an increase in entropy. Mg2+ was found to have the 
highest association constant followed by Ca2+ and then Sr2+ . Monovalent cations 
such as Na+ , L i+ and K+ were found to compete with Mg2+ for complexation with 
ATP.
A detailed investigation into the binding of ferric ions to ovotransferrin also 
employed the Omega calorimeter (Lin et al., 1991). Ovotransferrin is a two-domain
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protein which binds ferric ion to two binding sites: one on each domain. The binding 
o f  ferric ion to ovotransferrin and to the N- and C- half molecules o f  ovotransferrin 
was studied by titration microcalorimetry. The half molecules demonstrated similar 
binding parameters to those of the corresponding site in the intact ovotransferrin. 
Although these binding sites are approximately 40A apart, they were found to interact 
via ligand-dependent changes in the heats and free energies o f  domain-domain 
interactions.
The kinetics and thermodynamics o f  an enzyme reaction has been 
investigated. The system under study was the reaction catalysed by yeast cytochrome 
c oxidase (Morin & Freire, 1991). Calorimetry offered an easy method of 
determining information about the thermodynamics, kinetics and protonation changes 
associated with the oxidation of cytochrome c by the enzyme. Injection o f  catalytic 
quantities o f  cytochrome c into a solution of  yeast cytochrome c oxidase produced a 
calorimetric trace which was analysed to give the reaction enthalpy and the kinetic 
constant (figure 2.5).
o
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Figure 2 .5  C alorim etiic  trace fr o m  M orin a n d  Freire , 1991
The area under the curve equals the total heat produced by the reaction, 
therefore, the reaction enthalpy can be determined by dividing the total heat by the
amount of cytochrome c oxidized. The shape of the curve is defined by the kinetic 
behaviour of the reaction. For a 1st order rate reaction, the heat flow (dQ/dt) 
measured by the calorimeter is represented by equation 2 .22 .
dQ/dt =  AH V k[S]0 exp(-kt) (2.22)
where [S]0 =  initial substrate concentration, V =  volume, k =  rate constant
Rate constants determined by this method were found to be within 3% of 
values determined using spectral methods.
Enthalpy values measured in phosphate, MOPS, Tricine and Tris buffers at 
pH 7.0 had different values; from which the number of protons being released during 
the reaction could be calculated. This was found to be approximately one proton per 
cytochrome c oxidised.
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3 MATERIALS AND METHODS
The PGK studies required considerable preparative and purification effort, 
mainly involving over-producing yeast strains, since the relatively large quantities of 
wild-type enzyme required for calorimetric studies were not available at an economic 
price and since mutant enzymes are not commercially available. Materials for the 
antibiotic-peptide binding experiments were supplied from Cambridge University or 
were commercially available. This chapter gives details of the basic experimental 
procedures involved.
3.1 Yeast cultures
Yeast cultures transformed with plasmids pMA27 and pMA40b, containing 
wild-type and H388Q genes, respectively, were supplied by Dr. L. Gilmore, University 
of Edinburgh. Yeast cultures containing plasmids encoding for R168K mutant were 
supplied by Dr. J. Littlechild and Dr. H.C. Watson, University of Bristol.
3.2 Proteins
PGK was isolated from over-producing yeast strains as described later in this 
chapter. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from baker's yeast was 
obtained from Sigma Chemical Co. as a lyophilized and sulphate free powder. Bovine 
serum albumin (BSA) and Dalton Mark VII-L SDS-PAGE molecular weight marker
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set, containing a-lactalbumin, trypsin inhibitor, trypsinogen, carbonic anhydrase, 
GAPDH, egg albumin and bovine albumin were obtained from Sigma Chemical Co.
3.3 Substrates and Ligands
Sigma Chemical Co. supplied the following substrates: adenosine as free base, 
adenosine 5'-diphosphate as di(monocyclohexylammonium) salt (ADP), adenosine 5'- 
triphosphate as disodium salt (ATP), D(-)3-phosphoglyceric acid as disodium salt (3- 
PG) and tripolyphosphate as pentasodium salt.
3.4 SDS-PAGE Chemicals
Ammonium persulphate, N,N,N',N'-tetramethylene-diamine (TEMED) and 
bromophenol blue were supplied by Shandon Ltd. Acrylamide, N,N'-methylene-bis- 
acrylamide and p-mercaptoethanol were supplied by Sigma Chemical Co.
3.5 Fermentation and purification reagents
Bacto-peptone, yeast extract, bacto-agar and yeast nitrogen base without amino 
acids were obtained from DIFCO. Protamine sulphate, benzamidine, 
phenylmethylsulphonyl fluoride (PMSF), Sephacryl S-200 and DEAE-sephadex A-25 
were from Sigma Chemical Co.
3.6 Antibiotics and cell wall analogues
Vancomycin HC1, Ristocetin A, N-acetyl-D-alanine, N-acetyl-D-alanyl-D- 
alanine, Na,Ny-diacetyl-lys-D-ala-D-ala, D-alanyl-D-alanine were supplied by Dr.
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D.H. Williams, Cambridge University and members of his group. Additional supplies 
of Vancomycin HC1 and N-acetyl-D-alanine were obtained from Sigma Chemical Co.
3.7 General Chemicals
All other chemicals used were of A.R grade.
3.8 Preparation of PGK, substrate and ligand samples for calorimetry
PGK samples were stored at 4°C as ammonium sulphate precipitates. Before 
use, the enzyme samples were centrifuged to obtain a pellet, the supernatant was 
discarded and the pellet redissolved in a small volume of buffer. The enzyme solution 
was then dialysed for about 20 hours against 2 x 1 litre (or more) dialysis buffer, at 
4°C, with stirring. The enzyme solution was centrifuged after dialysis to remove any 
precipitated material and diluted with dialysis buffer to give a suitable concentration, 
which was measured from the absorbance at 280 nm (see section 3.13.1), assuming a 
molecular weight for PGK of 44 500 dalton. The experimental protein concentrations 
were usually in the region of 0.1 mM. Samples were degassed under vacuum with 
stirring for 2-3 minutes to remove dissolved air and to prevent the formation of bubbles 
in the sample cell of the calorimeter, which are a major source of baseline instability.
ATP, ADP, 3-phosphoglycerate and other ligand solutions were made up with 
final, equilibrated dialysis buffer. Typical concentrations were 20 mM for ADP and 
ATP, and 10 mM for 3-phosphoglycerate. The dialysis buffer contained magnesium at 
usually 4 mM concentration so that the magnesium complexes of ADP and ATP were 
formed. These samples were degassed as before.
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3.9 Preparation of antibiotic samples for calorimetry
Antibiotic solutions were prepared by weight in 0.1 M sodium phosphate 
buffer at pi I 7.0, containing 0.05% sodium azide (molecular weights are vancomycin = 
1448, ristocetin = 2063, N-acetyl D-alanine = 1 3 1 ,  N-acetyl D -alanyl-D -alanine = 202, 
D-alanyl-D-alanine = 160, and di-N-acetyl-L-lys-D-ala-D-ala = 372).
3.10 Procedure for microcnlorimetry using the LKIJ calorimeter
'I’llis calorimeter had previously been modified from a standard batch 
calorimeter to a titration version and upgraded so that data collection, ligand injection 
and mixing schedules arc fully computerized. Microlitre quantities o f  samples can be 
injected into the reaction cells using motor-driven, Hamilton M icroLab P injector 
syringes.
In a typical experiment, 7 ml o f  enzyme solution and 7 ml o f  buffer were 
added to the sample cell and reference cell, respectively. The syringes were rinsed and 
filled with substrate solution and the tubing connecting the syringes to the reaction cells 
was also charged with substrate solution. The calorimeter was allowed to equilibrate for 
approximately two hours, until a steady baseline reading was obtained. A typical 
experimental sequence consisted o f  10 to 20 injections o f  10-15 p i  substrate solution 
over a period of several hours. The data were integrated and analysed using as 
described in chapter 2.
3.11 Procedure using Omega (it rat ion microcalorimeter
The unstirred reference cell was filled with degassed distilled water containing 
0.05%  sodium azide (this acts as a reference only and rarely needs re-filling). The
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sample cell was filled to the top of the inlet tube with sample (enzyme) solution, using a 
syringe with tubing attachment. Care was taken to avoid air bubbles being trapped in 
the cell. After loading, the temperature of the cells was raised to the experimental 
temperature (usually 25 °C) and the system was allowed to reach thermal equilibrium 
(usually a few minutes). The injection syringe was rinsed and filled with substrate 
solution, mounted in the calorimeter and stirred at a constant 400 rpm.
Experiments were started as soon as the baseline was sufficiently stable (RMS 
noise 0.04 jiJ/sec or less). An injection schedule, usually 20 injections of 5 |il volume at 
3 minute intervals, was set up and executed under computer control. Appropriate 
dilution experiments were done under identical conditions. The data from the 
experiments were stored on disk for later evaluation.
The sample cell was cleaned daily with detergent (5% SDS, 1 mM Na.EDTA, 
pH 8.3) and all buffers contained sodium azide to prevent bacterial contamination.
The experimental data were corrected by subtracting the heats of dilution of 
the substrates; PGK dilutions and buffer/buffer dilutions were small and usually 
negligible. The data were analyzed using the Origin software, usually using the one set 
of sites model to give values of AH0 and K&, from which AG° and AS0 were calculated. 
Enthalpy values (A H ^ ) were also calculated by summing the individual heat effects 
for each injection and dividing by the amount of protein present in the cell; this 
approach is model free but could only be used in cases where enzyme saturation had 
been attained. Both values of AH0 are given in the PGK results section.
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3.12 P G K  en z y m e  activ ity  m e a s u re m e n ts
Tw o m ethods were used to determ ine PGK activity: method A was used for 
routine assays whilst method B was used for more detailed kinetic studies. In both cases 
PGK activity was assayed (as is conventional) in the direction of 1,3- 
diphosphoglycerate formation by coupling the PGK reaction to the reaction catalysed 
by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as displayed in figure 3.1. 
The rate o f  reaction was followed by m onitoring the decrease in absorbance at 340nm 
as a result o f  oxidation o f  NADH.
M g.A T P  M g.AD P N A D H  NAD+
glyceraldehyde-
3-phosphate 
PG K G A PD H
F igure 3.1 R eaction  schem e fo r  P G K  asssay
3.12.1 M ethod  A (Scopes, 1975)
H ie  stock assay buffer contained the components listed in table 3.1, and was 
adjusted to pH  7.5 with HC1. This buffer could  be stored for several weeks at 4 °C.
3-PG 1,3-DPG
Table 3.1 C om ponents o f  stock assay buffer
Component Concentration mM
Triethanolamine (T E A )............................................30
3 -P G ............................................................................... 10
KC1................................................................................. 50
M g S 0 4 .........................................................................5
Na2E D T A .................................................................... 0.2
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The assay mix was prepared from the stock assay buffer by adding BSA and 
NADH to give concentrations of 0.2 mgmH and 0.1 mM respectively. This mixture 
was prepared daily and was stable for several hours at 4 °C. ATP and GAPDH solutions 
were prepared in 30 mM TEA at pH 7.5 at concentrations of 50 mM and 1 mgml' 1 
respectively; these solutions could be stored frozen at -20 °C for several months.
The following reagents were added to a microcuvette of 1cm path length: 0.88 
ml assay mix, 40 |il stock GAPDH solution and 80 |il stock ATP solution. The 
microcuvette was placed in the thermostat block of a spectrophotometer (Pye Unicam 
SP 8-200 or Shimadzu UV-160A) and allowed to warm to 25 °C. A baseline was 
measured at 340 nm to check for contaminating enzyme, then 20-25 |il of a dilute PGK 
solution was added and the decrease in absorbance as a function of time was measured. 
PGK activity was calculated using a molar extinction coefficient of 6.22 x 10 for 
NADH at 340nm as follows:
No. of enzyme units added to cuvette = AA340/6.22,
where AA340 is the change in absorbance at 340 nm per minute (initial rate of reaction) 
and 1 unit of enzyme activity causes conversion of 1 fimol NADH to NAD per minute 
at 25 °C. The approximate specific activity is equal to the number of enzyme units per 
milligram of enzyme.
3.12.2 Method B (Scopes, 1978a)
In this method solutions are chosen such that the concentration of free 
magnesium ions is fixed at 1 mM. The stock assay buffer contained the components 
given in table 3.2 and was adjusted to pH 7.5 with glacial acetic acid. This buffer could 
be stored for several weeks at 4 °C.
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Table 3.2 Components o f stock assay buffer for method B 
Component Concentration mM
Triethanolamine..................................................30
Ammonium sulphate.......................................... 40
Magnesium acetate...............................................1
The assay mix was prepared as before by adding BSA and NADH to the stock assay
buffer to give concentrations of 0.2 mgml*1 and 0.1 mM. The ATP and 3-
phosphoglycerate solutions were prepared in the stock assay buffer, with the addition of
more magnesium acetate: 0.98 mol magnesium acetate/mol ATP and 0.09 mol
magnesium acetate/mol 3-phosphoglycerate. PGK was dialysed overnight against 30
mM TEA pH 7.5 and diluted so that addition of 25 pi to the assay cuvette resulted in a
maximum rate of AA0.„ = 0.3 min*1.340
The assay procedure was performed as described before but the microcuvette 
contained: 0.76 ml assay mix, 40 p.1 GAPDH, 100 pi ATP and 100 pi 3- 
phosphoglycerate.
3.12.3 Determination of Michaelis constants
The Michaelis constants for Mg.ATP binding were determined from initial 
velocity measurements at several ATP concentrations using method B. The 3- 
phosphoglycerate concentration was held constant at 10 mM, whilst the ATP 
concentration was varied from 0.1 to 4 mM for wild-type PGK, from 0.05 to 2 mM for 
H388Q mutant and from 0.4 to 4 mM for R168K mutant.
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The Michaelis constants for 3-phosphoglycerate binding were measured with a 
constant ATP concentration of 5 mM and different 3-phosphoglycerate concentration 
ranges: from 0.1 to 5 mM for wild-type, 0.05 to 5 mM for H388Q and 0.5 to 10 mM for 
R168K.
3.12.4 Sulphate activation measurements
The role of sulphate ions in the activation of wild-type PGK was investigated 
by measuring the specific activity of PGK at different concentrations of ammonium 
sulphate. In one experiment, the 3-phosphoglycerate and ATP concentrations were held 
constant at 0.1 mM and in another experiment the concentration of ATP and 3- 
phosphoglycerate was 0.5 mM. The assay mix and dialysis buffer were prepared as 
described in section 3.12.2, except that ammonium sulphate was omitted from the assay 
mix. A stock solution of 100 mM ammonium sulphate was prepared and aliquots of this 
solution were added to the cuvette to give the desired concentration of sulphate.
3.13 Determination of protein concentration
It is important to be able to determine the concentration of PGK with some 
accuracy, since this is an important parameter in the analysis of the microcalorimetric 
data. The standard method of determining the concentration of enzyme samples uses the 
UV absorbance at 280 nm, but an assay employing a Coomassie blue dye can also be 
used, since both methods produce similar values.
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3.13.1 Estimation of protein concentration by UV absorption
All proteins containing the aromatic residues, tyrosine and tryptophan, absorb 
at about 280 nm (Creighton, 1984). From the knowledge of the absorbance at 280 nm 
and the corresponding extinction coefficient, the protein concentration can be calculated 
according to the Lambert-Beer law. The extinction coefficient of a 1 mgml’1 PGK 
solution was taken to be 0.495, which is an average of extinction coefficients reported 
by Spragg et a i , 1976 and Bucher, 1955. This value was used for both wild-type and 
mutant PGK enzymes, since neither of the mutations involved changes in aromatic 
residues. Protein concentrations measured using this value accord with concentrations 
measured using the Coomassie blue technique.
3.13.2 Estimation of protein concentration by the Coomassie blue technique
This technique relies on the change in colour of a dye solution when the dye 
anion forms a non-covalent complex with a protein (Sedmak & Grossberg, 1977). The 
free dye has a brownish orange colour and absorbs at 465nm, whilst the bound dye is 
intense blue absorbing at 620 nm. The absorbance ratio A ^ q/ A ^  is measured and 
plotted against standard protein solutions of known concentration to form a calibration 
graph. The standard protein used was bovine serum albumin (BSA).
The dye solution contained 0.06% Coomassie G250 in 3% perchloric acid. The 
solution was stirred overnight at room temperature and then the undissolved material 
was removed by filtration and the solution diluted to give an A465 reading of 1.3-1.5. 
The following reagents were added to the cuvette to make a total volume of 2 ml: 1 ml 
dye stock, 925-995 pi H20  and 5-75 pi BSA (1 mg/ml). The absorbance ratio of a 
control solution (1ml dye + 1ml H20 ) was measured and subtracted from values
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obtained for protein samples. A new calibration graph was constructed for each batch of 
dye prepared.
The concentrations of PGK samples were determined by measuring the 
^62(/^465 rat^° severa  ^ dilutions and then reading the protein concentrations from 
the calibration graph. These results confirmed the choice of 0.495 for the extinction 
coefficient at 280 nm.
3.14 SDS polyacrylamide gel electrophoresis
Protein homogeneity was verified by gel electrophoresis under denaturing 
conditions using a modified Laemmli gel system (Laemmli, 1970). A vertical slab 
electrophoresis apparatus (Shandon Ltd.) was used. The composition of various buffers 
and solutions used in the electrophoresis experiments are described in table 3.3.
The separating gel was prepared as follows: 7.5 ml of separating buffer, 10.5 
ml H20  and 12 ml acrylamide stock solution were mixed and polymerization was 
initiated by the addition of 25 |il TEMED and 100 |il of a 10% ammonium persulphate 
solution. The solution was quickly poured between the glass plates of the 
electrophoresis apparatus to give a gel of 1.2 mm thickness. The gel was allowed to set 
for approximately 20 minutes. Once the gel had set, the stacking gel was prepared and 
poured onto the separating gel. 3.75 ml stacking gel buffer, 9.15 ml H20  and 1.34 ml 
acrylamide stock solution were mixed, and followed by addition of 15 |il TEMED and 
75 \i\ ammonium persulphate. A plastic comb was inserted into the stacking gel to act 
as a mould to form wells for the samples.
The protein samples were diluted to give a concentration of approximately 1 
mgrnE* using 10 mM Tris buffer at pH 7.0. An equal volume of double-strength
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T a b l e  3.3 Electrophoresis buffers
S e p a ra t in g  gel buf fe r
0.5 M Tris
0.4% SDS 
adjusted to pH 8.7 
with HC1
Stack ing  gel buf fe r
0.5 M Tris
0.4% SDS 
adjusted to pH 6.8 
with HC1
S a m p le  bu f fe r
30 ml of 10% SDS 
solution
12.5 ml stacking gel buffer 
10 ml glycerol 
adjusted to pH 6.8 
with HC1
Rese rvo i r  bu f fe r
0.125 M Tris
0.96 M glycine 
0.5%  SDS
adjusted to pH 8.3 and 
diluted 5X before use
Des ta in ing  solut ion
10% glacial acetic acid
Acry la m id e  s tock 
solution
30% acrylamide
0.8% bis-acrylamide
T r a c k i n g  dye
1% bromophenol blue
S ta in ing  solut ion
0.1% Coomassie blue 
R250
400 ml glacial acetic acid 
1000 ml methanol 
1000 ml H 20
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sample buffer containing 2% v/v (3-mercaptoethanol was added and the sample tubes 
were placed in boiling water for 2 minutes. Tracking dye was prepared by mixing equal 
volumes of p-mercaptoethanol and 1% w/v bromophenol blue and then 5 fil of this dye 
was added to each 100 p.1 of protein sample. Between 10 and 60 p.1 of sample per lane 
was applied to the gel. Standard protein markers were run in adjacent lanes for 
molecular weight calculations.
Electrophoresis in the gel was performed at a current of 8-10mA (or 150- 
200V) for approximately 16 hours, until the tracking dye had run almost to the bottom 
of separating gel. The gel was then removed from the apparatus and stained with 
Coomassie blue staining solution for 1 hour, with occasional shaking, and then 
destained with 10% acetic acid.
The molecular weight of protein bands could be determined from the relative 
migration of bands with respect to a standard protein set: Sigma Dalton Mark VII-L 
containing: a-lactalbumin (14200), soybean trypsin inhibitor (20100), jtrypsinogen 
(24000), carbonic anhydrase (29000), rabbit muscle GAPDH (36000), egg albumin 
(45000) and bovine albumin (66000). The position of PGK bands were easily identified 
since they were very strong and occurred at the about the same position as egg 
albumin.
3.15 Wild-type and mutant PGK plasmids
Although it is possible to extract PGK from ordinary baker's yeast, the yield is 
improved by using genetically engineered yeast strains which have been designed to 
over-produce PGK. The yeast strains used in this project were supplied already 
transformed with the required plasmids. The plasmids containing the wild-type and 
H388Q mutant PGK genes were received from Dr L. Gilmore and the plasmid
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containing the R168K mutant gene was donated by Dr. J. Littlechild and Dr. H.C. 
Watson. These plasmids are described below.
pMA27
pM A27 contains the gene encoding for yeast PGK, which was isolated from 
chrom osom e III on a 2.95 kbp H indlll fragment. pM A27 is derived from plasmid 
pBR322 and a fragment from the yeast 2\i plasmid. pM A27 is a yeast/ E .co li shuttle 
vector which m ay be propagated in E.coli strain trpC 117 using ampicillin selection or 
in Saccharom yces cerevisiae  strain M D 40-4C  (u r a l , trp 1, leu2-3, h i s 3 - l l ,  h is3 -\5 )  
using leucine selection (Wilson et al., 1984)(figure 3.2).
Leu2
PGK
Amp
ccO
F ig u re  3.2 p M A 2 7  
H 388Q  mutant
The 2.95 kbp fragment containing the PG K gene was excised from pMA27 
with H in d lll, inserted into phage M13 mp9 and used to transfect E.coli JM 01. Single­
stranded DNA was prepared and a gapped-duplex was formed by annealing a linear 
fragment of  M 13-m p9 to the single-stranded M 13-m p9-PGK .
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An oligonucleotide specifying a T  - A replacement was added and after 
extension and ligation, was used to transfect E.coli. Single-stranded DNA containing 
the mutant PGK gene was prepared, the mutant gene was isolated and purified before 
inserting into plasmid pM A40b (Wilson et al., 1987). pM A40b is very similar to 
pM A27 but with the E coRI fragment in theoppositeorientation (figure 3.3).
EcoRI,..Hind I I I H i n d l l l
EcoRI
F igure  3.3 pM A 40b  
R168K mutant
In this case, a new expression vector, pY E -PG K  was used to transform yeast 
cells, strain M D40/4C (Minard et al., 1989). A H in d \\\  fragment containing the yeast 
PGK gene was excised from pMA27, the sticky ends were filled in by DNA polymerase 
and DamVU linkers were ligated onto the blunt ends. A new shuttle vector pYE-PGK 
was formed from the double EcoRI fragment of plasmid pAT153 and pM A27. The 
PGK gene with Barn III linkers was ligated into the BamYU  site of pYE-vec to produce 
pY E-PG K  (figure 3.4). This vector has the advantage over pMA27 of having the PGK
79
gene at a unique restriction site within the vector. The R168K mutant was formed by 
oligonucleotide-directed mutagenesis (Minard et a l., 1990)
F igure  3 .4  p Y E -P G K
3.16 M a in te n a n c e  o f  yeast cu ltures
After initial transfer to Glasgow, the yeast cultures had to be carefully 
m aintained to ensure that they remained viable over long storage periods and to ensure 
that contam ination did not occur. This involved taking small amounts o f  a yeast culture 
and streaking onto a fresh agar plate to start a new subculture. Yeast grows quickly at 
30 °C, but very slowly at 4 °C therefore, after an initial growth period o f  approximately 
48 hours, the subcultures were stored in a cold room at approxim ately 4 °C.
Most o f  the yeast strains required various supplements to be able to grow 
however, although all the yeast strains are leu , the leu gene is carried by plasmids and 
therefore leucine does not need to be added to the growtli medium. Each yeast strain
Hm d 11 i
Eco  RI B o m t \ I
/
Hm c
€
Eco RI
80
requires different amino acid or base supplements. Table 3.4 lists the type o f  plasmid, 
the host yeast strain, and the supplement requirements of  that yeast strain.
Table 3.4 Plasmids, host yeast strains and supplem ents
Plasm ids
pM A27,pM A 40b 
pYE-PGK 
pM A27, pM A40b
Host Yeast
Y22
M D40-4C
M C40-10D
A g a r /M e d i u m  s u p p le m e n t
Ade, His, Met, Ura, Trp
His, Ura, Trp
none
The supplement stock solutions were prepared as 10 mg/ml solutions in
2distilled water, sterilised by autoclaving at a pressure o f  151b/in for 10 minutes and 
stored at 4 °C  until required. The yeast cultures were grown on GYNB agar plates 
which had been supplemented with the required amino acid and base (adenine or uracil) 
stock solutions: 1 ml supplement stock solution was added to 100 ml molten agar prior 
to pouring in the plates. The composition o f  the GYNB agar and several other types of 
media are given in table 3.5.
Table 3.5 C om position o f  m edia and agar
G Y N B GY NB a g a r  YPG
20 g/1 Glucose 20 g/1 Glucose 20 g/1 Glucose
6.5 g/1 Yeast nitrogen base 6 5 ^  Yeast nitrogen base 20 g/1 Yeast extract
(without amino acids) (without amino acids)
10 g/1 Bacto peptone
20 g/1 Bacto agar
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Yeast cultures were checked periodically using marker plates (these plates 
contained all but one of the essential supplements) and subcultures were plated every 2 
months. Subcultures were incubated at 30 °C for 48 hours and stored at 4 °C. An 
improved method of storing yeast cultures was on agar slants in screw-capped universal 
bottles: these cultures could be stored for up to 6 months without contamination.
3.17 Yeast Fermentation
3 x 5ml of GYNB media were inoculated with a single yeast colony and grown 
with agitation at 30 °C for 48 hours. These cultures were used to inoculate 3 x 500ml 
GYNB media and were grown at 30 °C for 48 hours. A Life-Sciences LM-15 fermentor 
was sterilised, filled with 12 litres of YPG medium, prewarmed and inoculated with 
two of the 500ml cultures; the third culture was added on the third day of fermentation. 
The contents of the fermentor were stirred at 100 rpm, aerated and maintained at 30 °C. 
Approximately 10 litres of medium were removed from the fermentor every 36 hours, 
centrifuged at lOOOrpm for 30 minutes in an Heraeus M-7000 centrifuge to obtain a 
yeast pellet. The fermentor was refilled with freshly autoclaved and cooled medium and 
the fermentation continued until 5 or 6 harvests had been collected. Yeast pellets were 
stored frozen at -70 °C until required.
3.18 Purification of Yeast PGK
PGK was isolated by modification of the method devised by Minard et al, 
1990. The procedure contains five main stages:
1. Lysis of yeast cells
2 . Selective ammonium sulphate precipitation
3. Precipitation by lowering pH
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4. Ion-exchange chromatography
5. Gel-filtration chromatography
All centrifugations were performed at 12000 rpm for 30 minutes in a MSE 
high-speed 18 refrigerator centrifuge at 4 °C. The progress of purification was 
monitored after each stage by gel electrophoresis and by measuring specific activities.
Stage 1. Cell lvsis
Yeast pellets containing either wild-type or mutant PGK were removed from 
the freezer and allowed to warm to room temperature. 500 ml of extraction buffer 
(containing 10 mM Tris, 0.1 mM Na.EDTA, 6 mM (3-mercaptoethanol, 10' 3 mM PMSF 
and 20' 3 mM benzamidine, adjusted to pH 7.5) was added to the pellet, and the pH was 
slowly adjusted to 10.6 with concentrated ammonia solution. It was then stirred 
overnight at 4 °C to minimise the action of protease enzymes, and in addition, the 
buffer contained PMSF and benzamidine to inhibit these enzymes. After this overnight 
lysis, the slurry was adjusted to pH 7.5 with 5 M lactic acid (previously adjusted to pH
3.5 with ammonia), the cell debris was removed by centrifugation and discarded. The 
supernatant was treated with protamine sulphate (1ml of a 10% solution/100ml extract) 
to precipitate most of the nucleic acid, and stirred at 4 °C for 30 minutes before 
centrifugation.
Stage 2. Ammonium sulphate fractionation
Ammonium sulphate (300g/litre extract) was added over 20 minutes, with 
stirring, to the supernatant. Stirring was continued for a further 30 minutes. After 
centrifugation, the pellet containing precipitated protein (non-PGK), was discarded and 
further 170g/litre extract ammonium sulphate was added to supernatant. This solution
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was stirred and centrifuged as before. Both supernatant and pellet were retained. The 
pellet was re-suspended in 10 mM Tris pH 7.0.
Stage 3. Lowering of pH
The supernatant from stage 2 was slowly acidified to pH 4.3 with 5M lactic 
acid buffer (pH 3.5 with ammonia). The precipitated protein, containing the majority of 
PGK, was collected by centrifugation and the supernatant was discarded. The pellet was 
redissolved in 10 mM Tris pH 7.0.
Stage 4. Anion-exchange chromatography
The protein solutions obtained in stages 2 and 3 were further purified 
using identical procedures, but the samples were not mixed.
The samples were dialysed overnight against 10 mM Tris pH 7.0, centrifuged 
to remove any precipitated material and then applied to a DEAE-sephadex A-25 anion 
exchange column (20 x 2.3cm) and eluted with the same buffer at a flow rate of 
roughly 1 ml/min. Fractions of approximately 10 ml were collected manually, starting 
as soon as the protein sample had been applied. Fractions which absorbed strongly at 
280 nm were combined and stored as ammonium sulphate precipitates (0.65g 
ammonium sulphate/ml).
Stage 5. Gel-filtration chromatography
The partially purified PGK ammonium sulphate precipitate was dialysed 
overnight against 10 mM Tris pH 7.5 containing 5% saturated ammonium sulphate,
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0.05% sodium azide, and then applied to a Sephacryl S-200 gel-filtration column (100 
x 3 cm). Fractions, containing 60 drops each, were collected using a LKB 7000 
Ultrorac fraction collector, starting 6 hours after sample loading. Fractions were tested 
for PGK activity (Method A), and only fractions with specific activities greater than 
500 units/mg were combined and used without further purification. Samples were 
stored at 4 °C as ammonium sulphate precipitates (0.65g ammonium sulphate/ml). 
These samples retained most of their activity even over long storage periods.
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4 PGK RESULTS
The basic questions to be examined in this thesis are: can isothermal titration 
microcalorimetry be used to probe molecular recognition problems of current interest 
and if so, how do the results obtained compare to alternative techniques? What 
additional information might calorimetry yield and to what extent might the 
thermodynamic data be interpreted in relation to structural information?
In this section (chapter 4) I present the basic results of a range of experiments 
on PGK, followed by a discussion and interpretation (chapter 5). Data for antibiotic 
studies and their interpretation are presented in subsequent chapters (chapters 6 and 7).
4.1 PGK preparation
The specific activities of the wild-type, H388Q and R168K mutant enzymes, 
when purified by the methods described in chapter 3, were in the ranges of 500-680 
units/mg, 100-180 units/mg and 130-220 units/mg, respectively, using the GAPDH- 
coupled activity assay. The overall percentage yields, calculated from equation 4.1,
total number of enzyme units after purification jqq 
total number of enzyme units after cell lysis (4 i)
varied over a wide range i.e. 20-65% for wild-type, 15-40% for R168K mutant, and 
20-40% for H388Q mutant. Part of the reason for the large variation in yields was poor
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long-term plasmid stability in the yeast cells. For example, the purification procedure 
for wild-type PGK was initially very successful in terms o f  yield. H ow ever over a 
period o f  approximately 18 months, the yields decreased from 400000 units o f  PGK 
activity per yeast pellet to less than 60000 units per pellet. This decrease in the 
percentage protein being expressed as PGK led to difficulties in obtaining pure PGK 
samples and low yields. This problem was resolved by transforming a new yeast strain, 
M C40-10D, with plasmids pMA27 and pM A40b. Yields improved dramatically and 
approximately 500 m g - lg  purified wild-type PGK could be obtained from one yeast 
pellet. A typical set o f  purification results for wild-type PG K  is shown in table 4.1.
Table 4.1 Purification o f  w ild-type PG K
Stage Total Activity 
(units)
Yield
('■'_)
Specific Activity 
(units/mg)
1 235 320 100 not measured
2 235 600 100 not measured
3 190 960 81 288
4 107 338 46 59
5 98 990 42 416
6 73 070 31 585
Stage 1: sample taken after removal of cell debris
Stage 2: sample taken after treatment with protamine sulphate
Stage 3: sample of supernatant after 1st ammonium sulphate fractionation
Stage 4: sample taken from redissolved ammonium sulphate precipitate following
second fractionation step
Stage 5: sample taken from redissolved pellet following pH crash 
Stage 6: sample 5 after ion-exchange and gel-filtration chromatography
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T he P G K  preparations were shown to be free o f  con tam ina ting  proteins 
differing in m olecu la r  weight by the presence of a single band in SDS polyacrylam ide 
gel electrophoresis  experiments as shown in figure 4.1.
Bovine albumin 
66 000
Egg albumin 
45 000
GAPDH 
36 000
Carbonic anhydrase 
29 000
Trypsinogen 
24 000
Trypsin inhibitor 
20 100
a-Lactalbumin 
14 200
Figure 4.1 SDS-gel showing marker protein bands, wild-type PGK, H388Q 
PGK and R168K PGK
4.2 Kinetic studies of PGK
Kinetic  experiments were performed as described in chap te r  3, using the 
G A PD H  coup led  assay system, with the free magnesium concentration fixed at 1 mM 
(Method B).
*
• *
m
Wild-type PGK H388Q PGK R168K PGK
Steady-state kinetic experiments were performed to determine Michaelis 
constants for substrate binding to wild-type, R168K and H388Q  mutant PGK. The 
results from these experiments (table 4.2) were used to assess purity o f  PG K samples 
and for comparison with previous kinetic experiments (table 4.3). The raw data 
obtained were transformed to linear plots using Lineweaver-Burk, Eadie-Hofstee and 
Hanes methods (Appendix B) and average values o f  K M and Vmax were taken. Kinetic 
data for wild-type PG K and 3-phosphoglycerate are shown in figure 4.2.
Table 4.2 K inetic param eters fo r  w ild-type and m utant P G K  at 25 °C
Enzyme Substrate K m  (mM) v max (units/mg)
Wild-type ATP 0.29 (0.03) 595 (67)
3-PG 0.52 (0.04) 651 (55)
H388Q ATP 0.12 (0.02) 132 (33)
3-PG 0.19 (0.03) 145 (27)
R168K ATP 0.79 (0.04) 176 (39)
3-PG 1.79 (0.05) 184 (44)
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F igure  4.2 K inetic  data f o r  3 -phosphoglycera te  binding to wild-type PG K
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Table 4.3 Literature values for K ..  and V
M  m a x
Wild-type PGK H 388Q R168K
ref. K m  (m M )  
ATP 3-PG
V
v m ax
h
(m M )  
ATP 3-PG
vv m ax
h
K M  (m M )  
ATP 3-PG
vv m ax
h
a 0.30 0.50 826
b 0.32 - - 0.11 f g
c 0.33 0.78 500 0.90 2.11 201
d 0.29 0.40 517
e 0.33 0.60 510 0.07 0.15 165
a = Mas et al. 1987, 1988 
b =  W ilson et al., 1987 
c = W alker et al., 1989 
d = Sherman et al., 1991 
e = Johnson et al., 1991
f =  "unchanged from wild-type" Wilson et al., 1987
g = "fivefold reduction from wild-type" Wilson et al., 1987
h =  units/mg
The effect of sulphate on the activity of wild-type PGK is shown in figure 4.3. 
The sulphate concentration was varied from 0 to 50 m M , whilst the 3-phosphoglycerate 
and A D P concentrations were fixed at either 0.5 m M  or 0.1 mM. The results are 
expressed as percentage activity with respect to the activity in the absence o f  sulphate. 
The activation pattern is dependent on substrate concentration. W hen both AD P and 3- 
phosphoglycerate are present at 0.5 mM, the enzyme activity reaches a maximum  value 
of about 400% at a sulphate concentration o f  approximately 20 mM. The activating 
effect is less marked at low concentrations o f  substrate (0.1 m M ), reaching a maximum
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value of 225% at a sulphate concentration of 14 mM. Inhibition is observed above 35 
m M  sulphate, for example the percentage acitvity at a 50 mM concentration o f  sulphate 
is only 47%.
400
^  200
0
60400 20
[Sulphate] mM
+  Substrate concentration = 0.1 m M
O  Substrate concentration = 0.5 m M
F ig u re  4.3 S u lp h a te  activation pa tterns f o r  two concen tra tions o f  substra te , 0.1 
m M  a n d  0.5 m M .
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4.3 Microcalorimetry of substrate/ligand binding to PGK
Kinetic experiments can give an indication of the relative binding affinities of 
substrates to PGK, but a more detailed study is required to determine the nature of the 
forces between the enzyme and the substrate. Microcalorimetry is useful for these 
studies since the heat effects which occur when the substrates or ligands bind to PGK 
are measured and, since no catalysis occurs with single substrates, the observed heat 
effects arise mainly from the heat of binding. Therefore microcalorimetry provides a 
convenient technique to obtain enthalpies of binding and also binding affinities. The 
comparison of the results obtained for the wild-type and mutant enzymes can give 
information regarding the effect that the mutation has on enzyme binding activity. In 
addition, since PGK has been found to undergo complicated substrate/anion activation 
or inhibition effects, these processes can also be studied using microcalorimetry by 
comparing the binding parameters of the substrates in the absence and presence of other 
ligands. These experiments can possibly give an insight into the control mechanisms 
which are used to modify substrate binding to enzymes and hence activity.
4.3.1 The LKB titration calorimeter experiments
Early experiments of substrate binding to PGK used an LKB microcalorimeter 
modified for titration, as described earlier. Several problems were associated with these 
measurements: the LKB calorimeter requires a long equilibration time of roughly 2 
hours or more and the time interval required to regain baseline levels between injections 
was approximately 20-30 minutes. This means that an experiment designed to attain 
enzyme saturation in 10 injections would require about 7 hours of experimental time. 
The second problem was that the calorimeter was sensitive to changes in room 
temperature: the baseline would drift throughout the day. Air conditioning did not 
alleviate this problem but rather resulted in a cyclic fluctuation of the baseline. The
ii
Q 
(k
J/
m
ol
)
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large cell volumes (7ml) and relatively low sensitivity required a substantial quantity 
(approximately 30-50mg) of protein for each titration curve. For these reasons, 
although reasonable titration data could sometimes be obtained, the experiments using 
the LKB calorim eter were abandoned in favour o f  the Om ega microcalorimeter. An 
example of the raw data and a titration curve obtained with the LKB calorim eter are 
shown in figures 4.4 and 4.5. The data have been corrected by subtracting the heat of 
mixing and the formation of a 1:1 enzyme-substrate complex has been assumed.
18 -
16 -
14 -
12 -
10 -
K =0.43 mM 
AH = -15.6 kJ/mol
4 -
1.21.00.80.60.20.0 0.4
ATP concentration (mM )
F ig u re  4 .4  B in d in g  isotherm  fo r  A T P  b ind ing  to wild-type P G K , data collected  
with L K B  calorimeter
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10th injection 9th injection 8th injection 7th injection
2nd injection i 1st injection M ix only
6th injection 5th injection J   4th injection — 3rd injection
F ig u re  4 .5  Raw data fo r  A T P  b ind ing  to w ild -type  P G K  using  L K B  calorim eter
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4.3.2 The Omega Calorimeter experiments
The experiments were performed at 25 °C, with an injection schedule usually 
of 20 injections of 5 pi at 3 minute intervals. In general, injection of substrate into the 
PGK enzyme solution results in exothermic heat effects which decrease in size during 
the titration until the enzyme becomes saturated. At this point, heat effects are still 
observed but these are similar in magnitude to the heat effects observed on titration of 
buffer with substrate. A typical dataset from a titration of PGK with substrate is shown 
in figure 4.6. Comparison of figure 4.5 and figure 4.6 demonstrates the advantages of 
the Omega calorimeter over the LKB calorimeter; in the latter experiment, 20 injections 
were obtained in 60 minutes, whereas, 10 injections required about 7 hours with the 
LKB calorimeter. Also, the baseline drift is insignificant using the Omega calorimeter.
The experimental data in figure 4.6 and subsequent data in this chapter have 
been corrected for substrate dilution effects and have been analysed using the one set of 
sites model with N fixed as 1, unless otherwise stated. The Omega calorimeter is 
calibrated in calories and hence the data analysis programs also use calories rather than 
the S.I units, joules. This means that the figures generated by Origin are in calories, 
whereas, the data given in the tables have been converted to joules.
4.3.3 Wild-type PGK
The initial microcalorimetric experiments were concerned with measuring the 
thermodynamic parameters for substrate binding to wild-type PGK under various 
experimental conditions (different buffers, pH, magnesium concentrations) to 
investigate the effects of these factors on the association constants and enthalpies of 
binding. The thermodynamics of binding of Mg.ATP, Mg.ADP and 3-phosphoglycerate
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F igure 4.6 A . R aw  data f o r  A D P  dilution experim en t
B. R aw  data f o r  titration o f  wild-type PG K with A D P
C. In tegra ted  a n d  corrected (B-A)  data . T he  so lid  line  th ro u g h  the  
exp erim en ta l po in ts  represents the theoretica l f i t  to the  data
TT
0 5 10 15 20
Injection N u m b e r
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to PG K could be examined. However the fourth substrate, 1,3-diphosphoglycerate, is 
not readily available and is too unstable in solution to be studied by microcalorimetry.
The binding parameters of substrate binding to wild-type PG K were measured 
in two different buffer systems, one at pH 7 (tris/MOPS buffer) and the other at pH 6 
(MES buffer). The results obtained in tris/MOPS buffer are presented in table 4.4, with 
the raw data and binding isotherms presented in figures 4.7 to 4.9. The binding of  ADP 
to PG K in tris/MOPS buffer is strongly exothermic, whilst the highest binding affinity 
occurs with 3-phosphoglycerate. The theoretical fitting curves agree well with the 
experimental data for the ADP and 3-phosphoglycerate experiments, but slight 
deviations can be noticed with the ATP data.
Table 4.4 Thermodynamic parameters for binding o f Mg.ADP, MgATP and 3- 
phosphoglycerate to wild-type PGK in Tris/MOPS at pH 7.0, 4mM magnesium acetate, 
0.1 mM DTT and 0.05% w/v sodium azide
Parameters M g.ADP M g.ATP 3-PG
K ( M '1) a
AH0 ( k J m o l 1) 
AG° ( k J m o f 1) 
AS0 ( Jm o W K '1) 
AH°add ( k J m o f 1)
3550 (480) 
-57.5 (4.9) 
-20.2 (0.3) 
-125 (16) 
-45.5 (1.0)
6855 (560) 
-34.3 (1.5) 
-21.9 (0.2) 
-44 (5) 
-28.9 (0.5)
180000(30000) 
-15.5 (0.7) 
-30.0 (0.4) 
+49 (3) 
-14.7 (2.2)
The calorimetric experiments were repeated in MES buffer at pH 6.0 and the 
results are listed in table 4.5 with the raw data and binding isotherms in figures 4.10 to 
4.12. The results obtained in MES buffer are roughly similar to those obtained in
kc
ai
/m
ol
e 
of 
in
je
ct
an
t 
[i
ca
l/s
ec
98
Time (min)
0 10 20 40 5030 60 70
0.00
- 0.66
-1.32
-1.99
-2.65
-3.31
-3.97
T T T T
0 5 10 15 20
Injection N u m b e r
F igure  4.7 Wild-type PGK and ADP. 50 m M  tris/M O PS p H  7.0, 4  m M  M g acetate,
0.1 m M  DTT and 0.05% w/v sodium  azide.
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Figure 4.8 W ild-type PGK and A TP . 50 m M  tris/MOPS p H  7.0, 4  m M  M g acetate,
0.1 m M  D TT and 0.05% w/v sodium azide.
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F igure 4.9 Wild-type PGK and 3-phosphoglycerate. 50 m M  tris/M OPS pH  7.0, 4
m M  M g acetate, 0.1 m M  D TT  a n d  0.05%  w/v sodium  azide.
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tris/MOPS buffer, except the binding of  ADP to PGK is somewhat less exothermic. 
Differences in binding parameters for the association of 3-phosphoglycerate with PGK 
are also noticed.
Table 4.5 Thermodynamic parameters for binding of Mg.ADP, Mg ATP and 3- 
phosphoglycerate to wild-type PGK in MES at pH 6.0, 4mM magnesium Acetate, 
0.1 mM DTT and 0.05% sodium azide
Parameters Mg.ADP M g.ATP 3-PG
K ( M '1) a
AH° ( k J m o l 1) 
AG° ( k J m o l 1) 
AS° ( Jm o H  K '1) 
AH°atld ( k J m o l 1)
5940 (790) 
-34.8 (0.8) 
-21.5 (0.3) 
-34 (4) 
-34 (4)
6610 (500) 
-34.8 (0.7) 
-21.8 (0.2) 
-44 (2) 
-35 (6)
113000 (6000) 
-19.1 (0.6) 
-28.8  (0.1) 
+33 (2) 
-17.5 (1.4)
Microcalorimetry was also used to investigate the binding o f  other ligands 
(sulphate, adenosine and tripolyphosphate) to PGK (table 4.6). The data are shown in 
figures 4.13 to 4.13. Both anions were observed to bind to PGK, in particular, the 
multivalent triphosphate binds with high affinity. In contrast, adenosine did not appear 
to bind to PGK. Figure 4.14 depicts the raw data for the titration of PGK with 
adenosine and, for comparison, the raw data for the injection o f  adenosine into buffer. 
Both experiments give rise to similar heat effects.
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Figure 4.10 Wild-type PGK and ADP. 50 m M  M ES pH  6.0, 4 m M  M g acetate, 0.1
m M  D TT  and 0.05% w/v sodium azide.
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F igure 4.11 Wild-type PGK and A T 1 \ 50 m M  M E S pH  6.0, 4 m M  M g acetate, 0.1
m M  DTT and 0.05% w/v sodium  azide.
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Figure 4.12 Wild-type PGK and 3-phosphoglycerate. 50 m M  M E S p H  6.0, 4 m M
M g acetate, 0.1 m M  D TT and 0.05% w/v sodium  azide.
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F igure 4.13 Wild-type PGK and am m onium  sulphate. 50 m M  M E S pH  6.0, 4 mM
M g acetate, 0.1 m M  D TT and 0.05% w/v sodium  azide.
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A. Wild-type PGK and adenosine. 50 mM MES pH 6.0, 4 mM Mg 
acetate, 0.1 mM DTT and 0.05% w/v sodium azide.
B. Adenosine dilution experiment
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Figure 4.15 Wild-type PGK and tripolyphosphate. 50 m M  M E S p H  6.0, 4 m M  M g
acetate, 0.1 m M  D T T  and  0.05% w!v sodium azide.
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Table 4.6 Thermodynamic parameters o f ligand binding to wild-type PGK in MES at 
pH 6.0, 4mM magnesium acetate, 0.1 mM DTT, 0.05% sodium azide.
Parameters sulphate adenosine triphosphate
K (M"1) a
AH° ( k J m o l1) 
AG° ( k J m o l1) 
AS0 (Jm o l" 'K 'l)  
AH°add (M m o l '1)
3850 (275) 
-6.8 (0.4) 
-20.4 (0.2) 
+46 (2) 
-6.0 (0.9)
weak /no  binding
60880 (9000) 
-16 .6 (1 .0 )  
-27.3 (0.4) 
+36 (4) 
-15 .9 (1 .5 )
4.3.4 Mutant PGK
The substrate titration experiments were repeated with mutant enzyme under 
conditions which were as close as possible to the experiments with wild-type PGK in 
M ES buffer. These experiments were required to demonstrate the effects of  a mutation 
at the active site of PGK and the effects of a mutation at a more distant position. Two 
mutant forms o f  PGK were investigated, H388Q and R168K, the results from the 
experiments with H388Q enzyme are given in table 4.7, and the results for R168K are 
in table 4.8. The raw data and calorimetric isotherms of  substrate binding to H388Q are 
illustrated in figures 4.16 to 4.18. The binding parameters obtained for H388Q are very 
similar to the values obtained for wild-type PGK, except that the binding o f  3- 
phosphoglycerate is more exothermic.
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Figure 4.16 H 388Q  PG K and ADP. 50 m M  M E S pH  6.0, 4 m M  M g acetate, 0.1
m M  D T T  and 0.05% w/v sodium azide.
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F igure 4.17 H388Q PGK and A TP . 50 m M  M E S  pH  6.0, 4 m M  M g acetate, 0.1
m M  D TT and 0.05% w/v sodium  azide.
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F igure  4.18 II3 8 8 Q  PG K  and  3-phosphoglycerate. 50 m M  M E S  p H  6.0, 4  m M  M g
acetate, 0.1 mM  D TT and 0.05% w/v sodium azide.
o<L>00
73
oA.
o
jU
o
E!
73
o
112
Table 4.7 Thermodynamic parameters for binding of Mg.ADP, Mg.ATP and 3- 
phosphoglycerate to H388Q PGK in MES pH 6.0, 4mM magnesium acetate, 0.1 mM 
DTT, 0.05% w/v sodium azide
Parameters M g.ADP M g.A TP 3-PG
K ( M '1) a
AH0 (kJmol’1) 
AG° ( k J m o r 1) 
AS0 ( J m o l^ K '1) 
AH°add ( k J m o f 1)
8372 (327) 
-33.2 (3.5) 
-22.4 (3.5) 
-36 (11 )  
-28 (3)
7845 (225) 
-34.7 (0.5) 
-22.2 (0.2) 
-41 (1) 
-31 (2)
118000(1700) 
-25.8 (2.6) 
-28.9 (2.6) 
+10 (3) 
-18.9 (3)
The experiments with R168K PGK indicated that alterations in substrate 
binding had occurred. ADP binding appears to be least affected by the mutation and 
could be analysed using the one set of sites model to give good agreement between the 
experimental data and the theoretical fitting curve. This model does not appear to be 
satisfactory for the titrations with ATP and 3-phosphoglycerate, however, the values 
obtained from the analyses are given below. The raw data for substrate binding to 
R168K  are shown in figures 4.19 to 4.21.
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Figure 4.19 R168K PGK and AD P. 50 m M  M E S pH  6.0, 4 m M  M g acetate, 0.1
m M  D TT  and 0.05% w!v sodium  azide.
kc
al
/m
ol
e 
of 
in
je
ct
an
t 
^c
al
/s
ec
114
1
0
-1
-2
-3
-4
-5
-6
0700
- 0.68
-1.37
-2.05
-2.74
-3.42
T im e (m in)
30 40
Injection Num ber
Figure 4.20 R168K PGK and ATP. 50 m M  M E S  p H  6.0, 4  m M  M g acetate, 0.1 mM
D T T  and  0.05% w/v sodium azide.
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Figure 4.21 R168K PGK and 3 -phosphoglycerate. 50 m M  M E S p H  6.0, 4  m M  M g
acetate, 0.1 mM  D TT  and  0.05% w/v sodium azide.
0 5 10 15 20
Injection N u m b er
116
Table 4.8 Thermodynamic parameters for binding o f Mg.ADP, Mg.ATP and 3- 
phosphoglycerate to R168K in MES pH 6.0, 4mM magnesium acetate, O.lmM DTP, 
0.05% w/v sodium azide
Parameters Mg.ADP M g.A TP 3-PG
K ( M '1) a 5300 5000 28000
AH° (kjm ol" ') -23.6 -33.1 -13.8
AG° (kjm ol"1) -21.2 -21.1 -25.4
AS0 (Jm o l- 'K - ') -8.3 -40.3 +38.9
AH°add ( k J m o r 1) -20.6 -20.2 -4.7
4.3.5 B uffer  effects on the  b ind ing  o f  3 -p h o sp h o g ly c e ra te  to w ild -type  P G K
There is evidence in the literature that the binding o f  3-phosphoglycerate to 
PG K  results in a change in pK of  the substrate carboxylate group (Wilson et al., 1988).II
This effect was studied here by performing experiments of 3-phosphoglycerate binding 
to PGK in buffers with different heats o f  ionization and/or pH. Table 4.9 contains the 
results from these experiments and the raw data obtained in tricine, PIPES, and 
piperazine buffers are given in figures 4.22 to 4.24. The binding curves obtained were 
different for each buffer: binding o f  3-phosphoglycerate to PG K in tricine gave rise to a 
low exothermic AH0 value, whereas at lower pH values, the binding was more 
exothermic.
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F igure 4.22 Wild-type PGK and 3-phosphoglycerate. 50 m M  tricine p H  8.0, 0.1
m M  D TT and 0.05% w!v sodium  azide.
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Figure 4.23 Wild-type PGK and 3-phosphoglycerate. 50 m M  P IP E S p H  7.0 ,
m M  D TP and 0.05% w/v sodium azide.
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F igure 4.24 Wild-type PGK and 3-phosphoglycerate. 50 m M  piperazine p H  6.0, 0.1
m M  D TT and 0.05% w/v sodium  azide.
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Table 4.9 3-phosphoglycerate binding param eters in 50 m M  buffer, 0.1 m M  DTT, 
0.05% w/v sodium  azide
Buffer pH AH0r
(kJm ol '1)
AH°obs
(kJm oP1)
AH°add
(kJm oP1)
K a
(M'1)
Tricine 8 31.2 -8.4 -9.6 2.1 x 105
Tris/M OPS 7 23.5 -15.5 -14.7 1.8 x 105
PIPES 7 11.3 -10.9 -10.2 4.1 x 104
MES 6 14.6 -19.1 -20.9 1.1 x 105
Piperazine 6 29.3 -12.1 -12.3 1.7 x 104
4.3.6 Effect of anions on binding of 3-phosphoglycerate
The binding parameters given in table 4.10 refer to the binding of 3- 
phosphoglycerate in the presence of the anions noted. It has already been shown that 
sulphate and tripolyphosphate bind to PGK (section 4.3.3) and these experiments aim to 
study the effect that this binding has on 3-phosphoglycerate binding parameters. 
Chloride and acetate ions were present as the magnesium salt at a concentration of 
60m M  in 50 m M  tris/MOPS, pH 7.0, 0.1 m M  D T T and 0.05% w/v sodium azide. 
Tripolyphosphate was present at a concentration o f  0.7 m M  in 50 m M  M ES, pH  6.0, 4 
m M  m agnesium acetate, 0.1 m M  D TT and 0.05% w/v sodium azide. The raw data and 
binding isotherm for 3-phosphoglycerate binding in buffer containing 60 mM 
m agnesium  acetate are given in figure 4.25. 3-phosphoglycerate did not appear to bind 
to PG K  in the presence of either a high concentration o f  magnesium chloride or at a 
relatively low concentration o f  tripolyphosphate. Although binding was observed in 
buffer containing 60 mM magnesium acetate, the binding was much weaker than usual.
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Figure 4.25 Wild-type PGK and 3-phosphoglycerate. 50 m M  tris/M O PS pH  7.0, 60
m M  M g acetate, 0.1 m M  D T T  and  0.05% w/v sodium azide.
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Table 4.10 3-phosphoglycerate binding parameters in presence o f anions
Parameters 60 mM 
M gCl2
60 mM  
M g acetate
0.7 m M  
tripolyphosphate
K ( M '1)a v 3112
AH° (kjm ol"1) no binding -22.0 no binding
AG° (kjm ol ' ) -19.9
AS0 ( J m o H K '1) -7.0
4.3.7 Sulphate effects on ligand binding
Sulphate is another anion which is known to bind to PG K and which has a dual 
activating/inhibiting effect on the enzyme activity (Scopes, 1978a). The mechanism of 
this action is not clear, but it would be interesting to know how the presence o f  sulphate 
affects the binding parameters for the natural substrates of  PGK. Therefore, the binding 
o f  M g.ADP, M g.ATP and 3-phosphoglycerate to PGK in the presence o f  a low 
concentration of sulphate was studied (table 4.11). The effect o f  sulphate on substrate 
binding is illustrated in figures 4.26 to 4.28. The binding o f  ATP is strongly affected by 
amm onium  sulphate, the binding affinity is decreased significantly. A significant 
decrease in binding affinity is also observed with 3-phosphoglycerate binding.
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Figure 4.26 Wild-type PGK and ADP. 50 m M  M E S  pH  6.0, 4 m M  M g acetate, 1.1
m M  am m onium  sulphate, 0.1 m M  D T T  and 0.05% w!v sodium azide.
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Figure 4.27 Wild-type PGK and ATP. 50 m M  M E S pH  6.0, 4 m M  M g acetate, 1.6
m M  am m onium  sulphate, 0.1 m M  D T T  and 0.05% w/v sodium  azide.
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Figure 4.28 Wild-type PGK and 3-phosphoglycerate. 50 m M  M E S pH  6.0, 4 m M
M g acetate, 1.1 m M  am m onium  sulphate, 0.1 m M  D T T  and  0.05%
w/v sodium  azide.
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Table 4.11 Binding parameters for Mg.ADP Mg.ATP and 3-phosphoglycerate in 
presence of 1.1-1.6 mM ammonium sulphate
Parameters Mg.ADP M g.ATP 3-PG
K ( M '1) a 5292 653 24760
AH° (k jm o l '1) -22.6 -68.0 -9.8
AG° ( k J m o l 1) -21.1 -16.1 -25.1
A S °(Jm o l- | K -1) -5 -174 +51
AH°add ( k J m o r 1) -19.3 not saturated -9.1
4.3.8 Studies of nucleotide binding to wild-type PGK
It is most likely that ADP and ATP bind to the same site on PGK, but to 
confirm that this does occur, a sample of PG K was titrated with AD P followed by 
titration with ATP. Similarly, a second PGK sample was titrated first with ATP and 
then with ADP. No binding effects were apparent in the second titrations.
The mode of binding of nucleotides to PGK is dependent on magnesium ions 
(e.g. Fairbrother et al., 1990b, Graham & Williams, 1991b). Therefore experiments 
involving the binding of ATP and ADP to PGK were conducted at several magnesium 
concentrations. Table 4.12 contains nucleotide binding parameters which were 
m easured at various magnesium ion concentrations in tris/MOPS and MES buffers. 
Som e of the experimental data contained in this table are illustrated in figures 4.29 to 
4.32. In the absence o f  magnesium, the binding affinities for AD P and ATP are 
increased although the enthalpy values remain roughly constant.
kc
al
/m
ol
e 
of 
in
je
ct
an
t 
pc
al
/s
ec
127
T im e (m in )
0 10 40 6020 30 50
0.00
-0.38
-0.77
-1.15
-1 .54
-1.92
-2.31
-2.69
-3.08
0 5 10 15 20
Injection N um ber
Figure 4.29 W ild-type PGK and ADP. 50 m M  tris/MOPS pH 7.0, 60m M  M g acetate,
0.1 m M  D TT and 0.05% w/v sodium azide.
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F igure 4.30 Wild-type PGK and AD P. 50 m M  M E S p H  6.0, 0.1 m M  D TT and
0.05% w/v sodium azide.
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Figure 4.31 Wild-type PGK and ATP. 50 m M  tris/M OPS p H  7.0, 0.1 m M  D T T  and
0.05% w/v sodium  azide.
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F igure  4.32 Wild-type PGK and ATP. 50 m M  M E S p H  6.0, 0.1 m M  D TT, 0.05%
w/v sodium azide
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Table 4.12 Effects o f magnesium concentrations on binding parameters for nucleotide 
substrates
Buffer pH [Mg2+1
(mM)
Ka
CM'1)
AH0
(kJmolH)
AG°
(kJmolH)
AS0
(kJmolH)
ADP Tris/MOPS 7 60 21090 -19.1 -24.7 + 19
Tris/MOPS 7 4 3550 -57.5 -20.2 -125
MES 6 4 5940 -34.8 -21.5 -45
MES 6 0 17400 -36.2 -24.2 -40
ATP Tris/MOPS 7 60 no binding
Tris/MOPS 7 4 6855 -34.3 -21.9 -44
Tris/MOPS 7 0 420000 -23.8 -32.1 +28
MES 6 4 6610 -34.8 -21.8 -44
MES 6 0 94000 -28.7 -28.4 -1.0
Although ATP and ADP appear to bind to only one site on PG K  in tris/MOPS 
and M ES buffers, experiments conducted in other buffers indicate that the substrates are 
actually binding at two sites. The data obtained in PIPES buffer can be analysed more 
easily using the two sets o f  sites model as shown in figures 4.33 and 4.34. The results 
from these titrations in PIPES buffer are given in table 4.13. During this analysis the N 
values were fixed at 1.
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F igure 4.33 Wild-type PG K and ADP. 50 m M  PIPE S p H  7.0, 4m M  M g  acetate,
0.1 m M  D T T  and 0.05% w/v sodium azide
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Figure 4.34 Wild-type PG K and ATP . 50 m M  PIPE S pH  7.0, 0.1 m M  D T T  and
0.05% w/v sodium  azide.
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Table 4.13 Results o f a two sets of sites analysis o f the binding o f ATP and ADP to 
wild-type PGK in 50 mM PIPES, 4 mM magnesium acetate, 0.1 mM DTT and 0.05% 
azide at pH 7.0.
ADP ATP
1st binding site (M"1)
AH0! (kJm oP1) 
2nd binding site K2 ( M '1)
AH°2  (kJm ol-0
26300(11150) 
-9.9 (1.1) 
818 (580) 
-84.9 (33)
13600 (9000) 
-7.1 (2.9) 
375 (177) 
-77.4 (8.9)
The binding sites for the nucleotide and triose substrates are located on 
different domains. However, it is still possible that the sites may be cooperative i.e. the 
binding o f  one substrate could alter the binding affinity for the second substrate. It is 
also possible that domain closure is triggered by the formation o f  the ternary 
substrate/enzyme complex. Therefore the ternary PG K/ADP/3-PG complex was studied 
by titrating a PGK sample with one substrate and then titrating the binary 
PGK/substrate complex with the second substrate. The PGK sample was left in the 
reaction cell following the first titration, the injection syringe was removed, rinsed and 
filled with new substrate and then a second titration was initiated. The ternary complex 
could also be formed by titrating a PG K sample with a mixture o f  ADP and 3-
135
phosphoglycerate. The results are given in tables 4.14 and 4.15, where the first, second, 
third and fourth columns in the table refer to titrations of PGK with ADP, PGK.ADP 
with 3-phosphoglycerate, PGK with 3-phosphoglycerate and PGK.3-PG with ADP, 
respectively.
When 3-phosphoglycerate binds to the binary PGK/ADP complex the 
association is endothermic, in contrast to the exothermic binding of 3-phosphoglycerate 
to PGK alone. The binding affinity is also decreased. There are also differences 
between the binding of ADP to PGK.3-PG and to PGK alone: the binding affinity is 
increased in the former association and the enthalpy change is less exothermic. These 
effects are observed in both MES and tris/MOPS buffers.
The titration of PGK with an ADP/3-phosphoglycerate mixture gave rise to a 
measured enthalpy change (AHadd) of -36 kJmol’1. The raw data and calorimetric 
isotherms for these experiments in MES buffer are given in figures 4.35 to 4.36 and the 
results in tris/MOPS buffer are presented in figures 4.37 to 4.38.
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Binary wild-type PGK A D P  com plex and  3-phosphoglycerate. 50 m M
M E S pH  6.0 , 4 m M  M g acetate, 0.1 m M  D T T  and  0.05% w/v sodium
azide
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Figure 4.36 B inary wild-type PGK.3-PG com plex and ADP. 50 m M  M E S  p H  6.0, 4
m M  M g acetate,0.1 m M  D TT arid 0.05% w/v sodium  azide.
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F igure 4.35 Binary wild-type PGK.ADP com plex and  3-phosphoglycerate. 50 m M
tris/MOPS pH  7.0, 4 m M  M g acetate, 0.1 m M  D TT  and 0.05% w/v
sodium azide
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Figure 4.32 B inary m id-type PGK.3-PG complex and ADP. 50 m M  tris/M O PS p H
7.0, 4 m M  M g acetate,0.1 mM  D TT, 0.05% w/v sodium  azide
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Table 4.14 Parameters for formation of ternary complex with wild-type PGK in MES 
buffer, pH 6
Parameters
PGK + 
M g.ADP 
( 1)
PGK.A DP 
+ 3-PG
(2 )
PG K  + 3-PG 
(3)
PGK.3-PG 
+ M g.ADP
(4)
K (M ’1) a 5940 18200 111300 19000
AH° ( k J m o f 1) -34.8 +2 .8 -19.1 -13.9
AG° ( k J m o l 1) -21.5 -24.3 -28.8 -24.4
AS° ( J m o l ' V 1) -45 +91 +33 +35
AH°add ( k J m o l1) -33.7 +2.7 -17.5 -12.4
Table 4.15 Parameters for formation o f ternary complex with wild-type PGK in 
tris/MOPS buffer, pH 7
Parameters
PGK + 
M g.ADP 
( 1)
PGK.ADP 
+ 3-PG 
| ( 2 )
PG K  + 3-PG
(3)
PGK.3-PG 
+ M g.ADP
(4)
K ( M '1) a 3550 27000 180000 11500
AH0 ( k J m o l 1) -57.5 +9.4 -15.5 - 10.1
AG° ( k J m o f 1) -2 0 .2 -25.3 -30.0 -23.2
AS0 (Jmol ' k ' 1) -125 116 49 44
AH°add ( k J m o f 1) -45.5 +8.7 -14.7 -9.2
4.3.10 H 388Q  te rn a ry  com plex
The interesting feature of this mutant enzyme is that the site o f  mutation is 
located within the hinge region o f  the enzyme. If  there is an interaction between
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substrate binding sites then this mutant could demonstrate altered interaction effects. 
The enthalpy change for the titration of PGK with ADP/3-phosphoglycerate mixture 
was found to be -41 kJmol’1. The results for these experiments are presented in table 
4 .16 and figures 4.39 to 4.40.
The binding o f  3-phosphoglycerate to the binary mutant enzyme complex is 
not endothermic, however, it is less exothermic and the binding affinity is decreased. 
The binding of  ADP occurs with a higher affinity than to PG K alone and the AH0 value 
is less exothermic.
Table 4.16 Parameters for formation o f ternary complex for H388Q mutant PGK
Parameters
PGK + 
M g.ADP
_____ ( 1 )______
PGK.A DP 
+ 3-PG 
_____ (2 ) .
PG K + 3-PG
(3)
PGK.3-PG 
+ M g.AD P 
(4)
K a ( M '1) 8372 67500 118000 38000
AH0 (kJmol’1) -33.2 -9.8 -25.8 -21.3
AG° ( k J m o f 1) -22.4 -27.5 -28.9 -26.1
AS0 ( J m o l ' V 1) -36 +59 + 1 0 +16
AH°add ( k J m o l1) -28.2 -4.6 -18.9 -14.9
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Figure 4.39 Binary H388Q PGK.ADP com plex and  3-phosphoglycerate. 50 mM
M E S pH  6.0, 4 m M  M g acetate, 0.1 m M  D T T  a n d  0.05% w/v sodium
azide.
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Figure 4.40 B inary H388Q PGK.3-PG com plex and ADP. 50 m M  M E S  p H  6.0, 4
m M  M g acetate,0.1 m M  D TT  and 0.05% w/v sodium  azide.
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5 DISCUSSION (PGK EXPERIMENTS)
The results given in chapter 4 fall into two main categories: the kinetic 
experiments which were used to investigate the binding of Mg.ATP and 3- 
phosphoglycerate to PGK, and the microcalorimetric experiments which involved the 
binding of substrates and ligands to PGK and also the effects of anion, pH etc. on the 
binding parameters.
The kinetic studies are relatively quick and straightforward to perform, 
requiring small amounts of enzyme. They were used to check the purity of enzyme 
samples and to compare the activities of the wild-type and mutant enzymes. The K ^  
values and specific activities of wild-type and mutant PGK (given in table 4.1) are 
similar to literature values described in table 4.2 and give confidence that the over­
producing yeast strains and purification methods are satisfactory.
Both mutant enzymes exhibit a three to fourfold reduction in specific activity 
compared to wild-type PGK. Although the mutation at residue 388 is distant from the 
substrate binding sites it affects the KM values, probably via long-range conformational 
or dynamic changes in the enzyme (Cooper et al., 1989, Johnson et al., 1991, Graham, 
et al., 1991). The Michaelis constants for Mg.ATP and 3-phosphoglycerate with 
H388Q are decreased to 0.12 and 0.19 mM respectively. The R168K mutant enzyme, 
which contains a mutation in the active site region, has higher KM values for both 
substrates (K ^ = 0.79 for ATP and K ^  = 1.79 for 3-PG): implying weaker binding 
compared to wild-type.
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Although the kinetic experiments are easy to perform they give only limited 
information about substrate binding; to obtain the enthalpy of binding a van't Hoff 
approach would be necessary but the accuracy of this technique is low and also of 
dubious validity. Also, in the direction of the assay (from 3-phosphoglycerate and ATP 
to ADP and 1,3-DPG), it is impossible to study the binding of ADP to PGK, or to look 
at the binding of each substrate individually. The remainder of this chapter will be 
concerned with microcalorimetric results and will demonstrate the much greater amount 
of information that can be achieved from a calorimetric approach.
Although flow calorimetry has previously been used in limited studies of 
PGK-substrate associations (Hu & Sturtevant, 1987), the results presented in this thesis 
are the first obtained using titration calorimetry. The first titrations of wild-type PGK 
with substrate solution demonstrated that it was feasible to use microcalorimetry to 
study binding: reasonable titration curves were obtained and these could be analysed to 
give values of N, K, and AH0. To test the accuracy of these experiments, the 
microcalorimetric dissociation constants were compared with dissociation constants 
found in the literature (table 5.1). The calorimetric data for substrate binding to wild- 
type PGK in Tris/MOPS and MES buffer are given in tables 4.4 and 4.5 and data from 
the earlier flow calorimetric measurements are given in table 5.2.
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Table 5.1 D issociation constants fo r  wild-type PG K
The numbers in the table are values, expressed in millimolar units.
Reference Method M g.ADP M g.ATP 3-PG
Scopes, 1978 
(Ionic strength 
= 0 .0 1M)
Equilibrium
gel-filtration
0 .0 1 0.009 0 .0 1 1
Scopes, 1978 
(Ionic strength 
= 0.1 M)
as above 0.04 0.105 0.032
T om pa et al., 
1986
inhibition and 
thiol reactivity 
studies
0.04 0.15 ---
W robel & 
Stinson, 1978
thiol reactivity 
studies
— 2.7 — -
Vas & Batke, 
1984
fluorimetric
titrations
0.15 0.15 0.03
present work 
(Tris/MOPS 
buffer)
calorimetry 0.28 0.15 0.006
present work 
(MES buffer)
calorimetry 0.17 0.15 0.009
The dissociation constants quoted in table 5.1 were m easured using several 
techniques, including thiol reactivity studies (Wrobel & Stinson, 1978) and equilibrium 
gel-filtration (Scopes, 1978b) etc. The dissociation constants vary over a wide range 
and the calorimetric dissociation constants are similar in m agnitude to some of  the 
previously measured values. All the dissociation constants are significantly lower than 
the Michaelis constants even though they should be equal for an enzyme following a 
simple Michaelis-Menten mechanism. However, kinetic experiments with PGK have
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indicated that this enzyme does not follow simple Michaelis-Menten kinetics since the 
Eadie-Hofstee plots are biphasic in the absence o f  ammonium sulphate, thus 40 mM 
ammonium sulphate is usually included in the assay buffer. This alone could be 
responsible for the differences between K M and since anions compete with the 
natural substrates for the binding sites. Other explanations are possible: experiments 
have shown that adenine nucleotides weaken the binding o f  3-phosphoglycerate (Vas & 
Batke, 1984) and there is also a strong possibility that the nucleotides bind at more than 
one site on the enzyme (Fairbrother et al., 1990, Graham & Williams, 1991). Also, the 
Michaelis-Menten approach assumes that the dissociation o f  the enzyme-product 
complex is fast and so the concentration of EP can be ignored in the forward reaction 
(Fersht, 1985), however, it is believed that the very high affinity o f  1,3- 
diphosphoglycerate for PGK means that the dissociation of  the PG K:1,3-D PG complex 
is the rate-determining step in the PGK reaction (Scopes, 1978b). In this case, K M is 
equal to Kd + k .j /k j .  It is not surprising therefore that there are differences between K M 
and K d values for PGK.
The AH0 values measured here can be compared with the values determined 
by flow calorimetry (Hu & Sturtevant, 1987).
Table 5.2 Binding enthalpies determ ined by flo w  calorim etry
Buffer composition
M g.ADP 
AH0 (kJ m o b 1)
Mg.ATP 
AH0 (kJ m o l '1)
3-PG 
AH0 (kJ m o b 1)
50 mM  PIPES 
pH 7.0 
4 mM  Mg CI2
10-4 m M D T E
-39 (3) -31 .6 (0 .07) +15.6 (0.3)
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The enthalpy values for Mg.ATP and Mg.ADP binding are similar to the 
values obtained in MES buffer in this thesis. However, there is a major discrepancy in 
the enthalpy values of 3-phosphoglycerate binding. Hu & Sturtevant observed 
endothermic binding of 3-phosphoglycerate, whereas, measurements conducted in this 
laboratory give unambiguous exothermic binding (table 4.9 present work, Sanders, 
1989). The slight changes in buffer composition (DTE instead of DTT and the absence 
of sodium azide) would not be expected to affect the enthalpy of binding to such an 
extent.
The main aim of this thesis was to compare the thermodynamics of substrate 
binding to wild-type and mutant enzymes in order to assess the effects of the mutations 
on substrate binding. The kinetic studies demonstrated that the KM values for substrate 
binding to H388Q were lower than those observed for the wild-type enzyme. Hence, 
the calorimetric association constants for H388Q should be higher than the association 
constants measured for wild-type PGK. From table 4.7, it can be seen that the 
association constants are higher than for wild-type PGK, but not significantly. The 
enthalpy changes are unaltered for ATP and ADP binding to the mutant enzyme. 
However the enthalpy of binding for 3-phosphoglycerate is somewhat more exothermic. 
We see from these results that the mutation at position 388 does not affect substrate 
binding to a great extent as might be expected for a mutation distant from the active 
site.
The more interesting mutant for molecular recognition studies is R168K, 
which contains a mutation in the active site. The study of R168K is of interest since this 
residue is on the N-domain close to the 3-phosphoglycerate binding site (Walker et al., 
1989). Unfortunately, the plasmids coding for this mutant enzyme appeared to be less 
stable than the plasmids for wild-type and H388Q mutant enzymes: leading to 
difficulties in obtaining suitably large quantities of pure enzyme and therefore only a
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few calorimetric experiments could be conducted. This mutation, as expected, affects 
the substrate binding parameters (table 4.8). The calorimetric binding isotherms when 
fitted with the one set of sites model do not agree well with the calculated curve. The 
difficulties in analysing the titration curves and the difficulties in obtaining large 
quantities of pure enzyme meant that no other experiments were performed with this 
mutant enzyme.
Since no further mutant enzymes were available for study, more detailed 
experiments were conducted with the wild-type enzyme. The 3-phosphoglycerate 
binding experiments were repeated in several other buffer systems and the binding 
parameters were found to vary depending on the buffer system in use, as shown in table 
4.9 The changes in AH0 values can be accounted for by protonation effects. The pKa 
for free 3-phosphoglycerate in solution is 6.84, therefore at pH 7, approximately 50% 
of 3-phosphoglycerate is dissociated. However, 3-phosphoglycerate binds to the 
enzyme predominantly in the ionized form: the pKa changes from 6.84 in solution to 
4.95 when bound to PGK (Wilson et al., 1988). This means that as the substrate binds 
to the enzyme protons are released and taken up by the buffer, producing an additional 
heat effect. This additional heat effect will vary from buffer to buffer depending on the 
heats of ionization of the buffer. A two-step reaction scheme can be written as follows:
(1) 3-PG.H + PGK 3-PG + PGK + H+ 3-PG.PGK + H+
(2) H+ + Buffer —  Buffer.H
The enthalpy change in the absence of protonation effects, AH°0> can be 
calculated using equation 2.21, assuming the pKa of free 3-phosphoglycerate is 6.84 
and that the substrate binds to the enzyme in the fully ionized form. The results are 
shown in table 5.3.
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Table 5.3 A //0^ and AN  values fo r  binding o f  3-phosphoglycerate to wild-type
PG K in different buffer systems
Buffer AH° 0
(k J m o f1)
AN
Tricine, pH 8 -6.4 0.065
Tris/M OPS, pH 7 -5.9 0.41
PIPES, pH 7 -6.3 0.41
MES, pH 6 -6.3 0.87
In the absence of protonation changes, 3-phosphoglycerate binding to PGK has 
a small exothermic enthalpy change which is, in effect, amplified by the uptake of 
protons by the buffer. Because of the importance o f  the protonation effects the AH0 
value measured in piperazine buffer at pH 6  should be the most exothermic, since this 
buffer has a large heat o f  ionization and 87% of 3-phosphoglycerate molecules are 
protonated at this pH. However, this is not the case. A possible explanation for the low 
enthalpy change measured in piperazine buffer, is that this buffer is adjusted to pH 6 
with HC1, whereas, the other buffers have been adjusted to the correct pH with NaOH. 
The chloride ions are present at a high enough concentration that inhibition effects are 
apparent.
Although the enthalpy changes are consistent with the proposed protonation 
changes, the values of the association constant at a given pH should be equal and there 
should be a downwards trend in association constants from pH 8 to pH 6 , since a 
greater proportion o f  3-phosphoglycerate molecules are already ionized at pH 8 . The
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observed association constants do not follow this trend either because o f  experimental 
error or because components of the buffer system (such as the chloride ions in 
piperazine buffer) are also binding to PGK and affecting the association constants.
3-phosphoglycerate is competitively inhibited by various anions which also 
bind to the N-domain o f  PGK. Experiments were performed to determine the effects of 
anions on 3-phosphoglycerate binding parameters. 3-phosphoglycerate titrations were 
conducted in the presence of 1.1 mM ammonium sulphate (table 4.11). Under these 
conditions the affinity constant of 3-phosphoglycerate is reduced to 24800 M ’1. For 
competitive inhibition (both substrate and inhibitor binding at the same site) the 
following relation holds,
K a
K o  =  ------------
i + K , m  ( 5 1 )
where [I] represents the concentration of inhibitor, K ' denotes the apparent associationa
constant and K } is the inhibition constant. Using this equation, a K { value o f  3200 M ’ 1 
can be calculated for the sulphate ion, which is similar to the K^ value o f  3850 M "1 
determined directly by calorimetric titration o f  PGK with amm onium  sulphate (table
4.6)
Some experiments were performed in the presence o f  60 m M  magnesium 
acetate and 60 m M  magnesium chloride (table 4.10) 3-phosphoglycerate did not bind to 
PG K  when the buffer contained 60 m M  magnesium chloride. However, binding was 
observed in the presence of 60 mM magnesium acetate. Using equation 5.1, an 
inhibition constant of 950 M "1 for the acetate ion was calculated from the 3- 
phosphoglycerate parameters. Since binding o f  3-phosphoglycerate appears to be
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completely inhibited by chloride ions it is reasonable to assume that the association 
constant for chloride ions is greater than 950 M’1.
In summary, sulphate, chloride and acetate decrease the values of the 
association constant and AH0 for 3-phosphoglycerate binding to PGK, consistent with 
competitive binding of anions and 3-phosphoglycerate.
The nucleotide substrates, ADP and ATP, bind to the same site on the enzyme. 
This was observed by titrating PGK with ADP in the presence of saturating 
concentrations of ATP and vice versa. No heat effects from binding (only dilution 
effects) were apparent during these titrations and it would therefore appear that the 
binding of these substrates is mutually competitive.
ADP and ATP titrations were also performed in 50 mM PIPES buffer at pH
7.0 to determine if protonation changes take place on binding nucleotide substrates. In 
this buffer it was impossible to obtain a theoretical fit to the data assuming that the 
substrate was binding at one site. This problem arose because of the large difference 
between the heats of dilution of substrate and the heat effects at enzyme saturation. 
After enzyme saturation has occurred, the observed heat effects resulting from injection 
of more substrate into the enzyme should be roughly equal in magnitude to the heat 
effects observed from injection of substrate into buffer. However, although the enzyme 
appeared to be saturated, the heat effects were more exothermic than the dilution heats. 
These effects suggested that the nucleotide substrates are binding at more than one site 
on the enzyme, even though the experiments in MES and Tris/MOPS buffer could be 
analysed assuming 1:1 complex formation.
The true substrates in the PGK catalytic reaction are the magnesium complexes 
of ADP and ATP and so the effect of magnesium ions on nucleotide binding was
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investigated by performing experiments in buffers containing 0, 4, and 60mM 
magnesium acetate and the results are shown in table 4.12.
In the absence of magnesium the binding affinities for ADP and ATP are 
increased. This can be explained if the nucleotide binding is dominated by electrostatic 
interactions between the phosphate groups and positively charged residues in the 
enzyme active site (either the basic patch residues or the lysine residues near the 
hydrophobic binding site): the presence of magnesium reduces the charge of the 
nucleotide and thus decreases the binding affinity.
ATP does not appear to bind to PGK at high concentrations of magnesium 
acetate; probably as a result of anion competition since, at high concentrations, anions 
may bind to the lysine residues near the y-phosphate of ATP, this could have the effect 
of inhibiting the binding of ATP but not the binding of ADP.
The choice of buffer system may also influence nucleotide binding since some 
buffers complex magnesium ions: this would alter the concentration of free magnesium 
ions and hence the binding parameters for the nucleotide substrates.
The titration of PGK with ADP in the presence of 1.1 mM ammonium 
sulphate results in altered binding parameters as shown in table 4.11. The association 
constant is similar in magnitude but the enthalpy change is less exothermic. A more 
substantial effect is observed with ATP. The binding is strongly weakened in the 
presence of 1.6 mM sulphate, with a decrease in association constant from 6610 M"1 to 
approximately 650 M '1. The poor fit to the experimental data in this case means that the 
fitting parameters are not quantitative and large errors in the thermodynamic values, 
especially for AH0, must be expected. These calorimetric results may reflect the 
observations by Scopes, 1978b, where sulphate was found to competitively inhibit the 
binding of ATP but not ADP.
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The formation o f  the dead-end ternary complex, PG K .A D P.3-PG , was studied 
to determine if there is an interaction between the nucleotide and triose binding sites.
(The ternary complex, PG K.A TP.3-PG, could not be studied since the heat o f  reaction 
would obscure the heat o f  binding). There are three ways of  form ing the ternary 
complex:
A. P G K  + A D P — ► PG K .A D P + 3-PG ^  PG K .A D P.3 -PG (tw o  titrations)
B. P G K  + 3-PG — ► PGK.3-PG + ADP — ► PG K .A D P.3-PG  (two titrations)
C. P G K  + A D P + 3-PG — ► PGK.ADP.3-PG (one titration)
In experiments A and B, the enzyme is titrated to saturation with the first substrate and 
then the binary enzyme-substrate complex is titrated with the second substrate. These 
reactions can be written in a thermodynamic cycle as shown in figure 5.1.
AH
PGK -► PGK.ADP
AH.
AH
AH
PG K.3-PG ------------ 3-PG.PG K.A DP
AH
F igure  5.1 T herm odynam ic  cycle f o r  the fo rm a tio n  o f  the  P G K  ternary  co m p lex
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According to Hess's law, the sum of AH0  ^ and AH ° 2 is equal to the sum of AH0  ^ and 
A H °4> which in turn is equal to AH0 .^
The results for the experiments with wild-type PG K  are given in tables 4.14 
and 4.15 and are visualized in figures 5.2 and 5.3. The experiments were also repeated 
with the H388Q mutant enzyme to determine whether the mutation in the hinge region 
affects substrate interactions (table 4.16 and figure 5.4). It is obvious from these results 
that the substrate binding parameters are altered in the presence o f  the other substrate; 
this applies to both the wild-type and the mutant enzyme. A D P weakens the binding of 
3-phosphoglycerate, whereas, 3-phosphoglycerate appears to enhance the binding of 
A D P.
o
a
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o
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<T3
X<
AH AS
I I PGK + ADP 
■ I  PGK.3-PG + ADP 
I I PGK + 3-PG
PGK.ADP + 3-PG
F igure 5.2 Wild-type PGK in M E S bu ffer at p H  6.0
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r ~ l  H388Q + ADP 
■ I  H388Q.3-PG + ADP 
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1  H388Q.ADP + 3-PG
Figure 5.4 II388Q  PGK in M E S  bu ffer at pH  6.0
157
The sums of  A H } + AH0, AH^ + AH4 and AH^ for the wild-type and H388Q 
mutant enzyme are shown in table 5.4. These results are roughly consistent with the 
thermodynamic cycle proposed in figure 5.1 for the experiments in MES buffer but not 
for the experiments in tris/MOPS buffer.
Table  5 .4  Sum s o f  All^ + A//?, A //? + A11 ^  and All,, fo r  w ild-type and H 3 8 8 Q  m utant 
enzym e
A H + AH AI L + A H .3 4 a h 5
Enzym e ( k J m o f 1) ( k J m o f 1) ( k J m o f 1)
W ild-type (MES)
W ild-type
(tris/MOPS)
-32 (0.9) 
-48 (5)
-33 (1.3) 
-26 (6 )
-36 (2) 
not measured
H 388Q -43 (4) -47 (6 ) -41 (4)
There should also be a relationship between the corresponding association 
constants for these reactions i.e,
K 1K 2 = K 3K4 = [P.PGK.A]/{[P][PGK][A]}
since the association constants are defined by
K 1 = [P G K .A ]/[[P G K ][A ]}, K2 = [P.PGK.A]/{[PGK.A][P]}
K 3 = [P .PG K ]/{[PG K ][P]}, K4 = [P.PGK.A]/{[P.PGK][A]}
where [P], [A], [PGK], [P.PGK], [PGK.A] and [P.PGK.A] denote the concentrations of 
3-phosphoglycerate, ADP, the binary complex o f  PGK with 3-phosphoglycerate, the 
binary complex of PGK with ADP and the ternary complex o f  PG K with both 3- 
phosphoglycerate and ADP, respectively.
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The products K jK ^and K 3K4 for wild-type and H 388Q PG K  are given in table 5.5.
Table 5.5 K  K  and K3K4 fo r  w ild-type and H 388Q  PG K
Enzym e K ]K 2 (M -1) K 3K4 (M->)
W ild-type (MES) 
W ild-type (tris/MOPS) 
H 388Q
1.1 (0.4) X  108 
9.3 (2.0) x 107 
5.6 (1.2) x 108
2 .1  (0 .2 ) x 1 0 9
2.1 (0.5) x 109 
4.5 (2.5) x 109
From the results shown in table 5.5, it is evident that there is a large 
discrepancy between K fK0 and K3 K4 for both the wild-type and mutant enzymes. This 
means that the thermodynamic cycle proposed for the formation of the ternary complex 
cannot be correct. The binding of 3-phosphoglycerate is weakened by the presence of 
AD P but the reciprocal effect is not observed, in fact, the binding o f  ADP is apparently 
enhanced by 3-phosphoglycerate. The most probable explanation for this is that ADP is 
binding at two sites on the enzyme; both ADP and ATP have been observed to bind at 
two sites on the enzyme in previous studies (Fairbrother et al., 1990, Graham & 
W illiams, 1991). This introduces an additional step (or several different steps) in the 
thermodynamic cycle and means that the observed association constants for the binding 
o f  A D P are actually composite values for two or more sites. Although the calorimetric 
data in MES and tris/MOPS buffers are consistent with ADP binding at a single site on 
the enzyme, it is possible that there is a second, weak binding site as suggested for the 
binding o f  nucleotides in PIPES buffer.
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These results can be compared with experiments reported by Vas & Batke in 
1984, in which the dissociation constants for the binding of substrates to pig-muscle 
PGK were determined by measuring the change in fluorescence of a PGK-ANS (1- 
anilino-8-naphthalenesulphonate) complex on titration with the substrate. The Kd 
values for each substrate are listed in table 5.2. Adenine nucleotides were found to 
weaken the binding of 3-phosphoglycerate by a factor of about 6.7. This effect is also 
observed in the present work where the association constant for 3-phosphoglycerate is 
decreased by a factor of 5.9 by Mg.ADP. In the study by Vas & Batke, the binding of 
nucleotide substrates was unaffected by 3-phosphoglycerate.
The two possible binding sites for ADP are the hydrophobic site on the C- 
domain and the electrostatic site on the N-domain. There are two ways in which 3- 
phosphoglycerate binding can be weakened: the presence of the nucleotide could be 
displacing the carboxylate group of 3-phosphoglycerate, as proposed by Vas & Batke 
(1984), or there could be competitive inhibition between ADP and 3-phosphoglycerate 
at the N-domain binding site. There is still the possibility that the binding sites may be 
interactive and so the situation is difficult to analyse successfully. However, when the 
nucleotide titrations were re-analysed using the two sets of sites binding model (table
5.6), there was some evidence for two binding sites: a high affinity site (probably the 
catalytic site identified by crystallography) and a low affinity binding site (probably at 
the basic patch).
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Table 5.6 Results o f  a two sets o f  sites analysis o f  the binding o f  A TP  and  AD P to wild- 
type P G K  in 50 m M  tris/M O PS, 4 m M  m agnesium  acetate, 0.1 m M  D TP and 0.05%  
azide at pH  7.0.
ADP ATP
1st binding site Kj ( M '1)
AH0 ! (kJmor1)
2 nd binding site
AH°2  (kJmorl)
44000 (46000) 
-15.9 (1.7) 
2400 (550) 
-41.1 (3.0)
29000 (22000) 
-19.1 (3.0) 
1020 (650) 
-23.8 (9.9)
Table 5.7 Results o f  a two sets o f  sites analysis o f  the binding o f  A TP  and AD P to wild- 
type P G K  in 50 m M  M ES, 4 m M  m agnesium  acetate, 0.1 m M  D TP  and 0.05%  azide at 
p H  6.0.
ADP ATP
1st binding site (M _1)
AH0! (kJmol'l) 
2nd binding site K 2 (M _1)
AH°2  (kJmol'l)
35000 (13000) 
-15.8 (1.3) 
2600 (800) 
-24.8 (1.0)
25000 (3000) 
-19.5 (1.9) 
1500 (700) 
-28.9 (2.8)
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This means that at high concentrations of ADP, the binding of 3-
phosphoglycerate is competitively inhibited by the ADP already bound on the N- 
domain. The endothermic displacement of ADP at this site by 3-phosphoglycerate 
would explain the endothermic binding of 3-phosphoglycerate to the binary PGK-ADP 
complex. If, however, the order of titrations is reversed so that the PGK-3-PG complex
is formed in the first instance, then the binding of ADP to the low affinity site may not
be observed and the resulting binding isotherm would be mainly from binding to the
high affinity site.
This theory could be substantiated by finding a nucleotide analogue which 
would bind to just one binding site, either the C-domain or the N-domain. Therefore, 
the binding of adenosine and tripolyphosphate to PGK was studied. If this approach 
was successful then it would be possible to determine if the binding of 3-
phosphoglycerate is weakened by the binding of a molecule at the C-domain binding 
site or by direct competition with the nucleotide on the N-domain.
If binding on the N-domain is mainly electrostatic then adenosine will be 
unlikely to bind on this domain; it should however bind in the hydrophobic site on the 
C-domain. When the experiment was performed, adenosine was found to bind either 
very weakly to PGK or not at all. It was difficult to achieve a sufficiently high
adenosine concentration because of the low solubility of adenosine in MES buffer; it
was therefore impossible to reach enzyme saturation. After titrating the enzyme with 
adenosine to give a final concentration of 1.4 mM, further titrations with 3- 
phosphoglycerate and ADP were performed. In both cases, the thermodynamic 
parameters were essentially unchanged and so it appears that adenosine did not bind to
[
the enzyme.
i
Ii
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Tripolyphosphate was used as a nucleotide "tail" mimic. Tripolyphosphate is 
unlikely to bind at the hydrophobic site, but since it is negatively charged, it should 
bind on the N-domain, at the general anion binding site. This ligand exhibited high 
affinity binding (table 4.6), significantly higher than other anions studied (sulphate, 
acetate) and there was no evidence of 3-phosphoglycerate binding in the presence of 
tripolyphosphate. Tripolyphosphate (at a concentration of about 0.7 mM) was observed 
to increase the binding affinity of ADP to PGK. The association constant was increased 
to about 10900 M_1 and the enthalpy change was -6.2 kJmol' 1 i.e. tripolyphosphate has 
similar effects on the binding of ADP as 3-phosphoglycerate.
It has been shown earlier that magnesium increases the binding affinity of 
nucleotide substrates, if this is the case then in the absence of magnesium more ADP 
may bind to the N-domain and further inhibit the binding of 3-phosphoglycerate. This 
was demonstrated experimentally and gives further evidence that the binding of 3- 
phosphoglycerate is weakened by competitive inhibition with ADP at the N-domain 
binding site.
In summary, the thermodynamics of substrate binding to PGK has been 
studied in some detail by microcalorimetry. Interpretation of these results has not been 
straightforward since the substrate binding studies were often complicated by 
competition effects involving anions or other substrates. However, some patterns have 
emerged: anions, such as chloride, acetate and sulphate, decrease the affinity of the 
substrates The inhibition effects by anions and the activation/inhibition effects by 
magnesium ions may be important in the regulation of enzyme activity in vivo.
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The bindings of Mg.ADP and 3-phosphoglycerate are not independent: 
Mg.ADP binds with an apparently higher affinity in the presence of 3- 
phosphoglycerate, whereas, the binding of 3-phosphoglycerate is weakened by 
Mg.ADP. The association constant of 3-phosphoglycerate to PGK in the presence of 
Mg.ADP (Ka = 18200, Kd = 0.05mM) is brought closer to the KM value for 3- 
phosphoglycerate measured in the kinetic experiments (0.5 mM). It is possible that in 
the true ternary complex, ATP.PGK.3-PG, the association constant would be further 
decreased and may equal the value of the Michaelis constant. The loosening of 3- 
phosphoglycerate binding might be of significance in the enzyme catalysis process. 
However, loosening of 1,3-diphosphoglycerate binding is probably of more importance, 
since this substrate has a very high association constant of >2 x 107 M*1 (Scopes, 
1978b) and in fact the release of 1,3-diphosphoglycerate is the rate-determining step in 
the enzymic reaction. Unfortunately, this cannot easily be studied by microcalorimetry 
due to the low stability of 1,3-diphosphoglycerate in solution.
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6 VANCOMYCIN AND RISTOCETIN RESULTS
The binding of peptidoglycan precursor peptides and their analogues to the 
antibiotics, vancomycin and ristocetin A was studied by isothermal titration 
microcalorimetry using the Omega system. Solutions of the antibiotics were titrated 
with N-ac-D-ala, N-ac-D-ala-D-ala, di-N-ac-L-lys-D-ala-D-ala and D-ala-D-ala and the 
enthalpy change and association constant for binding were measured. The experiments 
were performed at different temperatures, over a 25 °C temperature span, to allow the 
determination of ACp° values. Since both antibiotics are known to either dimerise or
aggregate in solution, the experiments were performed with two concentrations of 
antibiotic (0.1 mgml' 1 and 0.5 mgml’1). All the experiments were conducted in 0.1 M 
sodium phosphate buffer at pH 7.0. In some cases the thermodynamic parameters were 
dependent on antibiotic concentration, indicating possible dimerization effects.
6.1 N-acetyl D-ala
N-acetyl D-ala forms only weak complexes with vancomycin and ristocetin. 
Increasing temperature weakens binding further, therefore, since antibiotic saturation is 
not achieved under our accessible experimental conditions, there is a higher error in 
AH0 values at high temperatures. The binding parameters at 25 °C for vancomycin and 
N-acetyl D-ala appear to be independent of antibiotic concentration, and titration data 
fit consistently to a simple 1:1 model. The results from the titrations of vancomycin and
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ristocetin with N-acetyl D-ala are given in tables 6.1 and 6.2, with the raw data in 
figures 6 .1  and 6 .2 .
Table 6.1 Thermodynamic parameters o f N-acetyl D-ala binding to vancomycin
a [vancomycin] = 0.5 mgml * 
k [vancomycin] = 0.1 mgml ^
Peptide Temp Ka - A H 0 -AG° - A S 0 -ACp°
(°C) (M '1) (kJmol’1) ( k J m o r 1) (Jm o l '1^ 1) (Jm o l '1^ 1)
Ac-D-alaa 20 369(16) 32.3 (0.5) 14.4 (0.1) 61 (2)
25 296(12) 35.8 (0.5) 14.1 (0.1) 73 (2)
30 221 (18) 36.7 (0.3) 13.6 (0.2) 76(1) 525 (3)
35 187 (8) 38.6(1.1) 13.4 (0.1) 82 (4)
45 105 (8) 46.2 (2.5) 12.3 (0.2) 107 (8)
Ac-D-alab 25 272 (12) 34.2(1.1) 13.9 (0.1) 68 (4)
Table 6.2 Thermodynamic parameters o f N-acetyl D-ala binding to ristocetin
Peptide Temp Ka -AH0 -AG° -AS0 i > ■p o
(°C) (M '1) ( k J m o l 1) ( k J m o r 1) (Jm o l '1^ 1) (Jmol ' k -' )
Ac-D -alaa 2 0 1214(51) 29.9 (0.4) 17.3 (0.1) 43 (2)
25 955 (19) 32.5 (0.5) 17.0 (0.1) 52 (2)
30 620 (26) 35.8 (0.8) 16.2 (0.1) 65 (3) 653 (21)
35 478 (19) 38.7 (1.9) 15.8 (0.1) 82 (6)
45 260 (5) 46.2(1.5) 14.7 (0.1) 99 (5)
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Figure 6.1 Vancom ycin (0.5 m gm l'1) and N-ac-D -alanine at 25 °C
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F igure 6.2 Ristocetin (0.5 m gm l'1) and  N -ac-D -alanine at 25 °C
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6.2 N-acetyl D-ala-D-ala
N-acetyl D-ala-D-ala forms a 1:1 complex with ristocetin at both 
concentrations of antibiotic (see figures 6.3 and 6.4). However, the titration o f  a 0.5 
m g m f 1 vancomycin solution with this peptide results in an unusual binding isotherm 
(figure 6.5). The first few injections are increasingly exothermic and then, as the 
titration progresses, the injections become less exothermic. This is not consistent with 
simple 1:1 complex formation. Reducing the antibiotic concentration to 0.1 mgml"1, 
gave experimental data that could apparently be fitted to a 1:1 model (figure 6.6). The 
therm odynam ic parameters for the binding o f  this ligand to vancomycin are given in 
table 6.3 and in table 6.4 for binding to ristocetin.
Table 6.3 Therm odynam ic param eters o f  N -acetyl D -ala-D -ala binding to vancom ycin
Peptide Temp Ka - A H 0 -AG° - A S 0 "ACp°
(°C) ( M '1) ( k J m o f 1) ( k J m o f 1) ( Jm o l^ K -1) (Jm o l^ K -1)
dipeptideb 20 7701 33.5 (0.4) 21.8 (0.1) 40 (2)
25 6628 35.6 (0.6) 21.8 (0.1) 46 (2)
30 5294 37.7 (0.2) 21.6 (0.1) 5 3 (1 ) 331 (21)
35 4260 39.2 (0.2) 21.4 (0.1) 5 8 (1 )
45 2924 41.8 (0.3) 21.1 (0.1) 6 5 (1 )
1) 1 [vancomycin] = 0.1 mgml
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Figure 6.3 R istocetin (0.5mgm l-J) and N-ac-D-ala-D-ala at 25 °C
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Figure 6.4 Ristocetin (0.1 tnginl'1) and N-ac-D-ala-D-ala at 25 °C
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Figure 6.5 Vancomycin (0.5 m g m l1) and  N-ac-D-ala-D-ala at 25 °C
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Figure 6.6 Vcuicomycin (0.1 mgml-1) and N-ac-D-ala-D -ala at 25 °C
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Table 6.4 Thermodynamic parameters o f N-acetyl D-ala-D-ala binding to ristocetin
Peptide Tem p K a - A H 0 -AG° - A S 0 -ACp°
(°C) ( M '1) ( k J m o f 1) (kJmol"1) (Jm o l^ K -1) (Jm o l^ K -1)
dipeptide3 2 0 33759 31.7 (0.5) 25.4 (0.1) 21  (2 0
25 29508 34.8 (0.8) 25.5 (0.3) 31 (3)
30 22998 38.0 (0.9) 25.3 (0.3) 42 (3) 502 (40)
35 19538 40.6 (0.2) 25.3 (0.1) 5 0 (1 )
45 13789 44.2 (0.6) 25.2 (0.2) 60 (2 )
dipeptideb 25 40754 33.8 (1.5) 26.3 (0.1) 25 (5)
30 35590 36.0 (0.2) 26.4 (0.1) 31 (1) 400 (23)
35 30083 37.8 (0.3) 26.4 (0.1) 3 7 (1 )  .
6.3 D -a la -D -a la
D-ala-D-ala did not appear to bind to vancomycin or ristocetin. The heat 
effects observed in these experiments were very small and equivalent to the heats of 
dilution o f  the ligand.
6.4 Di-N-acetyl L -lys-D -ala-D -ala
The binding isotherm for the titration o f  tripeptide and 0.5 m gm l"1 
vancomycin is not consistent with simple 1:1 binding (figure 6.7) and is similar in 
shape to the binding isotherm of 0.5 mgrnl"1 vancomycin and N-acetyl D-ala-D-ala. All 
the experiments with the tripeptide result in N values less than 1, hence the values for 
AG°, AH0 and AS0 (tables 6.5 and 6 .6 ) are merely statistical fitting parameters, 
although they give an approximate indication of the high affinity o f  this ligand for the 
antibiotics.
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Figure 6.7 Vancomycin (0.5 m gm l'1) and di-N-ac-lys-D-ala-D-ala at 25 °C
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The increased affinity for the tripeptide ligand to vancomycin appears to arise 
from a substantial increase in enthalpy change. Examples of titration experiments with 
this ligand are given in figures 6 .8  to 6 . 1 0 .
Table 6.5 Thermodynamic parameters o f diacetyl-L-lys-D-ala-D-ala binding to 
vancomycin at 25 °C
Ka AH0 -AG° AS0 N
(M -1) (kJmof1) (kJmol )^ ( J m o l 'V 1)
tripeptide a 6 .6  x 1 0 5 57 .6(0 .1 ) 33.2 (0.7) 82 (2 ) 0.89 (0.01)
tripeptide b io X 53.3 (1.1) 32 .6 (0 .1 ) 69 (4) 0.86 (0.05)
a [vancomycin] = 0.5 mgml 
k [vancomycin] = 0.1 mgml '
Table 6.6 Thermodynamic parameters of diacetyl-L-lys-D-ala-D-ala binding to 
ristocetin at 25 °C.
Q  ** 1
[ristocetin] = 0.5 mgml 
k [ristocetin] = 0.1 mgml 1
Ka AM0 -AG° AS0 N
(M -1) (kJinol S (kJmol ) ( J m o f V 1)
tripeptide a 8.1 x 104 39.5 (0.5) 28.0 (0 .2 ) 34 (2) 0.89 (0.01)
tripeptide b 1.4 x 105 38.4 (0.6) 29.4 (0.1) 30 (2) 0.84 (0.01)
kc
al
/m
ol
e 
of 
in
je
ct
an
t 
pc
al
/s
ec
176
Time (min)
0 10 20 30 40 50 60 70
0.00
-3.47
-6.93
-10.40
-13.86
0 5 10 15 20
Injection Number
Figure 6.8 Vancom ycin (0.1 m gm l'1) and di-N-ac-lys-D-ala-D-ala at 25 °C
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Figure 6.9 Ristocetin (0.5 m gm l'1) and di-N-ac-lys-D-ala-U-ala at 25 °C
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Figure 6.10 Ristocetin (0.1 m gm l'1) and di-N-ac-lys-D-ala-D-ala at 25 °C
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6.5 Iica t capacities
The heat capacities quoted in the previous tables were calculated from the 
gradients of best-fit straight lines through the experimental data of  the variation of AH0 
with temperature as shown in figures 6.11 to 6.15.
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F igure 6.11 Enthalpy change versus temperature fo r  vancom ycin (0.5 m gm l'1) and
N-acetyl-D-alanine
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Figure 6.13 E nthalpy change versus temperature fo r  vancomycin (0.1 m gm l'1) and
N-acetyl-D-ala-D-ala
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F igure 6.15 Enthalpy change versus temperature fo r  ristocetin (0.1 m gm l'1) and N-
acetyl-D-ala-D-ala
182
6.6 v a n ' t  H off  en tha lp ies
Van't Hoff enthalpies were calculated from the association constants, measured 
in the calorimetric experiments, by determining the gradients o f  graphs o f  In K versus 
1/T (figures 6.16 to 6.19). The enthalpy values obtained from these calculations are 
given in table 6.7.
Table 6.7 van't H o ff enthalpies
Experim ent van't H off enthalpy
vancomycin a + N-ac D-ala 
vancomycin b + N-ac D-ala-D-ala 
ristocetin a + N-ac D-ala 
ristocetin a + N-ac D-ala-D-ala
-38.7 kJm ol ' 1 
-48.7 kJm ol"1 
-30.7 kJm ol - 1 
-28.9 kJm ol ' 1
a [vancomycin or ristocetin] = 0.5 mgml 
[vancomycin or ristocetin] = 0.1 mgml
183
O Experimental data 
•  Calculated data
  Linear fit to experimental data
  Curve through calculated data
I i I i I i 1 i I__
3.16 3.2 3.24 3.28 3.32 3.36 3.4
\ /T  (x 1 0 '3 K)
Linear fit to experimental data
Curve through calculated data
A Experimental data 
±  Calculated data
F ig u re  6.16 van 't H o f f  p lo t f o r  vancom ycin  (0.5 m g m l'1) a n d  N -acety l D -a lan ine
In K 9.2 
9 
8.8 
8.6 
8.4 
8.2 
8
7.8
3.24 3.28 3.32
1/T (x 10'3 K)
F igure 6.17 van't H o ff  plot fo r  vancom ycin (0.1 m g m l'1) and N-acetyl-D-ala-D-alu
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Figure 6.18 van't H off plot fo r  ristocetin (0.5 mgml'1) and N-acetyl D-alanine
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7 DISCUSSION (VANCOMYCIN & RISTOCETIN)
7.1 Previous studies
The results presented in chapter 6 were obtained from a series of experiments 
studying ligand binding to vancomycin and ristocetin with the aim of extending 
previous thermodynamic studies with these antibiotics. In particular, we wished to 
study the relative binding modes of several peptide molecules to the antibiotics and to 
interpret the results in terms of the molecular interactions formed between the ligands 
and the host molecule.
The types of experiment that have been used in the past to determine the 
thermodynamics of complex formation between vancomycin or ristocetin and ligands 
have included UV difference spectroscopy and titration microcalorimetry. The 
calorimetric titrations, which were used to study the binding of ac-D-ala, ac-D-ala-D- 
ala, ac-gly-D-ala and ac-D-ala-gly to ristocetin and vancomycin at temperatures of 25, 
30 and 37 °C, were carried out with an LKB batch microcalorimeter with titration 
assembly, and an LKB flow microcalorimeter (Rodriguez-Tebar et al., 1986). Some of 
the data from these experiments are shown in tables 7.1 and 7.2.
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Table 7.1 Thermodynamics parameters o f peptide binding to vancomycin (Rodriguez- 
T e b a r e ta i ,1986)
Temp -AG° -AH0 -AS0 -ACp°
(°C) ( k J m o l1) (kJm oF1) ( J m o l^ K '1) (Jm ol^K "1)
Ac-D-ala 25 14.0 (0.3) 30 .6 (1 .2 ) 56 (5)
30 13.9 (0.5) 30.9 (0.8) 56 (4) 93 (15)
37 13.4 (0.4) 31.7 (1.3) 59 (5)
Ac-D-ala- 25 25.8 (0.4) 30 .4 (1 .6 ) 15(6 )
D-ala
30 23.4 (0.6) 33 .4 (1 .8 ) 33 (8 ) 582 (45)
37 20.7 (0.8) 36.5 (1.7) 5 1 (8 )
There are similarities between the work of Rodriguez-Tebar et al. and the 
results presented in chapter 6 : although the magnitude o f  the numbers might not agree 
at least the general trends are the same. For example at 25 °C, acetyl D-ala-D-ala binds 
to both antibiotics with a higher affinity than does acetyl D-ala and both ligands bind to 
ristocetin with higher affinity than to vancomycin. However, the ACp° values vary
significantly between the two studies, possibly due to the generally larger errors 
associated with the AH0  values determined with the LKB calorimeter. Also, these 
experiments (Rodriguez-Tebar et a i, 1986) were performed over a narrower 
temperature range and the antibiotic concentrations are not clearly specified and 
therefore the differences in results could arise from dimerisation effects.
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Table 7.2 Thermodynamics parameters o f peptide binding to ristocetin (Rodriguez- 
Tebar et al., 1986)
Temp -A G ° -AH0 -AS0 i > o
( °C ) ( k J m o r1) ( k J m o f1) ( J m o l^ K '1) (Jm o l^ K -1)
Ac-D-ala 25 17.4 (0.5) 28.3 (1.4) 37 (6)
30 17.2 (0.3) 2 9 .2 (1 .7 ) 39 (7) 332 (59)
37 16.2 (0.3) 3 2 .2 (1 .6 ) 52 (6)
Ac-D-ala- 25 28.8 (0.4) 2 5 .4 (1 .6 ) -11 (6)
D-ala
30 23.4 (0.3) 2 8 .0 (1 .5 ) 1 5 (6 ) 582 (45)
37 20.7 (0.3) 30.1 (1.8) 30 (7)
Another thermodynamic study of antibiotic-peptide complex formation 
involved using UV difference spectroscopy to determine association constants 
(Williamson et al., 1984). The experiments were conducted at four temperatures, 
between 28 and 65 °C, and the enthalpy values were estimated from van't H off  plots. 
The buffer system used in these experiments was 0.02 M sodium citrate at pH 5.0 and 
the results are given in table 7.3. Again, in this study the same general trends are 
observed even though there are numerical differences.
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Table 7.3 UV studies (W illiam son et al., 1984)
dipeptide tri pep tide
Vancomycin AG° ( k J m o f 1) 25.9 (0.4) 35.6 (0.4)
AH° ( k J m o f 1) 32 (8 ) 73 (10)
Ristocetin AG° ( k J m o l 1) 31.4 (0.4) 33 (0.4)
AH0 ( k J in o f 1) ......31-4(8) .............. 42 (8 )
7.2 Present work
The calorimetric experiments clearly show that the binding affinities of the 
ligands to the antbiotics increase as the length o f  the peptide increases, with the 
exception o f  D-ala-D-ala. To rationalize these results, we must consider the known 
structures o f  the antibiotic/ligand complexes (figure 7.1).
represents 
hydrophobic 
interaction
represents 
hydrogen bond 
or salt-bridge
Antibiotic
Figure 7.1 Interactions between ristocetin or vancomycin and N-acetyl D-ala-D
ala
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For example, the complex between the antibiotics and N-ac-D-ala-D-ala is stabilised by 
five hydrogen bonds; three of these are to the carboxylate group and two to amide 
groups in the peptide. The other possibly significant contribution to binding is the 
hydrophobic interaction between the alanine methyl groups and surrounding benzene 
rings of the antibiotic.
In the N-ac-D-ala complex, four of the five hydrogen bonds should still be in 
place, however the hydrophobic interaction with the second alanine methyl group will 
not be present. Hydrogen bond formation is thought to be accompanied by very small 
enthalpic changes but by larger entropic changes and similarly the hydrophobic effect is 
mainly an entropy driven effect. This is qualitatively reflected in the calorimetric 
results: the enthalpy values for ristocetin with N-ac-D-ala and N-ac-D-ala-D-ala are 
very similar, but AS0 is more negative by about 20 Jmol^K’1.
The antibiotic complexes with D-ala-D-ala should involve four hydrogen 
bonds and hydrophobic interactions between the two methyl groups and the antibiotic. 
However, D-ala-D-ala does not appear to bind to either ristocetin or vancomycin. The 
reason for this must presumably be concerned with the free, charged amino group. The 
other alternative is that the peptide does bind but with AH0 approximately equal to zero, 
however, UV difference spectroscopy has also failed to find evidence for complex 
formation.
The heat capacity changes were large and negative for all the 
antibiotic/analogue peptide complexes. The observed negative ACp° values probably 
arise from the transfer of the peptide from water to a more hydrophobic environment 
and from the conformational change which takes place on binding resulting in the 
burial of some hydrophobic side-chains of the antibiotic.
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The ACp° values given in chapter 6 were calculated from the temperature 
dependence o f  the enthalpy changes, however, ACp° can also, in principle, be estimated 
from the degree o f  curvature in the van't Hoff plot. Plotting InK versus 1/T will produce 
a linear relationship with gradient equal to -AH°/R, providing ACp° is equal to zero. If 
ACp° is not equal to zero then a curve is obtained in the van't H off  plot. H ence  it should 
be possible to calculate ACp° values from the association constants de term ined  in the 
calorimelric experiments.
Van't Hoff plots for each antibiotic/peptide complex were constructed using 
the association constants measured in the calorimetric titrations. From inspection of 
these plots, the gradients appear to be linear rather than curved (within experimental 
error). Theoretical curves were drawn on the van't Hoff plots using the AC°p values 
determined from the relationship between AH° and T (see figures 6.16 to 6.19). In 
most cases the experimental and calculated points are similar. The largest deviation 
occurs with ristocetin and N-ac-D-alanine. these van't Hoff plots demonstrate the 
inaccuracy that can arise when using the van't Hoff equation to determine AH° and 
AC°p-
7.3 Dimerisation Effects
It has been documented that free and complexed ristocetin dimerises even at
3 -1low concentrations (Waltho & Williams, 1989). An association constant of 2 x 10 M 
for dimer formation of the ristocetin/tripeptide complex has been calculated from NMR
measurements. Similarly, vancomycin is known to aggregate and an association
2 - 1  f constant for dimer formation of 8 x 10 M" has been proposed (Nieto & Perkins,
1971a). It is possible that the antbiotic-peptide complexes will have different
dimerisation constants compared to the free antibiotics. Ristocetin is believed to form
dimers more readily in the presence of tripeptide since the carboxylate anion can
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interact indirectly with the protonated amine of ristosamine in the other half of the 
dimer (Waltho & Williams, 1991). Also, the hydrogen bonds between the ristocetin 
molecules are more buried from the surrounding water and hence are strengthened 
when the peptide is bound.
Using the dimerisation constants for both antibiotics, it can be estimated that a 
substantial amount of the dimeric species of vancomycin or ristoectin is present at 
concentrations of 0.5 mgml"1, but, when the antibiotic is diluted by a factor of 5, the 
monomeric species is prevalent. However it should be noted that the dimerisation 
constant for ristocetin applies only to the ristocetin/tripeptide complex and not to free 
ristocetin, which may dimerise to a lesser extent. Assuming that the ligands bind 
differently to the dimer than to the monomer, the thermodynamic parameters should 
show concentration dependent differences.
There is some evidence from the calorimetric experiments of dimer formation 
in the case of vancomycin with the peptides, N-acetyl D-ala-D-ala and the tripeptide 
ligand. Unusual binding isotherms are observed at a high concentration of vancomycin, 
whereas, the more usual 1:1 binding isotherms are observed at lower antibiotic 
concentrations. In an attempt to rationalize the binding curves for 0.5mgml-1 
vancomycin with N-ac D-ala-D-ala, the data were analysed using the two sets of sites 
binding model, with the antibiotic concentration set at half its real value (i.e. assuming 
that the antibiotic was fully dimerised). The data could be analysed in this way, but 
only if the peptide binds at one site on the dimer with an endothermic AH0 value and at 
the other site with an exothermic AH0 value. This model was deemed to be 
unsatisfactory in explaining ligand binding to vancomycin (since the antibiotic is 
unlikely to be 100% dimerised and since the two binding sites of the dimer should be
very similar) and an alternative model was proposed. In this new model, it is assumed 
that the ligand is binding to both the monomeric form (giving Kj and AHj) and the
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dimeric form (giving K2 and AH2) of vancomycin and that the dimer binding sites are 
identical. The formation o f  the dimer from two monomers (Kd and AHd) is also 
included in the calculation. Using this model and estimating the various binding 
constants, dimerisation constants and enthalpy values, sample titration data could be 
generated which show very close similarities to the observed titration data. An example 
is given in figure 7.2. In this example the following values were assigned:
Kj = 5000 M -1 AH! = -37 k Jm o l '1
K2 = 100000 M -1 AH2 = -58 kJmol-1
K d = 10 M '1 AHd = 0
It is also possible to calculate the dimerisation constant (Kd>) and enthalpy 
change (AHd-) for the following association, where A represents the antbiotic and X 
represents the ligand:
AX + AX ^  ^  A2X2
This is done using the equations:
Kd. = Kd.K22/ K ,2 and A %  = AHd + 2(AH2 -AH!).
K d' is calculated to be 4000 M _1 and AHd’ is equal to -42 kJmol"1 for the vancomycin-
N-acetyl-D-ala-D-ala example. Hence dimerisation is enhanced by the presence o f  the 
peptide ligand.
Although this model explains the observed titration data, it is not possible to 
obtain the thermodynamic parameters directly from the calorimetric data because o f  the 
large number of variables in the analysis.
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Figure 7.2 Exam ple o f  sim ulated titration data fo r  vancomycin (0.5 mgml~l )
and N-acetyl D-ala-D-ala
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8 CONCLUSIONS
The aim of this thesis was to study the thermodynamics of molecular 
recognition. The first model system, PGK, proved to be a more complex system than 
originally thought. However, microcalorimetry was able to characterize the 
thermodynamic parameters associated with the binding of substrates and ligands to the 
enzyme. The high affinity binding of 3-phosphoglycerate to PGK is mainly entropy 
driven, with a small exothermic contribution to binding. Titrations of PGK with 3- 
phosphoglycerate in different buffer systems yielded an assortment of AH0 and Ka 
values, which can be explained by substrate deprotonation upon binding to the enzyme. 
The release of protons to the buffer during binding gives rise to an additional heat effect 
which is detected by the calorimeter. Several anions were observed to inhibit the binding 
of 3-phosphoglycerate, for example, sulphate, chloride and triphosphate.
The nucleotide substrates appear to bind to PGK at more than one site. The 
binding curves could be analysed assuming either a single binding site or two different 
binding sites but during studies of the formation of the ternary complex, it became 
obvious that ADP must bind to more than one site. One of these binding sites appears to 
be competitive with 3-phosphoglycerate and thus the presence of ADP in the reaction cell 
leads to a significant decrease in the binding affinity of 3-phosphoglycerate.
Two mutant forms of PGK were also studied by microcalorimetry. The 
mutation in the interdomain region of PGK has little effect on the thermodynamics of
195
substrate binding. However as might be expected, the mutation in the active site area 
results in very different thermodynamic behaviour.
The antibiotic model system was an easier system to study by microcalorimetry. 
The binding isotherms, in the majority of cases, could be analysed assuming a single 
binding site per antibiotic molecule. There was a clear trend between binding affinity and 
the length of the peptide ligand. Two concentrations of antibiotic were used during the 
experiments and it was found that the binding parameters for the associations of 
vanomycin with N-acetyl D-ala-D-ala and the tripeptide were dependent on the antibiotic 
concentration. This suggested that the antibiotic was dimerising at the higher 
concentration. The unusual binding curves which were observed in these experiments 
could be simulated assuming that the ligand binds preferentially to the dimer molecule. 
The change in heat capacity associated with binding was measured using two methods: 
the van't Hoff relationship and the dependence of AH0 on temperature. The results for 
ACp° were consistent with a reduction in the hydrophobic surface area accessible to 
solvent upon complex formation.
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Appendix A Protein Engineering
Overview of site-directed mutagenesis
Protein engineering is concerned with the modification of protein structures. 
The aim is to improve the properties of a protein in a specific way i.e. change the 
substrate specificity of an enzyme or increase the stability of a protein. The structure of 
a protein can be altered in several ways: amino acid residues can be modified directly 
by chemical reactants or indirectly by altering the gene encoding for the protein. This 
second technique, protein engineering, enables amino acid residues to be substituted 
with any other naturally occurring amino acid.
The instructions for the biosynthesis of a protein are contained within a 
segment of the DNA called a gene. The gene is first transcribed to produce a 
complementary nucleic acid, messenger RNA, which is then translated into the protein 
chain. Each amino acid is designated by a sequence of three nucleotides (or codon) and 
therefore changing the nucleotide sequence of the codon introduces an amino acid 
replacement: this process is known as site-directed mutagenesis.
Once the gene has been altered it is cloned (reproduced identically) in a 
microorganism. However if a fragment of DNA is inserted directly into a cell it will 
not be replicated since it lacks the necessary coding regions to effect replication. The 
DNA fragment must be joined to another DNA molecule which is capable of directing 
its own replication. The carrier DNA is called a vector.
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Recombinant DNA technology
The methods used in recombinant DNA technology require several key 
enzymes: restriction endonucleases, DNA ligase and DNA polymerase. Genes can be 
removed from a chromosome using restriction endonucleases, and inserted into a vector 
using DNA ligase. This ability to form novel DNA molecules is known as recombinant 
DNA technology.
Restriction endonucleases are enzymes found in bacteria which were 
discovered to be able to kill viruses by splicing the viral DNA. Each enzyme recognises 
a sequence of usually 4 or 6 bases and then cuts the DNA in this region. The 
recognition sequences are symmetrical, that is, there are the same bases in each strand 
but they run in opposite directions. Restriction enzymes may cut in the centre of the 
sequence to give "blunt ends" or several base pairs apart to leave single-stranded tails or 
"sticky ends".
Restriction endonucleases are used in genetic engineering to cut a DNA 
molecule into fragments which can then be separated by gel-electrophoresis and the 
fragment containing the desired gene isolated. Fragments of DNA which have been cut 
with the same restriction enzyme to give complementary sticky ends can be covalently 
joined by DNA ligase. DNA ligase from phage T4 is also able to join molecules with 
blunt ends but with very low efficiency. DNA ligase and the restriction endonucleases 
allow DNA sequences to be recombined in vitro at will.
DNA polymerase I can synthesize double-stranded DNA from a template- 
primer complex. In addition to its 5' to 3' polymerase activity, this enzyme has two 
exonuclease activities: one acting in the 5' to 3' direction and the other in the 3' to 5' 
direction. The Klenow fragment of DNA polymerase I has the polymerase and 3' to 5' 
exonuclease activities only. In the presence of excess nucleoside phosphates, its
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exonuclease activity is suppressed and it can be used to generate double-stranded DNA 
from a single-stranded DNA template and primer.
Vectors
Vectors are usually plasmids or bacteriophages. A plasmid is a small, circular 
molecule of double-stranded DNA with the ability to undergo autonomous replication. 
The requirements of a vector are that it must have single restriction sites and clear 
selection markers. Selection markers are, for example, a resistance to an antibiotic: cells 
that have taken up the plasmid can be identified by plating the culture on media 
containing the antibiotic, only the cells containing the plasmid will be able to grow. 
Plasmids need to be small to increase the efficiency of transformation. A plasmid can 
be used as a cloning vector in two unrelated hosts, this requires two different origins of 
replication and the vector is called a shuttle vector.
The foreign DNA gene is inserted into the plasmid by cutting the DNA 
molecule with a restriction enzyme and then inserting the fragments into plasmid 
vectors cut open with the same enzyme. DNA ligase completes the newly formed 
plasmid. It is possible to achieve over-expression of a protein in the microorganism by 
inserting multiple copies of the plasmid into the cell and so a high yield of the protein 
can be obtained.
Transformation
The recombinants are introduced into the host cell by the process of 
transformation. This requires extreme conditions and is a low efficiency process. The 
selection markers are used at this stage to select colonies which have taken up the
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plasmid. Since all the colonies will not contain the gene of interest a selection 
procedure is required. The host cells can then be cultured and protein extracted.
Site-Directed Mutagenesis
This method allows single amino acid substitutions to be made in any part of 
the protein molecule. The vectors used for site-directed mutagenesis usually are based 
on M l3: a bacteriophage which replicates inside a host cell as double-stranded DNA 
but the DNA is later packaged and passed on as single-stranded DNA which can easily 
be isolated from the phage particles. The double-stranded form of the M l3 vector is 
isolated from infected cells and genes to be cloned are inserted. Single-stranded 
versions of the cloned gene are obtained from the phage particles.
An oligonucleotide, 15-20 bases long, is synthesized; this is easily done using 
e.g. automated solid-state phosphoramidite techniques. This oligonucleotide is 
complementary to the gene around the site of mutation but contains a mismatch at the 
base that is to be mutated. The oligonucleotide hybridizes to the single-stranded DNA 
and then DNA polymerase synthesizes the remainder of the strand. DNA ligase joins 
the ends of the synthetic primer to the new DNA. This vector can now be introduced 
into E.coli and the progeny cells will contain either the wild-type or mutant gene. The 
M13 vector is then isolated, the mutant gene excised, inserted into a suitable vector and 
used to transform an appropriate organism (Zoller & Smith, 1982)(figure A.l).
Comparison of wild-type and m utant enzymes
Once a site-directed mutant has been prepared, its behaviour can be compared 
with wild-type to give an indication of the effect of the mutation. Most mutations are
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designed to delete a single interaction, such as a hydrogen bond or salt-bridge. The only 
difference between the wild-type and mutant enzyme should be at the changed side- 
chain, however, it is possible that the mutant may be structurally altered or incorrectly 
folded and it is therefore necessary to verify the structure of the mutant so that a 
meaningful comparison can be made.
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complementary oligonucleotide  
with mismatch
D N A  polymerase
*
Closed duplex
/  \
R eplication
Wild typeMutant
Figure A.J Strategy fo r  site-directed mutagenesis
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A ppend ix  B Analysis o f  enzym e k inetic  d a ta
The Michaelis-Menten equation (eqn. 1.15) can be re-arranged in several ways 
to give straight-line relationships:
1 1 1
—  = —  —  + — —  Lineweaver-Burk
v vmax v max
[SI _  1 TCM . K M
V _ y  1^1 v  Eadie-Hofstee
V rr\ o v  ▼ rmax vmax
If the kinetic data fitted the Michaelis-Menten equation perfectly then all the 
above plots would yield the same K M and V max values. In practice, because there are 
errors in the results which are distorted differently in each plot, each analysis gives a 
different answer. In this thesis, all three plots were used and the and V max values 
obtained were averaged.
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A ppend ix  C A bb re v ia t io n s
1. A m ino  ac id  a b b re v ia t io n s
A m ino acid 3 letter 
code
1 letter 
code
Am ino acid 3 letter 
code
1 letter 
code
Glycine Gly G Glutamic acid Glu E
Alanine Ala A Glutamine Gin Q
Valine Val V Arginine Arg R
Leucine Leu L Histidine His H
Isoleucine lie I Phenylalanine Phe F
Serine Ser S Cysteine Cys C
Threonine Thr T Tryptophan Trp W
Aspartic acid Asp D Tyrosine Tyr Y
Asparagine Asn N Methionine Met M
Lysine Lys K Proline Pro P
2. B u ffe r  salts
PIPES piperazineN,N'-bis(2-ethanesulphonic acid)
M ES 2-(N-morpholino)ethanesulphonic acid
M OPS 3-(N-morpholino)propanesulphonic acid
Tris tris(hydroxymethyl)aminomethane
TR IC IN E N-tris(hydroxymethyl)methylglycine
TEA triethanolamine
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ABSTRACT
The binding of substrates and various other anions to 
yeast phosphoglycerate kinase (PGK) has been studied by 
titration microcalorimetry. Binding of 3-phosphoglycerate 
to a single high-af f inity site (K ca. 2xl05 ls
entropy driven (AG° « -3 0 kJ mol"1, AH0 - - 6  kJ mol“ , AS0 = 
+80 J K" 1 mol"1), with additional heat effects arising 
from deprotonation of the substrate near neutral pH. This 
binding is inhibited by a range of other anions 
(chloride, sulphate, triphosphate, other substrates), 
probably through competition for the same basic site. 
Nucleotide substrates (ATP and ADP) appear to bind to two 
separate sites on the enzyme, one of which is competitive 
with the phosphoglycerate site and other anions. 
Microcalorimetry of non-productive ternary complex 
formation (PGK:ADP:3-PG) reflects this multiplicity of 
sites. Comparative experiments with two site-directed 
mutants of PGK (His388->Gln and Argl6 8 ->Lys) are also 
reported.
2INTRODUCTION
The thermodynamic forces responsible for biomolecular 
recognition processes and interactions are of fundamental 
interest. Direct measurement of the energetics of ligand 
binding to enzymes under physiological conditions is now 
feasible using the improved calorimetric techniques that 
have recently become available. 1 Phosphoglycerate kinase 
(PGK; EC 2.7.2.3) is a particularly interesting case in 
this regard since it is possible in principle to study 
binding of individual substrate molecules in addition to 
the more usual analogues and inhibitors. PGK catalyses 
reversible phosphoryl transfer between 1,3-diphospho-D- 
glycerate (1,3-DPG) and adenosine diphosphate (ADP) to 
produce 3-phospho-D-glycerate (3-PG, phosphoglycerate) 
and adenosine triphosphate (ATP) in a key step of 
glycolysis. X-ray diffraction studies of the structures 
of PGK from various species2 - 4  have shown that the single 
polypeptide chain is organised into two structurally 
distinct domains of approximately equal size, with 
primary binding sites for nucleotide and glycerate 
substrates located on opposite domains in sites close to 
the interdomain cleft. Mg-ATP or Mg-ADP molecules bind 
competitively in a shallow depression on the C-domain in 
a site typical of a nucleotide fold. Early ambiguities 
regarding the precise location of the phosphoglycerate 
and diphosphoglycerate binding site have recently been 
resolved by studies of the pig muscle enzyme4 which 
confirm that 3-PG binds in a very basic site on the N- 
domain. In view of the distance between these binding 
sites, a hinge-bending model has been proposed for PGK in 
which movement around the waist region (or hinge) between 
the two domains expels water and brings the substrates 
into an orientation and proximity which facilitate 
phosphoryl transfer . 2 ' 3 Whether this arises from 
concerted ligand-induced conformational motion, or simply 
a change in thermal flexibility of the hinge5 - 7  is still 
to be confirmed. Consequently the binding of substrate 
molecules to these separate sites, together with the 
possible interactions between them in ternary enzyme- 
substrate complexes, is of considerable interest. We 
report here on studies of such processes by sensitive 
titration microcalorimetry techniques, using wild-type 
and site-directed mutant enzymes isolated from over­
producing strains of yeast.
MATERIALS AND METHODS
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; yeast, 
EC 1.2.1.12), adenosine (free base), adenosine 5'- 
diphosphate (ADP; monocyclohexylammonium salt), adenosine 
5'-triphosphate (ATP; disodium salt) , reduced /?- 
nicotinamide adenine dinucleotide (NADH), D (—)—3 —
phosphoglycerate (3-PG; disodium salt), and triphosphate 
(pentasodium tripolyphosphate) were obtained from Sigma. 
All other reagents were of AnalaR grade. Wild-type and
3mutant PGKs were prepared in-house from over-producing 
yeast strains, as described below.
Yeast Transformation and Culture
Plasmids pMA27 and pMA40b, containing the wild-type and 
His388->Gln PGK genes respectively (courtesy of Dr. L.A. 
Gilmore) , 8 were used to transform the S.cereviseae host 
Y22 (ade“ , his”, ura”, trp”, met", leu”) using the method 
of Beggs . 9 Transformants were isolated by leucine 
selection and, after full marker analysis, suitable 
colonies were grown in 10 litre batch culture at 3 0°C 
using a medium comprising yeast extract 1 0 g l-1, 
bactopeptone 10 g l” -1 and glucose 20 g l”1. Similar 
procedures were used to prepare Argl6 8 ->Lys PGK using 
yeast cultures supplied by Dr.J. Littlechild. SDS-PAGE 
analysis of crude cell extracts indicated that PGK was 
produced in high yield by all these cells.
PGK Isolation and Purification
PGK was purified from harvested yeast cells as previously 
described10 with the addition of an ion-exchange step 
using DEAE-Sephadex between the (NH4 )2S04 precipitation 
and S-200 gel filtration procedures . 1 1 PGK from the 
(NH4 )2 S04 fractionation was dialysed against lOmM TRIS- 
MOPS pH 7.0, and applied to the DEAE-Sephadex column (2.2 
x 2 0 cm) eluting with this buffer. The enzyme was not 
retained under these conditions and peak fractions were 
pooled and concentrated by (NH4 )2S04 precipitation prior 
to the final S-200 gel filtration stage. Purified protein 
was subsequently stored as an ammonium sulphate 
precipitate at 4*C until use.
PGK Assay
PGK activity was measured at 25 #C in the conventional 
"reverse” direction using the coupled assay of Scopes12  
using a high sulphate, fixed Mg24* concentration 
system . 1 3 ' 14 The assay buffer comprised 30mM 
triethanolamine-HCl, pH 7.5, 40mM (NH4 )2 S04 , ImM Mg 
acetate, 0.15mM NADH and 0.2 mg ml” 1 GAPDH. Substrates 
were prepared in assay buffer separately and contained 
additional Mg acetate at 0.091 and 0.975 mol mol” 1 for 3- 
PG and ATP, respectively, in order to maintain a free 
Mg2+ concentration of ImM . 13 The reaction was initiated 
by the addition of 20 /il of PGK solution to 0.98 ml of 
assay mix and the rate calculated using a millmolar 
extinction coefficient of 6.22 for NADH at 340nm. One 
unit of activity is defined as 1 /mol of NADH oxidised 
min” 1 . 12 Kinetic parameters were derived from least- 
squares analysis of Eadie-Hofstee plots. This assay 
procedure, when allowed to go to completion under the 
appropriate conditions, was also used in occasional 
trials to check the concentrations of substrates in 
experimental mixtures.
4The concentration of PGK (both wild-type and mutants) was 
determined by UV absorbance, using an extinction 
coefficient of 0.495 at 280nm for a 1 mg ml” 1 
solution1 5 ' 16 and assuming a relative molecular mass of 
45000.
Titration Microcalorimetrv
Enzyme-ligand titration isotherms were measured at 2 5°C 
using a Microcal Omega titration microcalorimeter, and 
data were analyzed in terms of various binding schemes by 
non-linear regression using the Microcal ORIGIN software 
package . 1 A typical titration sequence involved 2 0 
injections, at 3 minute intervals, of 5/il aligots of 
substrate (or ligand) solution into the stirred 
calorimeter cell (total volume =* 1.4ml) containing 
appropriate enzyme solution, so that each titration was 
complete in about 1 hour. Control experiments for heats 
of dilution of ligand and enzyme were performed under 
identical conditions and used • for data correction in 
subsequent analysis. Protein samples for microcalorimetry 
(typical concentration about O.lmM, 5 mg ml”1) were 
dialysed extensively against the appropriate buffer, 
centrifuged to remove any undissolved material, and 
briefly degassed prior to loading in the calorimeter 
cell. Known weights of substrate and ligand were 
dissolved in the same dialysis buffer, to minimize 
dilution artifacts, and loaded in the injection syringe 
at typically 10-2OmM concentrations. All experiments were 
repeated at least twice, and usually more, using 
different batches of enzyme. Literature values1 7 ' 18 of 
buffer ionization enthalpies (AHj) were confirmed by 
calorimetric titration with standard HC1. This also 
served to verify the calorimetric calibration.
RESULTS & DISCUSSION
Enzymes isolated here from over-producing strains of 
yeast - necessary to yield the relatively large (gram) 
quantities required for titration calorimetry - were 
homogeneous by SDS-polyacrylamide gel electrophoresis 
analysis and had K^ and specific activity (V™ay) values 
comparable to published data for pgk. 8 ' ' 2 0 In 
particular, the wild-type enzyme typically had a specific 
activity of about 600 units mg” 1 with Km (ATP) = 0.29mM 
and Km (3-PG) = 0.52mM. The mutant enzymes were somewhat 
less active, with Vmax = 13 0 and 150 units mg” 1 for
His388->Gln and Argl6 8 ->Lys mutants respectively. K_ 
values were 0.12(ATP) and 0.19(3-PG), and 0.79(ATP) ana 
1.79(3-PG) mM for His388->Gln and Argl6 8 ->Lys, 
respectively.
Using this material we have examined the binding of three 
substrates (3-PG, ATP, ADP) and other anions (sulphate, 
triphosphate) to PGK by titration microcalorimetry under 
a range of conditions. Most work has concentrated on the
5wild-type enzyme, with parallel experiments in some cases 
using the site-directed His388->Gln mutant PGK and, to a 
lesser extent because of poor expression and reduced 
yield, the Argl6 8 ->Lys mutant for comparison. Non­
productive ternary complexes of PGK with ADP and 3-PG 
have also been examined. Binding studies with the fourth 
substrate, 1 ,3-diphosphoglycerate, were not feasible 
because of its poor stability in water, though some 
experiments containing this as part of an ADP:1,3-DPG 
mixture were done. Examples of typical thermograms, 
illustrating various significant features for titration 
of wild-type PGK with substrate (ATP in this case) are 
given in Figure 1 . Initial injection of substrate to the
enzyme solution gives an exothermic response, under most 
conditions (e.g. Fig.lA), whose magnitude decreases with 
subsequent injections, eventually reaching levels 
representative of simple dilution of the injected ligand 
(Fig.IB), as expected for simple binding to protein 
sites. The heat of dilution of the protein (Fig.1C) is of 
order 5 /xJ per injection, and is usually negligible. The 
integrated heat effects from such experiments, after 
correction for heats of dilution (Fig.ID), can be fit to 
various theoretical binding schemes, including a simple 
1 : 1  complex model which yields both the binding constant 
(K) and enthalpy (AH) for the process. However, it became 
clear during the course of these studies that such a 
model was not always appropriate, especially in 
experiments involving nucleotide binding to the enzyme. 
For example, the best-fit line (single-site model) for 
the ATP binding data shown in Figure ID, shows small but 
significant systematic deviations from the observations. 
Furthermore, the calorimetric titration curves observed 
here for PGK are quite sensitive to ionic strength and 
other anion effects. Consequently we have to take into 
account several competing processes, mainly concerned
with non-specific and/or competitive anion binding in and 
around the enzyme active sites, that complicate detailed 
interpretation, as will emerge in the following
discussion of the binding of individual ligands. As an 
empirical guide, thermodynamic binding parameters 
determined by calorimetry for the various substrates
assuming 1:1 complex formation are summarized in Table 1, 
under a range of conditions for both wild-type and mutant 
enzymes.
Phospoglvcerate Binding
Contrary to previous preliminary observations by other 
workers using less sensitive calorimetric techniques , 2 1  
the titration of wild-type PGK with 3-PG gives an 
exothermic response (Figure 2A) which fits satisfactorily 
to a single binding site model, giving binding parameters 
illustrated in Table 1. These binding parameters are, 
however, very sensitive to the nature of the buffer and 
the presence of other anions. The dependence on buffer 
salts is particularly informative as it reflects changes 
in protonation of the enzyme/ligand system during
6binding . 1 8 ' 2 2 ' 23 Significant differences in measured AH° 
of binding of 3-PG to PGK in different buffers, even at 
the same pH, can be correlated with the different 
enthalpies of ionization of the buffer salts. The pKa (- 
COOH) of phosphoglycerate in solution is about 6.84,2^ so 
a significant fraction will be protonated near neutral 
pH. However nmr , 24 X-ray diffraction , 4 and other 
studies25 indicate that it is the predominantly 
unprotonated carboxylate (-C00-) form of 3-PG that binds 
to the protein active site. Consequently, in a well- 
buffered system near neutral pH, H+ ions must be released 
during binding to be picked up by the conjugate base 
component of the buffer mixture. In a calorimetric 
experiment this gives rise to an additional source of 
heat proportional to the number of protons released (Sv) 
and to the heat of ionization of the particular buffer 
(A H j)  s o  that the observed apparent enthalpy (AHQk s ) is 
given by:-
AHobs 88 AH0 “ 5l/-AHI
where AHq is the binding enthalpy in the absence of 
buffer effects. The data of Table 2 are broadly 
consistent with this. Assuming a pK^ of 6.84 for the free 
ligand, and that only the fully ionized form of 3-PG 
binds to the enzyme, gives consistent estimates for AHq 
of about -6.2 kJ mol”1. Thus most of the exothermicity of 
binding of 3-PG (except at high pH) arises from buffer 
protonation effects and not directly as a consequence of 
the binding interactions themselves. The binding affinity 
of fully ionized 3-PG can be estimated from the high pH 
measurements to be about 2 x 105 M - 1  under these 
conditions, corresponding to a AG° of about -30 kJ mol-1. 
Consequently the binding is mainly entropy driven AS0 - 
+80 J K - 1  mol-1), reflecting possibly the predominantly 
electrostatic nature of the interactions in the basic 
patch region of the protein, involving displacement of 
solvated water molecules . 26
Interestingly, the above analysis seems to imply that the 
effect of changing pH, in the pH 6 - 8 range at least, lies 
solely with the effect on the state of ionization of the 
3-PG ligand, and that no functionally important protein 
groups titrate in this region - at least none that affect 
3-PG binding. As suggested by nmr experiments , 24 it may 
well be that the various histidine side chains in the 
binding site region have anomalous pK's because of the 
strong electrostatic interactions with adjacent groups. 
Unfortunately, further calorimetric investigation of this 
is complicated by a range of non-specific ion effects 
which severely limit the range of buffers available and 
make interpretation ambiguous. In addition to phosphate, 
which is well known to interfere with PGK ligand binding
*1 *7 1  A  O  *7
and kinetics, -LJ' A ' we have shown in trial experiments 
that binding of 3-PG is inhibited by the presence of 
anions such as chloride (Cl-, 10-60 mM) , sulphate (S042-, 
1-2 mM), triphosphate (mainly HP^O104- near neutral pH, 1 
mM) , and in general by increasing ionic strength. Mg2+
7also has an inhibitory effect, possibly due to 
complexation with 3-PG. The sulphate effect is 
particularly interesting, since sulphate is known from
kinetic studies to act both as an activator or , at 
higher concentrations, as an inhibitor of the enzyme 
action . 13 Calorimetric measurements of 3-PG binding under 
standard conditions (pH 6-7) show that Ka for 3-PG falls 
from a value of about 1.4 x 105 M” 1 in the absence of 
sulphate to about 29000 M” 1 in the presence of 1.3 mM
SO4 ” . Assuming simple competitive binding of sulphate 
for the same site on the enzyme, this implies a Ka for 
sulphate binding of about 3 000 M_1, compared to a value 
of about 4000 M”*1 determined by direct calorimetic
titration of PGK with sulphate (see Fig. 4 and discussion 
below) . The apparent heat of binding of 3-PG was also 
reduced to about -7.8 kJ moP* under these conditions, 
consistent with simultaneous displacement of sulphate. No 
3-PG binding could be observed in the presence of ImM
triphosphate, suggesting a Kj > 10000 M ” 1 for this ligand 
consistent with the binding constant of about 60000 M” 1 
determined by direct titration (Fig.4 and below).
The phosphoglycerate binding thermogram is most
dramatically affected by the presence of ADP which, at 
millimolar concentrations, reverses the strong exothermic 
3-PG binding to give a much weaker endothermic effect 
(Figure 3). This is discussed in more detail below in the 
context of ternary enzyme-substrate complexes.
Nucleotide Binding
Binding to PGK of the nucleotide substrates ATP and ADP 
is mutually competitive: that is, calorimetric titration 
of the enzyme with ADP (say) in the presence of 
saturating concentrations of ATP (or vice versa) shows no 
additional heat effect, except at relatively high 
concentrations, confirming that these molecules share the 
same enzyme binding site(s). However, unlike 3-PG 
titration, there is some ambiguity regarding the 
appropriate binding model to be used for analysis. 
Although binding isotherms for Mg.ADP or Mg.ATP under 
standard conditions can in many cases be fit with a 
simple 1:1 complex model (Table 1), there is additional 
evidence (both from our own work on ternary complexes and 
inhibition effects - see below - and from other 
studies14'28'29) that the data are more consistent with 
(at least) two separate binding sites of relatively high 
("site a") and low ("site b") affinities, respectively. 
Consequently, nucleotide binding data have been further 
analysed in terms of a 2 -site model, and parameters are 
given in Table 3 for comparison. In most cases the fit of
the calorimetric data to a 2 -site model is more
satisfactory (for nucleotides) than a single-site 
approximation, and the factor of about 2 0 difference in
apparent binding affinities of the two sites is
compatible with previous estimates . 14 Interestingly, in 
the presence of 3-PG the weaker nucleotide binding site
8was much less apparent, and a single binding site model 
was equally satisfactory.
The more complicated binding pattern for ADP and ATP 
makes detailed interpretation of buffer or ionic strength 
effects difficult. Although there do appear to be some 
differences in thermodynamic binding parameters in 
different buffers at different pH, there is insufficient 
evidence to judge whether these arise from changes in 
protonation of either substrate or protein groups. Again, 
however, the range of buffers and conditions that could 
be examined was limited by non-specific and ionic 
strength effects that interfere with binding at the 
nucleotide site. Binding isotherms were also affected by 
Mg2 + concentrations (it is known that both substrates 
bind in the Mg2 + form2'3), and several non-specific
buffer effects could be ascribed to possible magnesium 
ion complexation by components of the buffer mixture.
Ternary PGK:ADP:3-PG Complexes
Figures 2 and 3 shows examples of typical calorimetric 
results for ternary complex formation. In such 
experiments PGK was first titrated to saturation with one 
ligand (ADP, say) , and then with the second (3-PG; see 
Fig.2C for example), or vice versa (as in Fig.3B), 
following alternate routes to the non-productive ternary 
complex in the thermodynamic cycle shown in Scheme 1. 
Each titration yields apparent K and AH0 estimates, and 
accumulated results - assuming single and separate 
binding sites for each ligand - are given in Table 1.
(SCHEME 1)
When analyzed according to this simple scheme, the 
binding of the two substrates are clearly not independent 
of each other since the presence of one markedly affects 
both the apparent K and AH0 of binding of the other. 
Specifically, binding of 3-PG to PGK in the presence of 
excess ADP gives a small endothermic response (as opposed 
to the exothermic binding in the absence of ADP), and the 
apparent binding affinity is also reduced (K2 < K3) . In 
contrast, although the presence of 3-PG makes subsequent 
binding of ADP less exothermic, the apparent K for ADP 
binding is actually enhanced under these conditions (K4 > 
Kl) .
Although at first sight such results might appear to lend 
support to the notion of major ligand-induced 
conformational change in the protein, there are some 
anomalies about the data as they stand which need 
explanation. Firstly the calorimetric enthalpies do not 
appear to satisfy Hess's law: that is, the sum of the
enthalpies of formation of the PGK:ADP:3-PG ternary 
complex should be the same whatever the order of addition
9of the substrates. Examination of data in Table 1 
(columns 1 + 3 versus 2 + 4) suggests that this is not 
generally the case. Similarly, for thermodynamic 
consistency, K-j_K3 must equal K2K4 (or the equivalent for 
sums of AG°) . But the agreement here is equally 
unsatisfactory: with K2K4 > K 1K3, in general. Although
such differences might conceivably be a result of 
combined experimental error, much more significant is the 
consistent lack of reciprocity in these results. In other 
words, whereas the presence of ADP apparently inhibits 3- 
PG binding (K3 < K2), if we change the order of addition, 
3-PG seems to activate ADP binding (K4 > K-jJ . This cannot 
be consistent with any simple scheme of interacting 
binding sites which requires K3 /K2 = K4 /K1, which is
patently not the case here. Our model must therefore be 
incorrect or incomplete.
A more rational explanation for the above observations 
emerges if we accept (as discussed above) that there are, 
in fact, two separate binding sites for ADP: one high-
affinity site (probably the crystallographically 
identified "active site" on the C-domain) , and a second 
low-affinity site at which ADP binds competitively with 
3-PG. Several consequences would follow from such a 
model. Firstly, in the presence of excess ADP, binding of 
3-PG would be inhibited by ADP already bound at the low- 
affinity site. Moreover, in order for 3-PG to bind, it 
must first displace ADP from this site. This endothermic 
displacement of ADP (ca. +57 kJ mol'* at pH 7, Table 1) 
more than offsets the subsequent exothermic 3-PG binding 
(ca. -15 kJ mor*), to give an apparent endothermic binding 
of 3-PG to form the ternary complex (ADP is still bound 
at the high-affinity site). Reversing the order of 
addition, the presence of excess 3-PG inhibits subsequent 
binding of ADP at its low-affinity site, possibly to such 
an extent that this site is either not observed or 
significantly weakened in these experiments such that we 
see mainly the effect of binding to the high-affinity ADP 
site. In other words, 3-PG apparently activates ADP 
binding by suppressing binding at the low-affinity site.
The values obtained for apparent binding constants and 
enthalpies for ternary complex formation seem to bear out 
this scheme. For example, assuming that ADP binds 
competitively at the 3-PG site with K of order 2500 M” 1 
(Table 3) , titration of PGK with 3-PG in the presence of 
1 mM ADP would be inhibited and would give an apparent 
association constant for 3-PG reduced by a factor of 
order 5 from that observed in the absence of ADP. Prior 
to addition of 3-PG, the low-affinity ADP site would be 
roughly 70% occupied with ADP. The endothermic 
displacement of this would more than compensate the 
(smaller) exothermic effect of binding 3-PG, so the 
overall apparent enthalpy might be of order +15 kJ mol”1, 
in general agreement with observation (Table 1) . 
Conversely, in the presence of millimolar concentrations 
of 3-PG, the relatively high affinity of 3-PG would 
strongly inhibit low affinity binding of ADP (KApp < 20
1 0
M ) , such that only the high affinity binding site of 
ADP would be observed under the titration conditions used 
here.
Given this complexity of binding sites it is, 
unfortunately, not yet possible from these data alone to 
determine whether there is any major interaction between 
the active sites in the ternary complex that might be 
related to catalytic function.
Binding of Other Ligands
Indirect evidence for at least one sulphate binding site 
on PGK comes from its inhibitory effect on 3-PG binding, 
for example (see above). Calorimetric titration with 
sulphate (Fig.4) demonstrates this binding directly, and 
the thermogram may be analyzed in terms of a single,
relatively weak, entropy-driven, ligand binding: K approx 
4000 M”1, AH0 = -7 kJ mol”1, AS0 = +45 J K” 1 mol”1. This 
is consistent with the Kj of about 3 000 M 1 estimated
from sulphate inhibition above.
Direct interaction of triphosphate can also be seen
(Fig.4). Binding in this case is somewhat tighter (K = 
60000 M”1) , but still entropy driven (AH0 =* -17 kJ mol”1, 
AS0 - +35 J K” 1 mol”1). And again this is consistent with 
binding at or near the 3-PG site, with consequent 
inhibition of 3-PG binding, as observed above.
With adenosine, only very weak binding could be detected 
by calorimetry under standard conditions at final ligand 
concentrations up to about 2.5 mM. This supports the 
picture that electrostatic interactions are predominant 
in PGK-ligand binding.
Although binding of 1,3-diphosphoglycerate has not been 
studied directly, because of its lack of commercial 
availability and instability in solution, we have made 
preliminary experiments in forming the catalytically 
active ternary complex. In these experiments PGK was 
titrated with an equimolar mixture of ATP + 3-PG 
containing a trace of PGK, made up immediately prior to 
the start of the experiment, to give an equilibrium
mixture containing ADP + 1,3-DPG. Such titrations (Figure 
4) are exothermic (apparent AH0 - -35 kJ mol'*) , with an 
apparent K of order 2-3 x 104 M”1. This is somewhat
smaller than might have been anticipated from the 
reported very high affinity of 1,3-DPG for PGK , 14 though 
interpretation of this kind of experiment involving 
multiple ligands with several potentially interacting 
binding sites is not straightforward, and the definitive 
calorimetric experiments have yet to be devised.
1 1
PGK Mutants
Calorimetric titration experiments with two site-directed 
mutants of PGK have been performed for comparison with 
the detailed wild-type study. The first of these mutants, 
His388->Gln, involves change of a single amino acid 
remote from the probable active site(s) of the protein, 
but located in the hinge region possibly implicated in 
the hinge-bending mechanism of catalytic activity . 24  
Changing the histidine residue at position 388 to a 
glutamine residue affects a crucial interaction with a 
glutamic acid residue, identified by crystallography, and 
results in possible changes in dynamic flexibility of the 
h i n g e . T h e  Argl6 8 ->Lys mutant, on the other hand, 
is a charge-conservative mutation of a residue involved 
in the 3-PG binding site. Both these mutants are 
catalytically active, but do show differences in binding 
parameters for various substrates (Table 1).
For His388->Gln the overall pattern of substrate binding 
parameters is broadly similar to that of the wild-type 
enzyme, as might be anticipated for a mutation remote 
from the active sites, though there are some quantitative 
differences that might be significant. In particular, 
although the apparent binding affinities and nucleotide 
enthalpies are very similar to wild-type under similar 
conditions, phosphoglycerate binding to this mutant 
appears to be somewhat more exothermic. Binding of 3-PG 
in the presence of ADP to form the ternary complex 
remains exothermic, unlike the endothermic response seen 
with the unmodified enzyme, and the apparent inhibitory 
effect of ADP on 3-PG binding is also reduced. This may 
simply mean that the low-affinity site (site b) has an 
even lower affinity for ADP in this mutant. Alternatively 
this might reflect some changes in overall interaction 
between the two protein domains brought about by mutation 
in the hinge region.
Only a limited number of experiments have been performed 
with the Argl6 8 ->Lys mutant, and the only significant 
change compared to wild-type (Table 1) is a roughly 4- 
fold reduction in binding affinity for 3-PG. This is 
reasonable considering the location of this mutation in 
the phosphoglycerate binding site, where Arg-168 
interacts directly with the phosphate oxygens of 3-PG . 4
Errors
Although the accuracy of calorimetric measurements is 
intrinsically quite high with modern instrumentation, and 
routine calibration of our system yields errors in 
absolute enthalpies of better than ±1 %, there are many 
factors which combine to reduce the real accuracy of 
parameters derived from calorimetric titrations of 
biological molecules as reported here. In particular, 
estimates of binding enthalpies rely on accurate 
knowledge of protein concentration in the experiment,
1 2
which we have determined here using careful 280nm 
absorbance measurements. However, protein molar 
extinction coefficients e28o) are onlY known to ±5%, at 
best , 16 and even this does not take into account any 
inactive, non-binding protein molecules that might arise 
due to partial degradation of the enzyme during storage 
or even during the course of an experiment (though tests 
of enzyme activity before and after calorimetric 
titrations showed no measurable loss of activity in 
occasional trials). Errors in ligand concentration, 
estimated here by weight assuming 1 0 0 % purity and cross­
checked enzymologically and (in the case of nucleotides) 
by AogQ measurements, can give rise to incorrect AH0 and 
K values. This, together with variations observed with 
repeat experiments with different enzyme preparations, 
even assuming that the correct binding model has been 
chosen, suggests that the estimated errors on AH0 are no 
better than ±10%, and that absolute K values are probably 
accurate to within a factor of 2. However, despite these 
relatively large (but realistic) uncertainties in 
absolute values for K and AH, since all data were 
analyzed using the same overall assumptions we can be 
reasonably confident that the overall trends reported 
here are correct.
SUMMARY & CONCLUSIONS
Using direct titration microcalorimetry techniques to 
study substrate binding to yeast phosphoglycerate kinase 
under near-physiological conditions, we have established 
the following:
(1) Binding of 3-phospho-D-glycerate to a single, high 
affinity site on the enzyme is entropy driven (AG° = -30 
kJ mol”1 , AH0 = - 6  kJmol"1, A s 0 = +80 J K" 1 mol”1).
(2) Displacement of hydrogen ions from the carboxyl group 
of 3-PG, to bind as the carboxyate, gives an additional 
exothermic heat effect arising from protonation of buffer 
molecules in solution.
(3) Binding of 3-PG is competitively inhibited by a range 
of anions, including ADP.
(4) Nucleotide substrates, ADP and ATP, bind to two sites 
on the enzyme, one of which is competitive with 3-PG.
(4) Ternary enzyme-substrate complex studies are 
complicated by the multiplicity of nucleotide binding 
sites, and there is no direct calorimetric evidence yet 
for major ligand-induced changes in the protein.
This study demonstrates both the feasibility of direct 
measurement of biomolecular interactions by modern 
calorimetric techniques, and the inherent complexity of 
such processes. In particular, the potential multiplicity 
of competing binding processes, together with the
13
polyelectrolyte nature of both binding sites and ligands, 
makes interpretation of the fundamental thermodynamic 
parameters for such interactions in aqueous systems a 
major challenge.
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Figure Legends
FIG.l: Titration calorimetry for the addition of ATP
(14.9mM, 20 x 5/il injections) to wild-type PGK
(0.115mM) in 50mM Tris/MOPS buffer, pH 7.0, 
containing 4mM magnesium acetate, O.lmM DTT and 
0.05% Na azide, at 25*C. The upper panel shows 
the calorimetric raw data (negative response is 
exothermic) for the titration (A) , together 
with controls for ATP dilution (B) and protein 
dilution (C) under identical conditions. The 
lower panel (D) shows the normalized, 
integrated enthalpy per titration injection, 
after correction for dilution heats, together 
with the best fit line to a single binding site 
model.
FIG.2 (A) Calorimetric response for titration of PGK
(O.lOmM) with 3-PG (lOmM, 15 x 5/iL injections) 
in 50mM MES buffer, pH 6, 25#C, containing 4mM
magnesium acetate, O.lmM DTT and 0.05% Na 
azide. (B) Titration with 3-PG (20 injections) 
under identical conditions, with the addition 
of 1.2mM ammonium sulphate. (C) Titration with 
3-PG (20 injections) as in (A) but with the 
prior addition of ADP (1.3mM) to the sample 
cell mixture.
FIG.3 Normalized integrated heats, corrected for
dilution, for addition of ADP (20mM, 20 x 5/il)
to PGK (O.lmM) in 50mM MES buffer, pH 6, 25#C,
containing 4mM magnesium acetate, O.lmM DTT and 
0.05% Na azide: (A) without 3-PG (open
symbols), (B) in the presence of 0.6mM 3-PG 
(closed symbols) . Data in (A) have been fit 
(solid line) to a 2-site model with parameters 
indicated in Table 3, whereas data in (B) fit 
satisfactorily to a single binding site model 
(Table 1).
FIG.4 Thermograms for binding of assorted ligands to
wild-type PGK (ca. O.lmM) in 50mM MES buffer, 
pH 6, 25*C, containing 4mM magnesium acetate,
O.lmM DTT and 0.05% Na azide: (A) Sulphate (as
ammonium sulphate); (B) triphosphate; (C) an
equimolar, equilibrium mixture of ADP and 1,3- 
DPG (prepared by mixing ATP and 3-PG with a 
trace of PGK immediately prior to the 
experiment).
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2SUMMARY
Isothermal titration (ITC) and differential scanning 
calorimetry (DSC) techniques are now routinely applicable to 
the study of non-covalent interactions in biomolecular 
recognition. Examples from our own current work on peptide 
antibiotic interactions and protein folding illustrate what 
may be achieved. ITC binding studies of vancomycin antibiotics 
with model peptides give information about the thermodynamics 
of group interactions, and also demonstrate possible 
complexities due to ligand-induced aggregation processes. The 
thermal stability of proteins in mixed aqueous solvents, 
studied by DSC, shows how the balance of forces responsible 
for folding stability may switch, without markedly perturbing 
the native structure. Separate experiments on the molecular 
recognition of unfolded polypeptide chains by cyclodextrins is 
consistent with simple binding of these cyclic polysaccharides 
to exposed aromatic groups on the thermally denatured protein.
31. INTRODUCTION
Biomolecular recognition processes rely on a subtle balance of 
non-covalent forces to control conformation and mediate 
binding. The folding of polypeptides and other biopolymers 
into unique conformations constitutes a molecular self­
recognition process in which the system, comprising 
macromolecule plus solvent, recognizes that, for certain 
specific polymer sequences, limited regions of conformation 
space are more favourable. Once folded, these specific 
conformations are then likely to provide specific binding 
sites for the recognition other molecules (ligands) that 
themselves depend on non-covalent interactions. This is 
fundamentally a thermodynamic problem. Although we might be 
able to name the sort of interactions involved (H-bonds, 
hydrophobic, electrostatic, Van der Waals forces, etc.) we, as 
yet, have little success in predicting their relative 
contributions ab initio. This arises because, unlike covalent 
forces that are overwhelmingly enthalpic and can be computed 
with quite high precision, the free energy changes associated 
with non-covalent interactions involve a delicate balance 
between (often large) enthalpic and entropic contributions in 
which solvent molecules play a major role.
There are several consequences of this. From the molecular 
modelling point of view the lack of appropriate 2 -body 
potential functions describing non-covalent forces leads to 
computational difficulties. Indeed, the inherently many-body 
nature of non-covalent interactions means that solvent must be 
explicitly included in any attempts to describe the overall 
energetics. And, indeed, even quite simple changes in solvent 
can alter the balance and nature of the interactions quite 
significantly. For example, as we shall see below, in recent 
work on the folding of a small protein we have shown how 
transfer from aqueous to water/methanol mixtures can change 
the apparent stabilizing interactions from predominantly 
hydrophobic (in water) to predominantly H-bonding (in MeOH 
mixtures) - at least as a first approximation - without 
significantly affecting the native conformation of the protein 
(Woolfson et al.. 1993).
In such a complex theoretical situation it is particularly
4important that we have reliable empirical approaches based on 
measurement of thermodynamic parameters for appropriate 
systems under relevant conditions. Although calorimetry gives 
the most direct thermodynamic information, until relatively 
recently the techniques were rather insensitive and tedious to 
use for most biological systems, and we have had to rely on 
less satisfactory indirect techniques. However, instrumental 
speed and sensitivity has improved dramatically in recent 
years so that direct calorimetric studies of interesting 
biomolecular systems is now routine, and instruments are 
commercially available for both isothermal titration (ITC) and 
differential scanning (DSC) work (Privalov & Potekhin, 1986; 
Sturtevant, 1987; Wiseman et_al., 1989; Wadso, 1991; Cooper & 
Johnson, 1993a,b,c). Here we will illustrate current 
applications and salient points of the technique with some 
recent examples from our own work on topics related to the 
folding and interaction of proteins and peptides, including 
studies on the effects of cyclic polysaccharides 
(cyclodextrins) and non-aqueous solvents on protein stability, 
and (in collaboration with Dr. D.H. Williams and his group) 
measurements on the vancomycin class of antibiotics.
2. ISOTHERMAL TITRATION MICROCALORIMETRY
ITC is used typically to study the thermodynamics of binding 
and other processes that can be initiated by mixing in 
solution. Earlier methods, based on the "heat-leak" principle 
pioneered in the biomolecular field by Sturtevant (1974) and 
Wadso (1983,1991), have been superceded by more recent 
instruments using efficient mixing and active feedback methods 
(Wiseman et al., 1989), or kinetic deconvolution techniques 
(Bastos et al., 1991), that are much faster and rather more 
convenient in use. Typical biomolecular thermal titrations 
involving, say, 2 0 or more injections of ligand into a 
macromolecule solution may now be done in 1 hour, or less, 
using reasonable amounts of material, and with an ultimate 
working sensitivity of the order of 5 /iJ per injection.
Current work in our laboratory includes measurement of enzyme- 
substrate complexes (McAuley-Hecht & Cooper, 1993), protein- 
nucleic acid interactions, and, as described below, peptide 
antibiotic binding.
5(a) Peptide Antibiotic Interactions
The binding of small peptide analogues of bacterial cell wall 
components to the vancomycin class of antibiotics is of both 
clinical and academic interest (Wright & Walsh, 1992), 
providing a potentially simple experimental model for 
biomolecular recognition studies. Dudley Williams and his 
group have done much to clarify the structural details by high 
resolution NMR and are now showing how the basic interactions 
may be broken down into the component parts (Williams et al., 
1990,1991,1993). To complement this work we are now doing 
systematic calorimetric measurements of these binding 
processes in solution.
The experiments are, in principle, relatively straightforward. 
Sequential addition of ligand (peptide) solution to the 
calorimeter cell containing antibiotic (or vice versa) gives a 
series of heat pulses associated with binding. In simple cases 
the size of each heat pulse (after appropriate corrections for 
heats of mixing and dilution) is proportional to the extent of 
complex formation and the enthalpy (AH) of the process. 
Consequently one obtains a thermal titration curve which may 
be analysed to give both AH and the binding constant (K) , 
which immediately leads directly to AG° and AS0. Examples 
showing the isothermal titration microcalorimetry of binding 
of di-N-acetyl-L-Lys-D-Ala-D-Ala (DALAA) to vancomycin under 
various conditions are shown in Figure 1. Measurements at 
different temperatures give the temperature dependence of AH 
(ACp), which may be significant, and data for a range of 
ligands are given in Table I.
Though the range of ligands studied is still far from 
comprehensive, data such as these form the basis for attempts 
to determine the individual functional group components of the 
interaction, and the availability of enthalpy and entropy 
data, in addition to free energy, will be a stringent test of 
such predictions. Some such small group contributions can be 
obtained experimentally. For example, what is the contribution 
of the peptide -C00“ group to the overall interaction ?
Binding of the acetate anion itself is rather too weak to 
measure directly by calorimetry - or, rather, the acetate 
concentrations required in the titration are so high that 
heats of dilution obscure the desired binding heats - but it 
can be determined by competition experiments. Figure 1 shows
6that increasing concentrations of acetate in the reaction 
mixture progressively inhibit binding to vancomycin of the 
much stronger ligand, DALAA. The apparent enthalpy of DALAA 
binding is also reduced, and the effect is seen also with 
other antibiotics. The data are consistent with simple 
competitive binding of acetate and DALAA for the same 
antibiotic binding site, so that titration with DALAA in the 
presence of acetate requires displacement of the acetate, and 
may be analysed to give the acetate binding parameters shown 
in Table I.
Here is not the place to attempt any interpretation of these 
data, but it is important to point out some of the 
complications that can arise. For example, during the course 
of these experiments it became clear that the binding of many 
ligands was not a straightforward process. In particular, the 
apparent K and AH values showed some dependence on total 
antibiotic concentration and, in some cases at higher 
antibiotic concentration, the thermal titration curves showed 
anomalous behaviour (Figure 2) inconsistent with simple 1:1 
complex formation. Such observations suggest that aggregation 
of the antibiotics is significant even at the relatively low 
concentrations used in these experiments (0.04 to ImM), and it 
is for this reason that previous calorimetric measurements 
using less sensitive techniques show some differences with the 
results presented here (Rodriguez-Tebar et al.. 1986; Arriaga 
et al., 1990). Ligand-induced changes in the aggregation state 
of the antibiotics have also been inferred from NMR 
experiments (Waltho & Williams, 1989; Gerhard et al.. 1993). 
The calorimetric observations may be described in terms of a 
simple ligand-induced dimerization or dissociation model 
which, in the simplest case, assumes two identical, non­
interacting binding sites on the antibiotic dimer. This 
involves the following equilibria (A = antibiotic, X = 
ligand):
A + A > to x 
• KD = [A2 ]/[A] 2 a h d
A + X AX ; K x = [AX]/ [A][X] A H X
A2 + X a 2x K2 = [A2X]/[A2 ][X] ah2
a 2x + X - a 2x2 ; K2 = [A2X2 ]/[A2X][X] ; ah2
7and AX + AX ^ A 2X2 ; KD ' = [A2X2 ]/[AX] 2 ; AHd '
Not all these parameters are independent, of course. For 
example:
Kd ' = Kd .K2 2 /K1 2 and AHd ' = AHd + 2 (AH2 - AH1)
which emphasises an important principle of thermodynamic 
linkage (Wyman, 19 64) that, in this case for instance, if 
ligand binding is more favourable to the dimer (K2 > K-^ ) then 
ligand binding will also induce dimerization (KD ' > KD), and 
vice versa.
With so many free variables it has not yet been possible for 
us to obtain unique sets of parameters by fitting the data. We 
can, however, model the observations with physically 
reasonable numbers that may be tested by other kinds of 
experiment. For example, the vancomycin/N-ac-D-ala-D-ala data 
of Fig.2 may be modelled approximately by the following 
parameters:
K-
K-
K i
= 5000 M
=  1 0 0 0 0 0  M
=  10 M
- 1
- 1
-1
AH-j_ = -37 kJ mol- 1  
AH2 = -58 kJ mol- 1  
AHn = 0
giving:
Kd ' = 4000 M - 1  ; AHd ' = -42 kJ mol- 1
This implies that this ligand binds preferentially to the 
vancomycin dimer, and that the relatively weak tendency toward 
dimerization of the free antibiotic is significantly enhanced 
by the presence of peptide ligand. We should emphasise that 
these are model parameters only, but similar order of 
magnitude estimates are found for other ligands studied.
Although we have concentrated here on the observations with 
vancomycin, we have also done most of these experiments with 
other members of the vancomycin family, including ristocetin, 
eremomycin, and derivatives. However, despite their familial 
relationship, their behaviour towards ligand binding can be 
quite different. For example, with ristocetin we also observe 
anomalous concentration-dependent ligand binding isotherms
8but, in this case, the data are more consistent with ligand- 
induced dissociation, rather than the association we see with 
vancomycin. This illustrates the potential complexity of even 
apparently simple molecular recognition systems, and 
emphasises the difficulties in generalizing from one system to 
another.
3. DIFFERENTIAL SCANNING CALORIMETRY
Differential scanning calorimetry is a relatively simple and 
familiar technique involving measurement of the differential 
heat energy uptake in the sample during a change in 
temperature. For systems showing a sharp thermal transition, 
such as lipid bilayer phase changes, DNA/RNA melting, or 
protein unfolding transitions, the resultant peak in excess 
heat capacity may be analyzed to give overall enthalpy, heat 
capacity, and other thermodynamic components of the process. 
The main technical difficulty with biological materials is 
that one ideally needs to work in dilute (< lmg/ml) aqueous 
solutions where the heat capacity of the sample may be 
overwhelmed by that of the water, but specialist instruments 
based on the designs of Privalov and Brandts are available 
(Privalov & Potekhin, 1986; Cooper & Johnson, 1993b).
(a) Protein Folding Forces
Protein folding and unfolding has been extensively 
characterized by DSC studies, in parallel with other methods, 
though the precise balance of thermodynamic forces responsible 
for the stabilization of protein conformations is still 
unclear - see Dill (1990) for review.
Building upon earlier work by Velicelebi & Sturtevant (1979) 
we have recently looked at the thermal unfolding of a small 
protein, ubiquitin, in mixed water/methanol mixtures (Woolfson 
et al.. 1993). High resolution NMR of this protein has shown 
that it retains its native conformation even up to 40% MeOH.
In the absence of methanol, ubiquitin is quite stable, but 
undergoes a cooperative thermal unfolding transition at 
elevated temperatures (Figure 3). The details of this 
endothermic transition are typical of small globular proteins
9in aqueous solution, including the distinctive increase in 
excess heat capacity of the unfolded chain with respect to the 
folded protein. This positive ACp mimics the thermodynamics of 
transfer of organic molecules from non-polar to aqueous 
phases, and is usually taken as the signature of hydrophobic 
stabilization of the folded protein (Kauzmann, 1959). In the 
presence of methanol, although its stability is reduced 
somewhat, the protein still undergoes a cooperative 
endothermic transition but with ACp = 0, in contrast to the 
behaviour in pure water. The transition is also significantly 
more endothermic (AH more positive) than would be expected in 
water at the same temperature. NMR experiments indicate that, 
although thermal unfolding is not apparently as complete as it 
is in water, aromatic side chains do become exposed in the 
high temperature state of ubiquitin in water/methanol 
mixtures. Consequently, although the protein may fold entirely 
adequately in mixed solvents, such folding lacks the 
thermodynamic characteristics of the hydrophobic interaction.
This illustrates, perhaps, some of the important principles 
and major difficulties in describing the thermodynamic basis 
of protein folding. Although much structural emphasis is 
placed on hydrogen bonding within protein structures, the 
thermodynamic contribution of such interactions to the 
stability of the folded protein in water is relatively small 
or non-existent. This is because polar, H-bonding groups 
usually have a strong affinity for water that, in small 
molecules at least, makes them more soluble in water than in 
non-polar environments. Consequently, although it is 
energetically important that all H-bonds be made, it is 
relatively unimportant whether these are intra-molecular bonds 
with other peptide or side chain groups, or inter-molecular 
with solvent water. The tightly packed, extensive H-bonded 
network we see within proteins is a necessary but not 
sufficient thermodynamic condition for folding, and the 
driving force is (probably) provided by the hydrophobic 
contribution. However, replace some of the solvent water with 
less polar molecules, and this balance may change. Hydrophobic 
residues may now favour the unfolded state, exposed to the 
non-polar solvent, but transfer of hydrogen-bonding groups 
would be less favourable because they would now be unable to 
make H-bonds with solvent. As far as the protein is concerned, 
at low temperature, the compact extensively H-bonded structure 
is favourable in either solvent, though the thermodynamic
1 0
characteristics might be quite different. Experimentally it is 
quite difficult to separate different contributions such as 
these since it is impossible to find solvent mixtures that 
change hydrophobicity, for example, without at the same time 
altering hydrogen bond affinities - indeed this is inevitable 
since the "hydrophobic effect" is really only another 
consequence of the hydrogen bond in water.
(b) Molecular Recognition of Unfolded Proteins
The standard picture of the unfolding of a globular protein 
involving exposure of non-polar residues leads directly to a 
simple method to recognise the unfolded state using 
cyclodextrins. These cyclic polysaccharides can bind to a wide 
range of non-polar molecules in water, usually by complexation 
within the relatively hydrophobic cavity of the toroidal 
molecule (Bender & Komiyama, 1978; Saenger, 1980; Szejtli,
1982). The broad specificity of this process is well 
established and has stimulated a wide range of applications, 
including recently such delightful examples as the formation 
of "molecular necklaces" of a-CD molecules threaded onto 
single polymer chains (Harada & Kamachi, 1992), and the 
inclusion of C60 into 7-CD to give water-soluble fullerenes 
(Andersson et al.. 1992). This remarkable versatility prompted 
the thought that cyclodextrins might also affect the thermal 
stability of proteins and other macromolecules (Cooper, 1992). 
Since the unfolding of a globular protein normally involves 
the exposure of buried hydrophobic amino acid side-chains 
(Kauzmann, 1959; Privalov & Gill, 1988), the binding of 
cyclodextrins to these exposed residues might destabilize its 
native conformation by shifting the equilibrium in favour of 
the unfolded polypeptide chain. This indeed appears to be the 
case. Differential scanning calorimetry (DSC) measurements of 
a series of proteins shows that a-CD promotes unfolding, and 
that increasing cyclodextrin concentrations progressively 
reduce the thermal stability of the proteins in a manner 
consistent with weak non-covalent attachment of a-CD molecules 
onto the unfolded chain. This novel means of perturbing 
conformation in solution is proving useful in probing the 
thermodynamics and kinetics of protein folding.
Figure 4 (a)-(d) gives examples of DSC traces showing the 
endothermic unfolding transitions of a representative series
1 1
of proteins in aqueous buffers, with and without a-CD. With 
the exception of PGK, and provided samples are not kept at 
high temperature for too long, all these thermograms are fully 
reversible and are typical of simple cooperative thermal 
unfolding transitions of proteins, a-cyclodextrin reduces the 
mean unfolding transition temperature (Tm ) for all proteins 
examined, and the effect is approximately linear with [a-CD] 
up to saturating concentrations (about 14% w/v at room 
temperature), as illustrated in Figure 5. Similar effects are 
seen with ^-cyclodextrin and with its more soluble 
hydroxypropyl derivative (Fig. 4e).
Two other effects are apparent in Figure 4. Firstly, alongside 
the reduction in Tm there is a consistent decrease in the 
transition enthalpy (AHm ) with increasing cyclodextrin 
concentration. Part of this arises from the normal temperature 
dependence of AHm for globular proteins, which is a 
manifestation of the heat capacity increment (ACp) on 
unfolding (Kauzmann, 1959; Privalov & Gill, 1988). However, 
even when corrected for this effect, the observed transition 
enthalpies are consistently lower than expected at these 
temperatures in the absence of CD, by upto about 4 0 kJ mol”1 
at the highest available concentrations. Secondly, the ACp 
values themselves are also consistently lower in the presence 
of CD, as indicated by the post-transition heat capacity 
baselines (except for PGK where this is obscured by the 
exothermic aggregation of the protein). Both these effects are 
consistent with the binding of cyclodextrin molecules to 
hydrophobic sites exposed on the unfolded polypeptide. Heats 
of complex formation between a-CD and aromatic groups are 
small but exothermic (typically -4 to -2 0 kJ mol”1; Lewis & 
Hansen, 1973; Cooper & MacNicol, 1978) and complex formation 
with such groups on the unfolded polypeptide would both reduce 
the overall transition enthalpy and, by burying these groups 
within the CD cavity, also reduce the ACp effect.
Mole-for-mole, the destabilizing effects of cyclodextrins are 
comparable to or even greater than conventional chemical 
denaturants such as urea or guanidine hydrochloride under 
similar conditions. Unlike urea or GuHCl, however, where the 
denaturing mechanism is far from clear, the cyclodextrin 
destabilizing effect can be described in terms of a quite 
simple binding model.
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Assume, for simplicity, that there are n identical and 
independent ligand (L) binding sites exposed when the native 
protein (N) undergoes the 2-state transition to the unfolded 
state (D). The unfolding transition may be described by the 
simple equilibrium:
N * D : K0 = [D]/[N]
with subsequent ligand binding given by:
D + L 55 DL : K = [DL]/[D][L]
DL + L 55 DL2 : K = [DL2 ] / [DL] [L]
D L j ^  + L 55 DLn : K = [DLn] / [DLn-1] [L]
where K is the intrinsic binding constant for ligand at any 
one site. Following standard methods, and bearing in mind the 
combinatorial factors, one may derive an overall apparent 
equilibrium constant for the unfolding process:
KApp = W t o t / W t o t  = K0 (l + K[L])n
which shows, as expected, that unfolding of the protein is 
promoted by increasing ligand concentrations. For the 
interpretation of DSC experiments, this is best expressed in 
terms of the effect on Tm , the mid-point temperature of the 
transition, obtained as follows.
The Gibbs free energy of unfolding at any temperature (T) is 
given by:
AG = —RT • lnKApp
= AG0 - nRT. In(1 + K[L]) ....... Equ. (1)
where R is the gas constant, and AGq = -RT.lnK0 is the free 
energy of unfolding in the absence of ligand. This may be 
further expressed in terms of the enthalpy of the transition 
(AHq ) at the mid-point temperature (Tm0) in the absence of 
ligand:
13
AG0 =  AHq ( 1  -  T / T m 0)
(Ignoring, for simplicity, any possible temperature dependence 
of the enthalpy. This is a reasonable approximation over the 
narrow temperature ranges considered here, but ACp effects may 
be incorporated if required.)
In the presence of ligand, the mid point of the unfolding 
transition will occur at temperature Tm when, by definition,
AG = 0. Re-arrangement of Equ.(1) under these conditions 
gives:
ATm/Tm = -(nRTm0/AH0) .ln(l + K[L])  (2)
where ATm = Tm - Tm0 is the shift in transition temperature of 
the protein brought about by the presence of ligand.
At low concentrations, with a weakly-binding ligand (K[L] <<
1) , this takes on the approximate linear form:
= -nKRTm02.[L]/AH0 --- (3)
These simple expressions allow one to estimate the number of 
ligand binding sites and their average intrinsic binding 
constants.
{Equivalent expressions for a model in which ligand binds to 
the native, rather than unfolded form of the protein are 
identical to Equ.2 & 3, except for a change of sign.}
Figure 5 shows data for three different proteins plotted 
according to Equ.2, from which one may estimate the apparent 
numbers of binding sites and binding constants listed in Table
II. Despite the simplifying assumptions, it is clear that this 
basic model is reasonably successful in explaining the 
observations, with estimates of n comparable to the number of 
available aromatic side-chains in these proteins and with weak 
K values expected for such cyclodextrin complexations at 
higher temperatures (Cooper & MacNicol, 1978).
Further work in this area is concentrating on the effects of 
these and chemically-modified cyclodextrins on the kinetics 
and reversibility of folding, and the use of polymerised
14
! cyclodextrins both to improve the recognition selectivity and 
to separate folded and unfolded proteins by chromatographic 
techniques.
4. EXPERIMENTAL METHODS
Calorimetric experiments reported here were done using 
Microcal MC2-D (DSC) or Omega (ITC) instruments as described 
elsewhere (Cooper, 1992; Cooper & Johnson, 1993a,b,c; McAuley- 
Hecht & Cooper, 1993), and analyzed using the ORIGIN suite of 
programs from Microcal Inc. Proteins, peptides, and 
cyclodextrins were from commercial suppliers (Sigma, Aldrich), 
with the exception of some modified peptides and antibiotics 
courtesy of Dr. D.H. Williams and his group. Protein 
concentrations were determined from 280nm absorbance 
measurements (Gill & von Hippel, 1989).
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FIGURE
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig.  5
LEGENDS
Isothermal calorimetry data for the titration of 
vancomycin (0.3mM) with 2 0 x 5/il injections of N,N'- 
diacetyl-L-lys-D-ala-D-ala (7mM) in 0.1M phosphate 
buffer, pH 7, at 25*C. The upper part of the figure 
gives the raw data showing the sequence of 
exothermic heat pulses for three separate titrations 
at different acetate concentrations. The lower 
figure gives the integrated heat energy per 
injection, together with theoretical fits to each 
thermal titration curve, illustrating the 
competitive inhibition by acetate. The reaction cell 
volume of the calorimeter is about 1.4ml.
ITC data for binding of N-acetyl-D-ala-D-ala to 
vancomycin at 25*C, pH 7. Each experiment consists 
of an identical sequence of 20 x 5/il injections of 
peptide ligand (12.3mM) into vancomycin solutions at 
three different concentrations (0.112, 0.3 69, and 
l.llmM).
Baseline-corrected DSC data for the thermal 
transition of ubiquitin in aqueous buffer (N/U) and 
4 0% methanol/water mixtures (N/A).
(a)-(d) DSC data for the thermal unfolding of 
proteins in the absence (dotted lines) and presence 
(solid lines) of a-cyclodextrin. (e) shows similar 
data for lysozyme with various concentrations of 
hydroxypropyl-0-cyclodextrin.
The decrease in thermal transition temperatures 
(ATm ) as a function of a-cyclodextrin concentration 
for three different proteins. The lines are non­
linear regression fits to equ.2 with the parameters 
given in Table II.
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